JP5751660B2 - Antibacterial device and antibacterial method for electronic device - Google Patents

Antibacterial device and antibacterial method for electronic device Download PDF

Info

Publication number
JP5751660B2
JP5751660B2 JP2010214611A JP2010214611A JP5751660B2 JP 5751660 B2 JP5751660 B2 JP 5751660B2 JP 2010214611 A JP2010214611 A JP 2010214611A JP 2010214611 A JP2010214611 A JP 2010214611A JP 5751660 B2 JP5751660 B2 JP 5751660B2
Authority
JP
Japan
Prior art keywords
drug
antibacterial
medicine
application surface
drug application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010214611A
Other languages
Japanese (ja)
Other versions
JP2011092700A (en
Inventor
康二 内田
康二 内田
健一 内田
健一 内田
Original Assignee
株式会社地球大気航空
康二 内田
康二 内田
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社地球大気航空, 康二 内田, 康二 内田 filed Critical 株式会社地球大気航空
Priority to JP2010214611A priority Critical patent/JP5751660B2/en
Publication of JP2011092700A publication Critical patent/JP2011092700A/en
Application granted granted Critical
Publication of JP5751660B2 publication Critical patent/JP5751660B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Apparatus For Disinfection Or Sterilisation (AREA)

Description

この発明は、電子機器の抗菌処理を行なう電子機器の抗菌装置および電子機器の抗菌方法に関するものである。   The present invention relates to an antibacterial device for an electronic device that performs antibacterial treatment of the electronic device and an antibacterial method for the electronic device.

近年、携帯電話や携帯情報端末(ＰＤＡ)等を始めとする各種携帯型の電子機器が広く普及している。この携帯型の電子機器は、手で持って操作したり、身体に接触させて使用するものが多い。例えば携帯電話は、手に持って耳に当てながら会話をするものである。このため携帯電話は、皮脂、手垢、唾液および汗等がキー(ボタン)部分や液晶部分の周囲等の窪み部分に付着して、これによる汚れが蓄積され易くなっている。また、携帯型の電子機器は、食事中は勿論、トイレ内や洗面所内等に持ち込んで使用されることもあり、ドアノブ、靴、トイレの便座等よりも多くの細菌が生息する場合もあり得ることが調査研究等で報告されている。従って、携帯型の電子機器においては、細菌の増殖を抑えることが希求されている。   In recent years, various portable electronic devices such as mobile phones and personal digital assistants (PDAs) have become widespread. Many of these portable electronic devices are operated by being held by hand or in contact with the body. For example, a mobile phone is a conversation that is held in the hand and placed on the ear. For this reason, sebum, hand dirt, saliva, sweat, and the like adhere to the recessed portions such as the periphery of the key (button) portion and the liquid crystal portion, so that dirt due to this easily accumulates. In addition, portable electronic devices may be used not only during meals but also in toilets and washrooms, and may have more bacteria than door knobs, shoes, toilet seats, etc. This has been reported in research studies. Therefore, there is a demand for suppressing the growth of bacteria in portable electronic devices.

前述した細菌の増殖を抑える方法として、各種製品の製品製造時に抗菌処理を施す方法が実施されている。この抗菌処理としては、製品製造の完成前に行なう「前加工方法」と完成後に行なう「後加工方法」が挙げられる。前加工方法としては、合成樹脂や合成繊維等の原料に抗菌剤を混ぜ込む方法が挙げられる。また後加工方法としては、抗菌剤入りの樹脂でコーティングする方法や、抗菌剤に製品を浸したり該抗菌剤を製品に吹付ける方法等が挙げられる。しかるに前記抗菌処理は、抗菌剤が製品の外面に露出している部分だけが抗菌効果があり、製品の外面に汚れが付着した場合には抗菌効果が大幅に低下する欠点がある。従って、抗菌処理を施した電子機器であっても、使用中の細菌の増殖を抑えることは困難であり、適時に抗菌処理を行なう必要がある。特に、最近の新型インフルエンザの発生により、手で使う電子機器には一層の抗菌処理が希求されている。しかし、携帯電話等の電子機器は、防水処理が施されていないものが殆どであり、水や液体薬剤等を直接付与して洗浄することはできない。   As a method for suppressing the growth of bacteria described above, a method of performing antibacterial treatment at the time of manufacturing various products has been implemented. Examples of the antibacterial treatment include a “pre-processing method” performed before completion of product manufacture and a “post-processing method” performed after completion. Examples of the pre-processing method include a method of mixing an antibacterial agent with raw materials such as synthetic resin and synthetic fiber. Examples of the post-processing method include a method of coating with a resin containing an antibacterial agent, a method of immersing the product in the antibacterial agent, and a method of spraying the antibacterial agent on the product. However, the antibacterial treatment has a drawback that only the portion where the antibacterial agent is exposed on the outer surface of the product has an antibacterial effect, and when the dirt adheres to the outer surface of the product, the antibacterial effect is greatly reduced. Therefore, even in an electronic device that has been subjected to antibacterial treatment, it is difficult to suppress the growth of bacteria during use, and it is necessary to perform the antibacterial treatment in a timely manner. In particular, due to the recent outbreak of new influenza, further antibacterial treatment is desired for electronic devices used by hand. However, most electronic devices such as mobile phones are not waterproofed and cannot be cleaned by directly applying water or liquid chemicals.

そこで、液化発香性消毒剤を吸収させたスポンジ状の吸着布をハウジングに内装して、携帯電話をこのハウジング内に収容することで殺菌処理を行なうようにした携帯電話用の殺菌装置が提案されている(例えば、特許文献１)。この殺菌装置は、吸着布に前記消毒剤を染み込ませておき、ハウジング内に携帯電話を収容して、消毒剤が含まれたハウジング内の空気と携帯電話とを接触させることで、該携帯電話の殺菌処理を行なうようになっている。   Therefore, a mobile phone sterilization device is proposed in which a sponge-like absorbent cloth that absorbs a liquefied fragrant disinfectant is housed in a housing, and the mobile phone is housed in the housing for sterilization. (For example, Patent Document 1). In this sterilization apparatus, the disinfectant is impregnated in the adsorbent cloth, the mobile phone is accommodated in the housing, and the mobile phone is brought into contact with the air in the housing containing the disinfectant. The sterilization process is performed.

特開２００７−３０７３７４号公報JP 2007-307374 A

前記特許文献１の殺菌装置は、複数回の殺菌処理を行ない得る量の消毒剤(薬剤)を予め吸着布に染み込ませておき、薬剤を補給することなく長期間に亘って使用し得るようになっている。このため特許文献１の殺菌装置は、長期間に亘って吸着布に薬剤を保持するので、該薬剤の蒸発を防止するための蓋部をハウジングに設ける必要がある。しかし、非殺菌処理時の殺菌装置の設置場所(保管場所)が各ユーザー毎に異なり、ハウジングを蓋部で覆蓋する構造であっても、ハウジング内の温度の変化や湿度等による水分および空気との接触等により薬剤が変質または分解する。すなわち、特許文献１の殺菌装置では、吸着布に染み込ませた薬剤が劣化すると、殺菌効果が低下して携帯電話の殺菌処理を効率的に行なうことができなくなる欠点がある。また、蓋部を開放する度に気化した薬剤がハウジング外へ飛散してしまうため、携帯電話の殺菌に使用されることなく飛散する薬剤があり、薬剤の無駄が発生してランニングコストが嵩む問題もある。更に、吸着布の内部に染み込んだ薬剤は、気化し難いので携帯電話の殺菌に時間がかかり殺菌効率が低下する不都合がある。   The sterilization apparatus of Patent Document 1 is preliminarily soaked in an absorbent cloth with an amount of disinfectant (medicine) that can be sterilized multiple times, so that it can be used for a long time without replenishing the drug. It has become. For this reason, since the sterilization apparatus of patent document 1 hold | maintains a chemical | medical agent to an adsorption | suction cloth for a long period of time, it is necessary to provide the cover part for preventing evaporation of this chemical | medical agent in a housing. However, even when the installation location (storage location) of the sterilization device during non-sterilization treatment is different for each user and the housing is covered with a lid, moisture and air due to temperature changes and humidity in the housing The drug is altered or decomposed due to contact with water. That is, the sterilization apparatus of Patent Document 1 has a drawback that when the medicine soaked in the absorbent cloth deteriorates, the sterilization effect is lowered and the mobile phone cannot be sterilized efficiently. In addition, since the vaporized medicine is scattered outside the housing every time the lid is opened, there is a medicine that is scattered without being used for sterilization of the mobile phone, resulting in waste of the medicine and increasing running costs. There is also. Furthermore, since the medicine soaked into the absorbent cloth is difficult to vaporize, it takes time to sterilize the mobile phone, resulting in a disadvantage that the sterilization efficiency is lowered.

そこで本発明は、従来の電子機器の殺菌装置に内在する前記問題に鑑み、これを好適に解決するべく提案されたものであって、電子機器の抗菌処理を効率的で低コストかつ適切に行なうことができる電子機器の抗菌装置および電子機器の抗菌方法とを提供することを目的とする。   Therefore, the present invention has been proposed to solve the above-mentioned problems inherent in the conventional electronic device sterilization apparatus, and it is an efficient, low-cost, and appropriate antibacterial treatment for electronic devices. It is an object to provide an antibacterial device for an electronic device and an antibacterial method for an electronic device.

前記課題を解決し、所期の目的を達成するため、本願の請求項１に記載の発明は、
電子機器を抗菌処理する抗菌装置であって、
本体に配設され、抗菌成分を含む液状の薬剤の浸透が不能な薬剤付与面を有する薬剤付与部と、
前記本体および前記薬剤付与部の少なくとも一方に設けられ、前記電子機器を前記薬剤付与面から離して該薬剤付与面に正対するよう支持する支持手段と、
前記薬剤付与部とは別体に構成され、前記薬剤を前記薬剤付与面に広げる薬剤拡張手段とを備え、
前記薬剤付与部は、前記支持手段で支持された前記電子機器に前記薬剤付与面が対向するよう前記本体に配設され、
前記薬剤拡張手段は、前記薬剤付与面と対面可能な押付面を有し、回転支持手段により、前記薬剤付与面に滴下した薬剤の液滴より狭い案内空間を設けて該薬剤付与面に該押付面が対向する近接位置と、該押付面が該薬剤付与面から離間した退避位置との間で回転変位可能に前記本体に配設され、
前記薬剤拡張手段は、前記薬剤付与面に滴下した薬剤を、前記回転支持手段による該薬剤拡張手段の前記近接位置への回転変位により、薬剤付与面と前記押付面とで挟圧して該薬剤付与面へ広げるよう構成し、
前記薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、前記支持手段で支持した前記電子機器を抗菌処理するよう構成したことを要旨とする。 In order to solve the above problems and achieve the intended purpose, the invention according to claim 1 of the present application provides:
An antibacterial device for antibacterial treatment of electronic equipment,
A drug application portion disposed on the main body and having a drug application surface incapable of penetrating a liquid drug containing an antibacterial component;
A support means provided on at least one of the main body and the drug application section, and supporting the electronic device so as to face the drug application surface away from the drug application surface;
The drug application unit is configured separately from the drug application unit, and includes a drug expansion unit that spreads the drug on the drug application surface ,
The drug application part is disposed in the main body so that the drug application surface faces the electronic device supported by the support means,
The drug expansion means has a pressing surface that can face the drug application surface, and the rotation support means provides a guide space that is narrower than a drug droplet dropped on the drug application surface, thereby pressing the drug application surface. Disposed on the main body so as to be rotationally displaceable between a proximity position where the surfaces face each other and a retreat position where the pressing surface is separated from the drug application surface;
The drug expanding means is configured to apply the drug by dropping the drug dropped on the drug applying surface between the drug applying surface and the pressing surface by rotational displacement of the drug expanding means to the proximity position by the rotation support means. Configured to spread to the surface,
The gist is that the electronic device supported by the support means is subjected to antibacterial treatment with an antibacterial component contained in the drug vaporized from the drug spread on the drug application surface .

請求項１〜５に係る発明によれば、薬剤付与部の薬剤付与面に付与した液状の薬剤を、該薬剤付与面に浸透させることなく、薬剤拡張手段により薬剤付与面に簡易かつ適切に広げることができる。そして、薬剤付与面に広げた薬剤に被抗菌処理部分が正対するよう電子機器を支持手段で支持し得るので、気化した薬剤の抗菌成分を該被抗菌処理部分に適切に接触させることができ、大気に開放した状態でも電子機器の抗菌処理を効率的に行なうことを可能とする。また、薬剤付与面に広げた薬剤が該薬剤付与面に浸透しないので、該薬剤の気化を促進することを可能とすると共に、抗菌処理毎に必要とされる薬剤の量を少なくしてランニングコストを抑え、電子機器の抗菌処理を低コストで行なうことを可能とする。更に、薬剤付与面に薬剤が残って劣化しないので、薬剤の無駄を防止できると共に、抗菌処理を実施する毎に抗菌効果が高い(抗菌効果が低下していない)新しい薬剤を使用して抗菌処理を適切に行なうことができる。更にまた、支持手段に支持された電子機器と液状の薬剤とが接触しないので、該薬剤が電子機器内へ侵入することによる該電子機器の故障を防止し得る。
特に請求項１に係る発明によれば、薬剤付与面に滴下した薬剤を、薬剤拡張手段を回転変位させて該薬剤拡張手段の押付面と薬剤付与部の薬剤付与面とで挟圧することで、該薬剤を薬剤付与面に広げることができる。従って、少ない量の薬剤を使用して電子機器の抗菌処理が可能であり、薬剤の無駄な使用を防止して経済的である。また、抗菌装置に多量の薬剤を補給しないので、薬剤の劣化を防止し得ると共に、薬剤の劣化による抗菌処理の不良を防止することができる。そして、薬剤拡張手段を姿勢変位させるだけの操作により、薬剤付与部の薬剤付与面に薬剤を簡単かつ適切に広げることができる。 According to the invention of 請 Motomeko 1-5, the drug liquid was applied to the drug imparting surface of the drug deposition unit, without infiltrating agent imparting surface, easily and properly to the drug applied surface by drug expansion means Can be spread. And since the electronic device can be supported by the support means so that the antibacterial treatment part faces the drug spread on the drug application surface, the antibacterial component of the vaporized drug can be appropriately brought into contact with the antibacterial treatment part, It makes it possible to efficiently perform antibacterial treatment of electronic equipment even in a state where it is open to the atmosphere. In addition, since the drug spread on the drug application surface does not penetrate the drug application surface, it is possible to promote the vaporization of the drug and reduce the amount of drug required for each antibacterial treatment, thereby reducing the running cost. This makes it possible to perform antibacterial treatment of electronic equipment at a low cost. Furthermore, since the drug remains on the drug application surface and does not deteriorate, it is possible to prevent the waste of the drug, and antibacterial treatment using a new drug that has a high antibacterial effect (no decrease in antibacterial effect) every time the antibacterial treatment is performed. Can be performed appropriately. Furthermore, since the electronic device supported by the support means does not come into contact with the liquid medicine, it is possible to prevent the electronic equipment from being broken due to the medicine entering the electronic equipment.
In particular, according to the first aspect of the present invention, the drug dropped on the drug application surface is subjected to rotational displacement of the drug expansion means and sandwiched between the pressing surface of the drug expansion means and the drug application surface of the drug application unit, The drug can be spread on the drug application surface. Accordingly, an antibacterial treatment of an electronic device can be performed using a small amount of medicine, and it is economical to prevent wasteful use of the medicine. Further, since a large amount of drug is not replenished to the antibacterial device, it is possible to prevent the deterioration of the drug and prevent the antibacterial treatment from being poor due to the deterioration of the drug. Then, the medicine can be easily and appropriately spread on the medicine application surface of the medicine application section by the operation of merely displacing the medicine expansion means.

請求項２に記載の発明は、電子機器を抗菌処理する抗菌装置であって、
本体の上面に設けられたシートセット部と、
前記本体と別体のシート状に形成されると共に、抗菌成分を含む液状の薬剤の浸透が不能な薬剤付与面を有し、該薬剤付与面が傾斜するように前記シートセット部に沿わせて配設される薬剤付与部と、
前記本体に設けられ、前記電子機器を、前記シートセット部に沿わせて配設された前記薬剤付与部の薬剤付与面から離して該薬剤付与面に正対するよう支持する支持手段と、
前記薬剤付与面に設けられたＪＩＳ Ｒ６０１０に準拠したＰ２４０〜Ｐ８００の粒度の凹凸で構成され、薬剤付与面の傾斜上部に滴下される前記薬剤を該薬剤付与面に広げる薬剤拡張手段とを備え、
前記支持手段は、
前記本体における前記シートセット部の傾斜上部に設けられ、該シートセット部との間に前記薬剤付与部を挟んで該薬剤付与部の上部を保持する支持バーと、
シートセット部と重なるように倒伏してシートセット部に沿って配設された薬剤付与部を保持する倒伏姿勢と、シートセット部から起立した起立姿勢との間で姿勢変位可能な枠状のシート押え部材とを備え、
起立姿勢の前記シート押え部材で前記薬剤付与部を支持して、前記シートセット部に沿って配設された薬剤付与部の薬剤付与面の傾斜よりも緩い傾斜で該薬剤付与面を保持して、薬剤付与面の傾斜上部に前記薬剤を滴下可能に構成され、
前記シートセット部に沿わせて配設された前記薬剤付与部の前記薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、前記支持バーおよび倒伏姿勢のシート押え部材で支持した前記電子機器を抗菌処理するよう構成したことを要旨とする。
従って、請求項２に係る発明によれば、薬剤付与面に付与された薬剤を、薬剤付与面の凹凸により発現する表面張力により該薬剤付与面の全体に広げることができる。 The invention according to claim 2 is an antibacterial device for antibacterial treatment of electronic equipment,
A sheet set portion provided on the upper surface of the main body,
Formed in a separate sheet form from the main body, and has a drug application surface that is incapable of penetrating a liquid drug containing an antibacterial component, along the sheet set portion so that the drug application surface is inclined A drug application unit disposed;
Support means provided on the main body and supporting the electronic device so as to face the drug application surface away from the drug application surface of the drug application unit disposed along the sheet set unit;
It consists of pre-Symbol granularity of P240~P800 conforming to JIS R6010 provided in drug imparting surface irregularities, and a drug expansion means to expand the agent to be dropped on the inclined upper portion of the drug applied surface agent imparting surface ,
The support means is
A support bar that is provided on an inclined upper portion of the sheet set portion in the main body, and holds the upper portion of the drug application portion with the drug application portion sandwiched between the sheet set portion;
A frame-like sheet whose posture is displaceable between a lying posture that holds the medicine application portion disposed so as to overlap the sheet setting portion and that is disposed along the sheet setting portion, and a standing posture that stands up from the sheet setting portion A holding member,
The medicine application part is supported by the sheet pressing member in a standing posture, and the medicine application surface is held with an inclination gentler than the inclination of the medicine application surface of the medicine application part disposed along the sheet set part. , Configured to be able to drop the drug on the inclined upper portion of the drug application surface,
The antibacterial component contained in the drug vaporized from the drug spread on the drug application surface of the drug application part disposed along the sheet set part was supported by the support bar and the sheet pressing member in a lying posture. The gist is that the electronic device is configured to be antibacterial treated .
Therefore, according to the invention which concerns on Claim 2, the chemical | medical agent provided to the chemical | medical agent provision surface can be spread to the whole said chemical | medical agent provision surface by the surface tension expressed by the unevenness | corrugation of a chemical | medical agent provision surface.

請求項３に記載の発明は、電子機器を抗菌処理する抗菌装置であって、
抗菌成分を含む液状の薬剤の浸透が不能な薬剤付与面を有し、本体に該薬剤付与面が傾斜するように配設された薬剤付与部と、
前記本体および前記薬剤付与部の少なくとも一方に設けられ、前記電子機器を前記薬剤付与面から離して該薬剤付与面に正対するよう支持する支持手段と、
前記薬剤付与面に設けられたＪＩＳ Ｒ６０１０に準拠したＰ２４０〜Ｐ８００の粒度の凹凸で構成され、前記薬剤を前記薬剤付与面に広げる薬剤拡張手段とを備え、
前記薬剤拡張手段は、前記薬剤付与面の傾斜上部に設定された該薬剤付与面への前記薬剤の滴下位置より遠い領域を、滴下位置に近い領域より前記粒度が細かくなるよう構成し、
前記薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、前記支持手段で支持した前記電子機器を抗菌処理するよう構成したことを要旨とする。
従って、請求項３に係る発明によれば、薬剤付与面に付与された薬剤を、薬剤付与面の凹凸により発現する表面張力により該薬剤付与面の全体に広げることができる。 The invention according to claim 3 is an antibacterial device for antibacterial treatment of electronic equipment,
A drug application portion having a drug application surface incapable of penetrating a liquid drug containing an antibacterial component, and disposed so that the drug application surface is inclined on the main body;
A support means provided on at least one of the main body and the drug application section, and supporting the electronic device so as to face the drug application surface away from the drug application surface;
It is composed of irregularities having a particle size of P240 to P800 conforming to JIS R6010 provided on the drug application surface, and includes a drug expansion means for spreading the drug on the drug application surface,
The drug expanding means is configured such that the area farther from the position where the drug is dropped onto the drug application surface set on the upper slope of the drug application surface is smaller than the area near the position where the drug is applied,
The gist is that the electronic device supported by the support means is subjected to antibacterial treatment with an antibacterial component contained in the drug vaporized from the drug spread on the drug application surface .
Therefore, according to the invention which concerns on Claim 3, the chemical | medical agent provided to the chemical | medical agent provision surface can be spread to the whole said chemical | medical agent provision surface by the surface tension expressed by the unevenness | corrugation of a chemical | medical agent provision surface.

請求項４に記載の発明は、電子機器を抗菌処理する抗菌装置であって、
本体に配設され、抗菌成分を含む液状の薬剤の浸透が不能な薬剤付与面を有する薬剤付与部と、
前記本体および前記薬剤付与部の少なくとも一方に設けられ、前記電子機器を前記薬剤付与面から離して該薬剤付与面に正対するよう支持する支持手段と、
前記薬剤付与部と別体に構成され、前記薬剤を前記薬剤付与面に広げる薬剤拡張手段とを備え、
前記薬剤付与部は、前記支持手段で支持された前記電子機器に前記薬剤付与面が対向するよう前記本体に固定され、
前記薬剤拡張手段は、スライド手段により前記薬剤付与部の薬剤付与面に沿ってスライド変位するよう前記本体に配設され、該薬剤付与面に対向しかつ該薬剤拡張手段のスライド変位方向と交差する方向へ延在する薬剤均し縁部を備え、
前記薬剤均し縁部は、該薬剤均し縁部と前記薬剤付与面との間に滴下される前記薬剤の液滴より狭い案内空間を設けて該薬剤付与面に対して非接触状態で対向し、
前記薬剤拡張手段は、前記薬剤均し縁部と前記薬剤付与面との間に滴下した薬剤を、前記案内空間において該薬剤均し縁部に沿って前記スライド変位方向と交差する方向へ導き、前記薬剤均し縁部で拡張した薬剤を、薬剤付与面に対して前記スライド手段によるスライド変位方向へ広げるよう構成し、
前記薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、前記支持手段で支持した前記電子機器を抗菌処理するよう構成したことを要旨とする。
従って、請求項４に係る発明によれば、薬剤均し縁部と薬剤付与面との間に滴下した薬剤を、該薬剤均し縁部に沿って薬剤拡張手段のスライド変位方向と交差する方向へ拡張させ、該薬剤拡張手段をスライド変位させることで、拡張した薬剤を薬剤付与面に対して該スライド変位方向へ広げることができる。従って、少ない量の薬剤を使用して電子機器の抗菌処理が可能であり、薬剤の無駄な使用を防止して経済的である。また、抗菌装置に多量の薬剤を補給しないので、薬剤の劣化を防止し得ると共に、薬剤の劣化による抗菌処理の不良を防止することができる。そして、薬剤拡張手段をスライド変位させるだけで、薬剤付与面に薬剤を簡単かつ適切に広げることができる。 The invention according to claim 4 is an antibacterial device for antibacterial treatment of electronic equipment,
A drug application portion disposed on the main body and having a drug application surface incapable of penetrating a liquid drug containing an antibacterial component;
A support means provided on at least one of the main body and the drug application section, and supporting the electronic device so as to face the drug application surface away from the drug application surface;
It is configured separately from the drug application unit, and comprises a drug expansion means for spreading the drug on the drug application surface,
The medicine application part is fixed to the main body so that the medicine application surface faces the electronic device supported by the support means,
The medicine expanding means is disposed in the main body so as to slide and displace along the medicine applying surface of the medicine applying section by a sliding means, and faces the medicine applying surface and intersects the sliding displacement direction of the medicine expanding means. With a drug leveling edge extending in the direction,
The drug leveling edge portion is provided in a non-contact state with the drug application surface by providing a guide space narrower than the drug droplet dropped between the drug leveling edge and the drug application surface. And
The medicine expanding means guides the medicine dropped between the medicine leveling edge and the medicine application surface in a direction intersecting the slide displacement direction along the medicine leveling edge in the guide space , The medicine expanded at the medicine leveling edge is configured to spread in the slide displacement direction by the slide means with respect to the medicine application surface ,
The gist is that the electronic device supported by the support means is subjected to antibacterial treatment with an antibacterial component contained in the drug vaporized from the drug spread on the drug application surface .
Therefore, according to the invention which concerns on Claim 4, the direction which cross | intersected the sliding displacement direction of the chemical | medical agent expansion means along the said chemical | medical agent leveling edge with the chemical | medical agent dripped between the chemical | medical agent leveling edge part The expanded medicine can be expanded in the slide displacement direction with respect to the medicine application surface. Accordingly, an antibacterial treatment of an electronic device can be performed using a small amount of medicine, and it is economical to prevent wasteful use of the medicine. Further, since a large amount of drug is not replenished to the antibacterial device, it is possible to prevent the deterioration of the drug and prevent the antibacterial treatment from being poor due to the deterioration of the drug. Then, the drug can be spread easily and appropriately on the drug application surface simply by sliding the drug expansion means.

請求項５に記載の発明は、電子機器を抗菌処理する抗菌装置であって、
本体に配設され、抗菌成分を含む液状の薬剤の浸透が不能な薬剤付与面を有する薬剤付与部と、
前記本体および前記薬剤付与部の少なくとも一方に設けられ、前記電子機器を前記薬剤付与面から離して該薬剤付与面に正対するよう支持する支持手段と、
前記薬剤付与部と別体に構成され、前記薬剤を前記薬剤付与面に広げる薬剤拡張手段とを備え、
前記薬剤付与部は、スライド手段により、前記支持手段で支持された前記電子機器に前記薬剤付与面が対向した位置および該電子機器から該薬剤付与面が退避した位置の間でスライド変位するよう前記本体に配設され、
前記薬剤拡張手段は、前記本体における前記薬剤付与部の移動経路上に設けられ、前記薬剤付与面に対向しかつ前記薬剤付与部のスライド変位方向と交差する方向へ延在する薬剤均し端部を備え、
前記薬剤均し端部は、前記薬剤付与面に滴下される前記薬剤の液滴より狭い案内空間を該薬剤付与面との間に設けて該薬剤付与面に対して非接触状態で対向し、
前記薬剤拡張手段は、前記薬剤付与面に滴下した薬剤を、前記案内空間において前記薬剤均し端部に沿って前記スライド変位方向と交差する方向へ導き、前記薬剤均し端部で拡張した薬剤を、薬剤付与面に対して前記スライド手段による前記薬剤付与部のスライド変位方向へ広げるよう構成し、
前記薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、前記支持手段で支持した前記電子機器を抗菌処理するよう構成したことを要旨とする。
従って、請求項５に係る発明によれば、薬剤付与面に滴下した薬剤を、薬剤均し端部に沿って薬剤付与部のスライド変位方向と交差する方向へ拡張させ、該薬剤付与部をスライド変位させることで、拡張した薬剤を薬剤付与面に対して該スライド変位方向へ広げることができる。従って、少ない量の薬剤を使用して電子機器の抗菌処理が可能であり、薬剤の無駄な使用を防止して経済的である。また、抗菌装置に多量の薬剤を補給しないので、薬剤の劣化を防止し得ると共に、薬剤の劣化による抗菌処理の不良を防止することができる。そして、薬剤付与部をスライド変位させるだけで、該薬剤付与部の薬剤付与面に薬剤を簡単かつ適切に広げることができる。 The invention according to claim 5 is an antibacterial device for antibacterial treatment of electronic equipment,
A drug application portion disposed on the main body and having a drug application surface incapable of penetrating a liquid drug containing an antibacterial component;
A support means provided on at least one of the main body and the drug application section, and supporting the electronic device so as to face the drug application surface away from the drug application surface;
It is configured separately from the drug application unit, and comprises a drug expansion means for spreading the drug on the drug application surface,
The medicine application section is slidably displaced by a slide means between a position where the medicine application surface is opposed to the electronic device supported by the support means and a position where the medicine application surface is retracted from the electronic device. Arranged in the body,
The medicine expanding means is provided on a movement path of the medicine application section in the main body, and faces the medicine application surface and extends in a direction intersecting the slide displacement direction of the medicine application section. With
The medicine leveling end portion is provided with a guide space narrower than the medicine droplet dropped onto the medicine application surface between the medicine application surface and faces the medicine application surface in a non-contact state.
The drug expanding means guides the drug dropped on the drug application surface in the guide space along the drug leveling end in a direction intersecting the slide displacement direction, and expands at the drug leveling end. Is configured to spread in the slide displacement direction of the drug application portion by the slide means with respect to the drug application surface ,
The gist is that the electronic device supported by the support means is subjected to antibacterial treatment with an antibacterial component contained in the drug vaporized from the drug spread on the drug application surface .
Therefore, according to the fifth aspect of the present invention, the drug dropped on the drug application surface is expanded along the drug leveling end in the direction intersecting the slide displacement direction of the drug application part, and the drug application part is slid By displacing, the expanded medicine can be spread in the slide displacement direction with respect to the medicine application surface. Accordingly, an antibacterial treatment of an electronic device can be performed using a small amount of medicine, and it is economical to prevent wasteful use of the medicine. Further, since a large amount of drug is not replenished to the antibacterial device, it is possible to prevent the deterioration of the drug and prevent the antibacterial treatment from being poor due to the deterioration of the drug. Then, the drug can be easily and appropriately spread on the drug application surface of the drug application unit simply by sliding the drug application unit.

請求項６に記載の発明は、前記薬剤拡張手段は、前記薬剤付与面の傾斜上部に設定された該薬剤付与面への前記薬剤の滴下位置より遠い領域を、滴下位置に近い領域より前記粒度が細かくなるよう構成したことを要旨とする。 In the invention according to claim 6, the drug expansion means is configured such that the region farther from the position where the drug is dropped onto the drug application surface set on the inclined upper portion of the drug application surface is the particle size than the region near the drop position. The gist is that it is configured to be finer .

請求項７に記載の発明は、前記支持手段は、前記電子機器の前記薬剤付与面に対向する面と該薬剤付与面との間隔が、０ｍｍより大きく２０ｍｍ以下となるように該電子機器を支持することを要旨とする。
従って、請求項７に係る発明によれば、薬剤付与面に付与された薬剤の気化した抗菌成分と効率的な接触が可能な範囲に電子機器がセットされるので、該電子機器の抗菌処理を効率的に行なうことができる。 According to a seventh aspect of the present invention, the support means supports the electronic device such that a distance between the surface of the electronic device facing the drug application surface and the drug application surface is greater than 0 mm and 20 mm or less. The gist is to do.
Therefore, according to the invention according to claim 7, since the electronic device is set in a range that allows efficient contact with the vaporized antibacterial component of the drug applied to the drug application surface, the antibacterial treatment of the electronic device is performed. It can be done efficiently.

また、前記課題を解決し、所期の目的を達成するため、本願の請求項８に記載の発明は、
電子機器を抗菌処理する抗菌方法であって、
液体の浸透が不能な薬剤付与面の傾斜上部に、抗菌成分を含む液状の薬剤を滴下し、前記薬剤付与面に滴下した前記薬剤を、この薬剤付与面に設けられたＪＩＳ Ｒ６０１０に準拠したＰ２４０〜Ｐ８００の粒度の凹凸により該薬剤付与面に広げ、
前記薬剤付与面を、前記薬剤を滴下した状態より傾斜角度が大きくなるようにセットし、前記凹凸により薬剤を薬剤付与面に広げて、前記電子機器の該薬剤付与面に対向する被抗菌処理部分以上に広げ、
前記電子機器を、前記薬剤付与面に広げられた薬剤に前記被抗菌処理部分が非接触で正対するよう支持し、薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、電子機器を抗菌処理することを要旨とする。 In order to solve the above-mentioned problem and achieve the intended purpose, the invention according to claim 8 of the present application is
An antibacterial method for antibacterial treatment of electronic equipment,
A liquid medicine containing an antibacterial component is dropped on the inclined upper portion of the medicine application surface where the liquid cannot penetrate, and the medicine dropped on the medicine application surface is added to P240 according to JIS R6010 provided on the medicine application surface. Spread to the drug application surface by unevenness of particle size of ~ P800,
The drug application surface is set so that the inclination angle is larger than the state where the drug is dripped , the drug is spread on the drug application surface by the unevenness , and the antibacterial treatment portion facing the drug application surface of the electronic device spread to more,
The electronic device is supported so that the antibacterial treatment part faces the drug spread on the drug application surface in a non-contact manner , and the antibacterial component contained in the drug vaporized from the drug spread on the drug application surface allows the electronic device to The gist is to antibacterialize the equipment .

請求項８〜１０に係る発明によれば、薬剤付与部の薬剤付与面に付与した液状の薬剤を、薬剤付与面に浸透させることなく薬剤拡張手段で該薬剤付与面に広げて、薬剤付与面に広げた薬剤に被抗菌処理部分が正対するよう電子機器を支持するようにしたので、気化した薬剤の抗菌成分を該被抗菌処理部分に適切に接触させて電子機器の抗菌処理を効率的に行なうことができる。また、薬剤付与面に広げた薬剤が該薬剤付与面へ浸透しないので、該薬剤の気化を促進することができると共に、抗菌処理毎に必要とされる薬剤の量が少なくなってランニングコストが抑えられ、電子機器の抗菌処理を低コストで行なうことができる。更に、抗菌処理を実施する毎に、抗菌効果が高い(抗菌効果が低下していない)新しい薬剤を使用することができ、常に安定した抗菌処理を適切に行ない得る。更にまた、支持手段に支持させた電子機器を液状の薬剤と接触させないので、該薬剤が電子機器内へ侵入することによる該電子機器の故障を防止し得る。
特に請求項８に係る発明によれば、薬剤付与面の凹凸により発現する表面張力により、薬剤付与面に付与した薬剤を該薬剤付与面へ適切に広げることができる。 According to the invention of 請 Motomeko 8-10, the drug liquid was applied to the drug imparting surface of the drug deposition unit, spread the agent imparting surface with a drug expansion means without infiltrating agents imparting surface, the agent imparting Since the electronic device is supported so that the antibacterial treatment part faces the drug spread on the surface, the antibacterial component of the vaporized drug is appropriately brought into contact with the antibacterial treatment part for efficient antibacterial treatment of the electronic device. Can be done. In addition, since the drug spread on the drug application surface does not penetrate into the drug application surface, vaporization of the drug can be promoted and the amount of the drug required for each antibacterial treatment is reduced, thereby reducing the running cost. Therefore, antibacterial treatment of electronic equipment can be performed at low cost. Furthermore, each time an antibacterial treatment is performed, a new drug having a high antibacterial effect (an antibacterial effect is not lowered) can be used, and a stable antibacterial treatment can always be appropriately performed. Furthermore, since the electronic device supported by the support means is not brought into contact with the liquid medicine, it is possible to prevent the electronic equipment from being broken due to the medicine entering the electronic equipment.
In particular, according to the invention according to claim 8, the drug applied to the drug application surface can be appropriately spread to the drug application surface by the surface tension expressed by the unevenness of the drug application surface.

請求項９に記載の発明は、電子機器を抗菌処理する抗菌方法であって、
液体の浸透が不能な薬剤付与面の一部分に、抗菌成分を含む液状の薬剤を滴下し、
前記薬剤付与面に滴下した前記薬剤を、該薬剤の液滴より狭い案内空間を設けて薬剤付与面と対向する薬剤拡張手段により該薬剤拡張手段に沿って広げると共に、薬剤拡張手段と薬剤付与面との相対的なスライド変位により、前記電子機器の該薬剤付与面に対向する被抗菌処理部分以上に広げ、
前記電子機器を、前記薬剤付与面に広げられた薬剤に前記被抗菌処理部分が非接触で正対するよう支持し、薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、電子機器を抗菌処理することを要旨とする。
従って、請求項９に係る発明によれば、薬剤拡張手段および薬剤付与面を相対的にスライド変位させることで、薬剤付与面に付与した薬剤を該薬剤付与面へ適切に広げることができる。 The invention according to claim 9 is an antibacterial method for antibacterial treatment of an electronic device,
A liquid medicine containing an antibacterial component is dropped on a part of the medicine application surface where the liquid cannot penetrate,
The drug dripped onto the drug application surface is spread along the drug expansion means by a drug expansion means facing the drug application surface by providing a guide space narrower than the drug droplet, and the drug expansion means and the drug application surface With relative slide displacement, and spread over the antimicrobial treatment part facing the drug application surface of the electronic device,
The electronic device is supported so that the antibacterial treatment part faces the drug spread on the drug application surface in a non-contact manner, and the antibacterial component contained in the drug vaporized from the drug spread on the drug application surface allows the electronic device to The gist is to antibacterialize the equipment .
Therefore, according to the ninth aspect of the invention, the medicine applied to the medicine application surface can be appropriately spread on the medicine application surface by relatively slidingly displacing the medicine expansion means and the medicine application surface.

請求項１０に記載の発明は、電子機器を抗菌処理する抗菌方法であって、
液体の浸透が不能な薬剤付与面の一部分に、抗菌成分を含む液状の薬剤を滴下し、
前記薬剤付与面に滴下した前記薬剤を、該薬剤付与面に対して相対的な近接・離間方向へ回転変位が可能に構成され、近接位置において薬剤付与面に滴下した薬剤の液滴より狭い案内空間を設けて薬剤付与面と対向する薬剤拡張手段により、前記電子機器の該薬剤付与面に対向する被抗菌処理部分以上に広げ、
前記電子機器を、前記薬剤付与面に広げられた薬剤に前記被抗菌処理部分が非接触で正対するよう支持し、薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、電子機器を抗菌処理することを要旨とする。
従って、請求項１０に係る発明によれば、薬剤拡張手段および薬剤付与面を相対的に回転変位させることで、薬剤付与面に付与した薬剤を該薬剤付与面へ適切に広げることができる。 The invention according to claim 10 is an antibacterial method for antibacterial treatment of electronic equipment,
A liquid medicine containing an antibacterial component is dropped on a part of the medicine application surface where the liquid cannot penetrate,
The medicine dripped onto the medicine application surface is configured to be capable of rotational displacement in a direction close to and away from the medicine application surface, and is guided narrower than the medicine droplet dropped onto the medicine application surface at the proximity position. Spreading more than the antibacterial treatment part facing the drug application surface of the electronic device by means of drug expansion means facing the drug application surface with a space,
The electronic device is supported so that the antibacterial treatment part faces the drug spread on the drug application surface in a non-contact manner, and the antibacterial component contained in the drug vaporized from the drug spread on the drug application surface allows the electronic device to The gist is to antibacterialize the equipment .
Therefore, according to the invention according to claim 10, by relatively rotating displacement drug expansion means and drug imparting surface, the agent was applied to the drug imparting surface can be appropriately spread the agent imparting surface.

請求項１１に記載の発明は、前記電子機器は、前記被抗菌処理部分が前記薬剤付与面に対して０ｍｍより大きく２０ｍｍ以下となるよう支持されることを要旨とする。
従って、請求項１１に係る発明によれば、薬剤付与面から気化した薬剤の抗菌成分と電子機器の被抗菌処理部分とを適切に接触させることができ、該電子機器の抗菌処理を効率的に行なうことができる。 The gist of the invention described in claim 11 is that the electronic device is supported such that the antibacterial treatment portion is greater than 0 mm and not greater than 20 mm with respect to the drug application surface.
Therefore, according to the eleventh aspect of the present invention, the antibacterial component of the drug vaporized from the drug application surface can be appropriately brought into contact with the antibacterial treatment part of the electronic device, and the antibacterial treatment of the electronic device can be efficiently performed. Can be done.

本発明に係る電子機器の抗菌装置によれば、電子機器の抗菌処理を効率的で低コストかつ適切に行なうことを可能とする。
別の発明に係る電子機器の抗菌方法によれば、電子機器の抗菌処理を効率的で低コストかつ適切に行なうことができる。 According to the antibacterial device for an electronic device according to the present invention, the antibacterial treatment of the electronic device can be efficiently performed at low cost and appropriately.
According to the antibacterial method of an electronic device according to another invention, the antibacterial treatment of the electronic device can be efficiently performed at low cost and appropriately.

本発明の実施例１に係る電子機器の抗菌装置を示す斜視図である。It is a perspective view which shows the antibacterial device of the electronic device which concerns on Example 1 of this invention. 図１に示す抗菌装置の側面図である。It is a side view of the antibacterial device shown in FIG. 薬剤付与プレートと薬剤付与部材とを示す平面図である。It is a top view which shows a chemical | medical agent provision plate and a chemical | medical agent provision member. 薬剤付与プレートと薬剤付与部材とを一部破断して示す側面図である。It is a side view which shows a medicine giving plate and a medicine giving member partially broken. 薬剤付与面に薬剤を付与する過程を示す説明図であって、(ａ)は受滴部に薬剤を滴下する状態を示し、(ｂ)は薬剤付与部材を降下させる状態を示し、(ｃ)は薬剤付与面に薬剤を付与した後に携帯電話をセットする状態を示している。It is explanatory drawing which shows the process of providing a chemical | medical agent to a chemical | medical agent provision surface, Comprising: (a) shows the state which dripping a chemical | medical agent to a droplet receiving part, (b) shows the state which drops a chemical | medical agent provision member, (c) Indicates a state in which the mobile phone is set after the drug is applied to the drug application surface. 本発明の実施例２に係る電子機器の抗菌装置を示す斜視図である。It is a perspective view which shows the antibacterial device of the electronic device which concerns on Example 2 of this invention. 図６に示す抗菌装置の平面図である。It is a top view of the antibacterial device shown in FIG. 図６に示す抗菌装置の側面図である。It is a side view of the antibacterial device shown in FIG. 薬剤付与面に薬剤を付与する過程を示す説明図であって、(ａ)は本体から引出した薬剤付与プレートの薬剤付与面に薬剤を滴下する状態を示し、(ｂ)は薬剤付与プレートを本体内を押込む途中の状態を示し、(ｃ)は薬剤付与プレートを本体内に押込んだ状態を示している。It is explanatory drawing which shows the process of providing a chemical | medical agent to a chemical | medical agent provision surface, Comprising: (a) shows the state which dripped a chemical | medical agent on the chemical | medical agent provision surface of the chemical | medical agent provision plate pulled out from the main body, (b) The state in the middle of pushing in is shown, (c) has shown the state which pushed the chemical | medical agent provision plate into the main body. 本発明の実施例３に係る電子機器の抗菌装置を示す斜視図である。It is a perspective view which shows the antibacterial device of the electronic device which concerns on Example 3 of this invention. 図１０に示す抗菌装置の側面図である。It is a side view of the antibacterial device shown in FIG. 薬剤付与面に薬剤を付与する過程を示す説明図であって、(ａ)は後方へ回転させた薬剤付与プレートの薬剤付与面に薬剤を滴下する状態を示し、(ｂ)は押付プレートを薬剤付与プレートに押付けた状態を示し、(ｃ)は薬剤付与プレートから押付プレートを離間させた状態を示している。It is explanatory drawing which shows the process of providing a chemical | medical agent to a chemical | medical agent provision surface, Comprising: (a) shows the state which dripped a chemical | medical agent on the chemical | medical agent application | coating surface of the chemical | medical agent application plate rotated backward, (b) A state where the pressing plate is pressed against the applying plate is shown, and (c) shows a state where the pressing plate is separated from the medicine applying plate. 本発明の実施例４に係る電子機器の抗菌装置を示す斜視図である。It is a perspective view which shows the antibacterial device of the electronic device which concerns on Example 4 of this invention. 図１３に示す抗菌装置の側断面図である。It is a sectional side view of the antibacterial device shown in FIG. 図１３に示す抗菌装置の平面図である。It is a top view of the antibacterial device shown in FIG. (ａ)は、本体に薬剤付与シートをセットする状態を示す説明断面図であり、(ｂ)は、薬剤付与シートに薬剤を滴下した後に携帯電話をセットする状態を示す説明断面図である。(a) is explanatory explanatory drawing which shows the state which sets a chemical | medical agent provision sheet to a main body, (b) is explanatory sectional drawing which shows the state which sets a mobile telephone after dripping a chemical | medical agent to a chemical | medical agent provision sheet. (ａ)は、薬剤拡張凹凸を備えた薬剤付与シートの構成を概略的に示す部分断面図であり、(ｂ)は、薬剤拡張凹凸により発現する表面張力により、薬剤付与シートの薬剤付与面に薬剤が拡張されることを示す部分断面図である。(a) is a partial cross-sectional view schematically showing the configuration of a drug application sheet having drug expansion irregularities; (b) is a drug application surface of the drug application sheet due to surface tension expressed by the drug expansion irregularities; It is a fragmentary sectional view showing that a medicine is expanded. 実施例４の抗菌装置において、薬剤付与シートに対する薬剤の滴下方法の別例を示す説明図である。In the antibacterial device of Example 4, it is explanatory drawing which shows another example of the dripping method of the chemical | medical agent with respect to a chemical | medical agent provision sheet. 別形態の薬剤付与面を備えた薬剤付与シートを示す説明図であって、(ａ)は、２種類の異なる粒度から構成された薬剤付与面を備えた薬剤付与シートを示し、(ｂ)は、マーキングを中心として該マーキングから遠ざかるほど粒度が細かくなるよう構成された薬剤付与面を備えた薬剤付与シートを示している。It is explanatory drawing which shows the chemical | medical agent provision sheet provided with the chemical | medical agent provision surface of another form, Comprising: (a) shows the chemical | medical agent provision sheet provided with the chemical | medical agent provision surface comprised from two different particle sizes, (b) 1 shows a drug application sheet having a drug application surface configured such that the particle size becomes finer as the distance from the marking is increased. 本願発明者が行なった実験１の概要説明図である。It is outline | summary explanatory drawing of the experiment 1 which this inventor performed. 実験１において小径の拡張紙に薬剤を付与した状態で抗菌処理を行なう場合を示す写真である。In Experiment 1, it is a photograph which shows the case where an antibacterial process is performed in the state which provided the chemical | medical agent to the small diameter expansion paper. 実験１において大径の拡張紙に(ａ)と同量の薬剤を付与した状態で抗菌処理を行なう場合を示す写真である。In Experiment 1, it is a photograph which shows the case where an antibacterial process is performed in the state which gave the chemical | medical agent of the same quantity as (a) to the large diameter expansion paper. 実験１において小径の拡張紙に付与した薬剤による抗菌処理で得られた試料１の写真である。4 is a photograph of Sample 1 obtained by an antibacterial treatment with a drug applied to a small-diameter expanded paper in Experiment 1. 実験１において大径の拡張紙に付与した薬剤による抗菌処理で得られた試料２の写真である。It is the photograph of the sample 2 obtained by the antibacterial process by the chemical | medical agent provided to the large diameter expansion paper in Experiment 1. FIG. 本願発明者が行なった実験２の概要説明図である。It is outline | summary explanatory drawing of the experiment 2 which this inventor performed. 実験２に関し、抗菌処理を行なわない非抗菌処理物品に繁殖した菌のコロニー態様の一例において、コロニーの面積の規定内容を示す説明図である。It is explanatory drawing which shows the prescription | regulation content of the area of a colony in an example of the colony aspect of the microbe propagated on the non-antibacterial treatment article which does not perform an antibacterial treatment regarding the experiment 2. FIG. 実験２に関し、抗菌処理を行なった被抗菌処理物品に繁殖した菌のコロニー態様の一例において、コロニーの面積の規定内容を示す説明図である。It is explanatory drawing which shows the prescription | regulation content of the area of a colony in an example of the colony aspect of the microbe propagated on the to-be-antibacterial-treated article which performed the antibacterial treatment regarding the experiment 2. FIG. 実験２におけるコントロールの写真である。It is a photograph of the control in Experiment 2. 実験２において抗菌処理間隔が５ｍｍの実験結果を示す写真である。In Experiment 2, it is a photograph which shows the experimental result whose antibacterial treatment space | interval is 5 mm. 実験２において抗菌処理間隔が７ｍｍの実験結果を示す写真である。In Experiment 2, it is a photograph which shows the experimental result whose antibacterial treatment space | interval is 7 mm. 実験２において抗菌処理間隔が１０ｍｍの実験結果を示す写真である。In Experiment 2, it is a photograph which shows the experimental result whose antibacterial treatment interval is 10 mm. 本願発明者が行なった実験３の概要説明図である。It is outline | summary explanatory drawing of the experiment 3 which this inventor performed. 実験４において抗菌処理時間が５秒の場合の状態を示す写真である。In Experiment 4, it is a photograph which shows a state in case antibacterial treatment time is 5 second. 実験４において抗菌処理時間が５分の場合の状態を示す写真である。It is a photograph which shows a state in case the antibacterial treatment time is 5 minutes in Experiment 4. 実験４において抗菌処理時間が１５分の場合の状態を示す写真である。It is a photograph which shows a state in case the antibacterial treatment time is 15 minutes in Experiment 4. 実験４において抗菌処理時間が３０分の場合の状態を示す写真である。In Experiment 4, it is a photograph which shows a state in case antibacterial processing time is 30 minutes. 実験４において抗菌処理時間が４５分の場合の状態を示す写真である。In Experiment 4, it is a photograph which shows a state in case antibacterial processing time is 45 minutes. 実験４において抗菌処理時間が６０分の場合の状態を示す写真である。It is a photograph which shows a state in case the antibacterial treatment time is 60 minutes in Experiment 4. 本願発明者が行なった実験５の概要説明図であって、(ａ)は、大気開放状態で抗菌処理を行なう場合を示し、(ｂ)は、密閉状態で抗菌処理を行なう場合を示している。It is outline | summary explanatory drawing of the experiment 5 which this inventor performed, Comprising: (a) shows the case where an antimicrobial treatment is performed in air | atmosphere, and (b) shows the case where an antimicrobial treatment is performed in a sealed state. . 実験５において、薬剤Ｃとしてローズウッドオイルを使用して大気開放状態で抗菌処理を行なった場合の実験結果を示す写真である。In Experiment 5, it is a photograph which shows the experimental result at the time of performing an antibacterial process in the atmosphere open | release condition using rosewood oil as the chemical | medical agent C. 実験５において、薬剤Ｃとしてローズウッドオイルを使用して密閉状態で抗菌処理を行なった場合の実験結果を示す写真である。In Experiment 5, it is a photograph which shows the experimental result at the time of performing an antibacterial process in the airtight state using rosewood oil as the chemical | medical agent C. 実験５において、薬剤Ｃとしてラベンダーティートゥリーオイルを使用して大気開放状態で抗菌処理を行なった場合の実験結果を示す写真である。In Experiment 5, it is a photograph which shows the experimental result at the time of performing an antibacterial process in the open air condition using lavender tea tree oil as the chemical | medical agent C. 実験５において、薬剤Ｃとしてラベンダーティートゥリーオイルを使用して密閉状態で抗菌処理を行なった場合の実験結果を示す写真である。In Experiment 5, it is a photograph which shows the experimental result at the time of performing an antimicrobial treatment in the airtight state using lavender tea tree oil as the chemical | medical agent C. 本願発明者が行なった実験６において、研磨布紙(拡張紙)に精製水を付与したコントロールを示す写真である。It is a photograph which shows the control which gave purified water to the abrasive cloth paper (expansion paper) in the experiment 6 which this inventor performed. 本願発明者が行なった実験６において、研磨布紙(拡張紙)に薬剤を付与したものを示す写真である。It is a photograph which shows what added the chemical | medical agent to the abrasive cloth paper (expansion paper) in Experiment 6 which this inventor performed. 実験６において、濾紙に薬剤を付与したものを示す写真である。In Experiment 6, it is a photograph which shows what gave the chemical | medical agent to the filter paper. 実験６において、フェルトに薬剤を付与したものを示す写真である。In Experiment 6, it is a photograph which shows what gave the chemical | medical agent to felt. 図３１(ａ)に示す研磨布紙(拡張紙)に精製水を付与したもので抗菌処理を行なった場合の実験結果を示す写真である。It is a photograph which shows the experimental result at the time of performing an antibacterial process with what gave purified water to the polishing cloth (expansion paper) shown to Fig.31 (a). 図３１(ｂ)に示す研磨布紙(拡張紙)に薬剤を付与したもので抗菌処理を行なった場合の実験結果を示す写真である。It is a photograph which shows the experimental result at the time of performing an antibacterial process with what gave the chemical | medical agent to the polishing cloth (expansion paper) shown in FIG.31 (b). 図３１(ｃ)に示す濾紙に薬剤を付与したもので抗菌処理を行なった場合の実験結果を示す写真である。It is a photograph which shows the experimental result at the time of performing an antibacterial process by what gave the chemical | medical agent to the filter paper shown in FIG.31 (c). 図３１(ｄ)に示すフェルトに薬剤を付与したもので抗菌処理を行なった場合の実験結果を示す写真である。It is a photograph which shows the experimental result at the time of performing an antibacterial process by what provided the chemical | medical agent to the felt shown in FIG.31 (d).

次に、本発明に係る電子機器の抗菌装置および抗菌方法につき、好適な実施例を挙げて、添付図面を参照して以下に説明する。   Next, an antibacterial device and an antibacterial method for an electronic device according to the present invention will be described below with reference to the accompanying drawings by way of preferred examples.

(実施例１)
図１は、実施例１に係る電子機器の抗菌装置Ｍ１の概略斜視図であり、図２は、図１に示す抗菌装置Ｍ１の右側面図である。実施例１の抗菌装置Ｍ１は、電子機器である携帯電話Ｔの抗菌処理を行なうものである。この抗菌装置Ｍ１は、携帯電話Ｔが着脱可能にセットされる本体Ｆ１と、抗菌成分を含む液状の薬剤Ｃが付与される薬剤付与面２５を有し、前記薬剤付与面２５を携帯電話Ｔに向けた状態で本体Ｆ１に配設される薬剤付与プレート(薬剤付与部)Ｂ１と、前記薬剤Ｃを、薬剤付与面２５に広げる薬剤拡張部材(薬剤拡張手段)Ｓ１とを備える。また抗菌装置Ｍ１は、本体Ｆ１にセットする携帯電話Ｔを、薬剤付与面２５から離した姿勢で支持する支持手段を備えている。なお実施例１では、図１に示すように、抗菌装置Ｍ１を卓上等の水平面に置いた使用状態において、垂直方向を抗菌装置Ｍ１の「上下方向」、前記薬剤付与面２５に沿う水平方向を抗菌装置Ｍ１の「左右方向」、この左右方向と水平に直交する方向を抗菌装置Ｍ１の「前後方向」と指称する。そして携帯電話Ｔは、その幅方向を抗菌装置Ｍ１の左右方向に整合させた姿勢で本体Ｆ１にセットされる。 (Example 1)
FIG. 1 is a schematic perspective view of an antibacterial device M1 of an electronic apparatus according to a first embodiment, and FIG. 2 is a right side view of the antibacterial device M1 shown in FIG. The antibacterial device M1 of Example 1 performs an antibacterial treatment of the mobile phone T that is an electronic device. The antibacterial device M1 has a main body F1 on which a mobile phone T is detachably set, and a drug application surface 25 to which a liquid drug C containing an antibacterial component is applied, and the drug application surface 25 is attached to the mobile phone T. A drug application plate (medicine application part) B1 disposed in the main body F1 in a state of being directed and a drug expansion member (drug expansion means) S1 that spreads the drug C on the drug application surface 25 are provided. Further, the antibacterial device M1 includes support means for supporting the mobile phone T set in the main body F1 in a posture away from the medicine application surface 25. In Example 1, as shown in FIG. 1, when the antibacterial device M1 is placed on a horizontal surface such as a desktop, the vertical direction is the “vertical direction” of the antibacterial device M1, and the horizontal direction along the drug application surface 25 is The “left-right direction” of the antibacterial device M1 and the direction horizontally orthogonal to the left-right direction are referred to as “front-back direction” of the antibacterial device M1. The mobile phone T is set on the main body F1 in a posture in which the width direction is aligned with the left-right direction of the antibacterial device M1.

本体Ｆ１は、図１および図２に示すように、携帯電話Ｔを下方から支持する略矩形状のベース部１０と、このベース部１０の後端から後方傾斜した状態で立設された立壁部１１とを備える。ベース部１０は、机上や卓上等に載置した際の抗菌装置Ｍ１の安定化を図るもので、上面が後方に向かうにつれて下方へ僅かに傾斜している。また、ベース部１０の前部左端および前部右端には、後述するシールド部材３６を回転可能に枢支する枢支ピン１２,１２が、左側方および右側方へ突出するように形成されている。   As shown in FIGS. 1 and 2, the main body F <b> 1 includes a substantially rectangular base portion 10 that supports the mobile phone T from below, and a standing wall portion that is erected in a state of being inclined rearward from the rear end of the base portion 10. 11. The base part 10 is intended to stabilize the antibacterial device M1 when placed on a desk or tabletop, and is inclined slightly downward as the upper surface goes rearward. Further, at the front left end and the front right end of the base portion 10, pivot pins 12, 12 that pivotally support a shield member 36 to be described later are formed so as to protrude leftward and rightward. .

立壁部１１は、図１および図２に示すように、ベース部１０と一体的に形成された縦長で略矩形状を呈しており、機器セット部Ｈ１を指向する前面に、前記薬剤付与プレートＢ１が配設されている。立壁部１１の後面にはスプリング収容部１３が設けられ、前記薬剤拡張部材Ｓ１を上方へ付勢するスプリング１４が、該スプリング収容部１３に縦向きに収容されている。また、立壁部１１の左端部において上端から下方へ所要距離離間した部位には、左外方へ突出するストッパ１５が設けられ、立壁部１１の右端部において上端から下方へ所要距離離間した部位には、右外方へ突出するストッパ１５が設けられている。これらストッパ１５,１５は、薬剤拡張部材Ｓ１の上方への移動を規制するものである。   As shown in FIGS. 1 and 2, the standing wall portion 11 has a vertically long and substantially rectangular shape integrally formed with the base portion 10, and the medicine application plate B <b> 1 is disposed on the front surface facing the device setting portion H <b> 1. Is arranged. A spring accommodating portion 13 is provided on the rear surface of the standing wall portion 11, and a spring 14 that urges the drug expansion member S <b> 1 upward is accommodated vertically in the spring accommodating portion 13. Further, a stopper 15 that protrudes to the left is provided at a portion that is spaced apart from the upper end at the left end portion of the standing wall portion 11, and a portion that is spaced apart by a necessary distance from the upper end at the right end portion of the standing wall portion 11. Is provided with a stopper 15 that protrudes outward to the right. These stoppers 15 and 15 regulate the upward movement of the drug expansion member S1.

また、立壁部１１における左端部のストッパ１５から下方および右端部のストッパ１５から下方には、図１〜図４に示すように、該左端部および右端部に沿って延在する溝状のガイドレール(スライド手段)１６,１６が形成されている。これらガイドレール１６,１６には、薬剤拡張部材Ｓ１に設けた後述の突部(スライド手段)３３,３３が夫々摺動可能に嵌合している。なお、図１中の符号１７は、滴下した薬剤Ｃを受止めると共に、受止めた該薬剤Ｃを薬剤付与プレートＢ１に向けて流下案内する受滴部である。この受滴部１７は、立壁部１１に凹設した第１受面１７Ａと、薬剤拡張部材Ｓ１に設けた第２受面１７Ｂとで形成される。また、立壁部１１の前面下部には、携帯電話Ｔの下部分を当て受ける第１スペーサ(支持手段)１８が、前方へ突出した状態で横長に形成されている。   Further, as shown in FIGS. 1 to 4, a groove-shaped guide extending along the left end portion and the right end portion is provided below the left end stopper 15 and below the right end stopper 15 in the standing wall portion 11. Rails (sliding means) 16 and 16 are formed. Projection portions (sliding means) 33, 33, which will be described later, provided on the drug expansion member S1 are slidably fitted to the guide rails 16, 16. In addition, the code | symbol 17 in FIG. 1 is a droplet receiving part which receives the dripped medicine C and guides the received medicine C downward toward the medicine application plate B1. The droplet receiving portion 17 is formed by a first receiving surface 17A that is recessed in the standing wall portion 11 and a second receiving surface 17B that is provided on the drug expansion member S1. In addition, a first spacer (supporting means) 18 that receives the lower part of the mobile phone T is formed in the front lower portion of the standing wall portion 11 in a horizontally long state so as to protrude forward.

薬剤付与プレートＢ１は、図１および図２に示すように、前記立壁部１１の前面側に装着された矩形状の部材である。そして、薬剤付与プレートＢ１の機器セット部Ｈ１に臨む外面は、平坦で板面状をなす縦長の薬剤付与面２５が設けられている。この薬剤付与プレートＢ１は、少なくとも薬剤付与面２５となる外面部分が空隙を有さないソリッドとなっており、薬剤付与面２５に付与された液状の薬剤Ｃが該薬剤付与プレートＢ１の内部へ浸透することが不可能となっている。ここで、前記「ソリッド」とは、材質が硬質という意味ではなく、薬剤塗布プレートＢ１の外面部分に薬剤Ｃが浸透していく空隙がないことを意味する。すなわち薬剤塗布プレートＢ１は、外面部分が薬剤Ｃの浸透を不可能とするソリッドとなっていれば、材質は金属や硬質樹脂等の硬質部材、シリコンまたはゴム等の軟質部材であってもよい。そして、薬剤付与面２５は、携帯電話Ｔの外面における被抗菌処理部分(実施例では、携帯電話Ｔの液晶表示面およびキー操作面)の大きさおよび形状に基づき、該被抗菌処理部分より一回り大きく設定されている。なお、薬剤付与プレートＢ１の上端部は、前記受滴部１７の下縁に臨んでおり、受滴部１７に滴下した薬剤Ｃは、薬剤付与面２５へ流下するようになる。   As shown in FIGS. 1 and 2, the drug application plate B <b> 1 is a rectangular member attached to the front surface side of the standing wall portion 11. And the outer surface which faces the apparatus setting part H1 of chemical | medical agent provision plate B1 is provided with the vertically long chemical | medical agent provision surface 25 which makes flat plate shape. The drug application plate B1 is a solid in which at least an outer surface portion serving as the drug application surface 25 does not have a gap, and the liquid drug C applied to the drug application surface 25 penetrates into the drug application plate B1. It is impossible to do. Here, the “solid” does not mean that the material is hard, but means that there is no gap through which the medicine C penetrates in the outer surface portion of the medicine application plate B1. That is, the drug application plate B1 may be made of a hard member such as metal or hard resin, or a soft member such as silicon or rubber, as long as the outer surface portion is a solid that does not allow the drug C to permeate. Then, the medicine application surface 25 is based on the size and shape of the antibacterial treatment portion (in the embodiment, the liquid crystal display surface and the key operation surface of the mobile phone T) on the outer surface of the mobile phone T. It is set large around. Note that the upper end portion of the drug application plate B1 faces the lower edge of the droplet receiving unit 17, and the drug C dropped on the droplet receiving unit 17 flows down to the drug application surface 25.

薬剤拡張部材Ｓ１は、図１および図２に示すように、立壁部１１から前方へ延出した操作部３０と、この操作部３０の後端左右から後方へ延出して立壁部１１の背面側に回り込むように形成された支持部３１とを備えている。そして、支持部３１における立壁部１１の背面に回り込んだ部位の左右中間には、前記スプリング１４の上端に上方から当接する当接部３２が設けられている。また、支持部３１における立壁部１１の左端部に対向する部位および該立壁部１１の右端部に対向する部位には、立壁部１１の左端部に設けたガイドレール１６および右端部に設けたガイドレール１６に夫々嵌合する前記突部３３,３３が形成されている。従って薬剤拡張部材Ｓ１は、各突部３３,３３が対応するガイドレール１６,１６に沿ってスライド変位することで、立壁部１１に対して昇降移動が可能である。そして薬剤拡張部材Ｓ１は、常にスプリング１４の弾性力により上方へ付勢されており、支持部３１が立壁部１１に設けた前記ストッパ１５,１５に当接した上方停止位置(図２、図５(ａ))と、操作部３０がベース部１０に近接した下方停止位置(図５(ｂ))との間でスライドし得る。すなわち薬剤拡張部材Ｓ１は、薬剤付与プレートＢ１における薬剤付与面２５の全長に亘って移動可能となっている。   As shown in FIGS. 1 and 2, the drug expansion member S <b> 1 includes an operation part 30 that extends forward from the standing wall part 11, and a rear side of the standing wall part 11 that extends rearward from the left and right rear ends of the operation part 30. And a support portion 31 formed so as to go around. An abutting portion 32 that abuts on the upper end of the spring 14 from above is provided at the left and right middle of the portion of the support portion 31 that wraps around the back surface of the standing wall portion 11. Further, a guide rail 16 provided at the left end portion of the standing wall portion 11 and a guide provided at the right end portion at a portion facing the left end portion of the standing wall portion 11 and a portion facing the right end portion of the standing wall portion 11 in the support portion 31. The protrusions 33, 33 that are fitted to the rails 16 are formed. Therefore, the medicine expansion member S1 can be moved up and down with respect to the standing wall portion 11 by sliding displacement of the projections 33 and 33 along the corresponding guide rails 16 and 16. The drug expansion member S1 is always urged upward by the elastic force of the spring 14, and the upper stop position where the support portion 31 is in contact with the stoppers 15 and 15 provided on the standing wall portion 11 (FIGS. 2 and 5). (a)) and the operation part 30 can slide between the lower stop position close to the base part 10 (FIG. 5B). That is, the drug expansion member S1 can move over the entire length of the drug application surface 25 of the drug application plate B1.

前記薬剤拡張部材Ｓ１の操作部３０において薬剤付与プレートＢ１に臨む後端部には、図３および図４に示すように、本体Ｆ１の左右方向へ水平に延在する薬剤均し縁部３４が設けられている。この薬剤均し縁部３４は、前記薬剤付与プレートＢ１における薬剤付与面２５の左右方向の全幅に亘って延在する長さとなっている。また、薬剤均し縁部３４と薬剤付与プレートＢ１の薬剤付与面２５とは、所定の薬剤拡散間隔Ｄ１で非接触状態に対向しており、これら薬剤付与面２５と薬剤均し縁部３４との間に案内空間が設けられている。すなわち薬剤拡散間隔Ｄ１は、図３および図４に示すように、薬剤付与面２５と薬剤均し縁部３４との間に滴下または流動した前記薬剤Ｃが、これら薬剤付与面２５および薬剤均し縁部３４の両方に、表面張力により接し得る距離となっている。従って、薬剤均し縁部３４と薬剤付与面２５との間に設けた案内空間に移動した薬剤Ｃは、表面張力により該案内空間内へ流れ込み、該案内空間を伝って薬剤均し縁部３４の延在方向(薬剤付与面２５の左右方向)へ移動するようになる。なお薬剤拡散間隔Ｄ１は、薬剤付与面２５と薬剤均し端部３４との間で表面張力により薬剤Ｃを拡張させるため、具体的には０.１ｍｍ以下で設定するのが望ましい。   As shown in FIGS. 3 and 4, a medicine leveling edge 34 extending horizontally in the left-right direction of the main body F1 is provided at the rear end facing the medicine application plate B1 in the operation part 30 of the medicine expansion member S1. Is provided. The medicine leveling edge 34 has a length extending over the entire width in the left-right direction of the medicine application surface 25 of the medicine application plate B1. Further, the drug leveling edge 34 and the drug application surface 25 of the drug application plate B1 face each other in a non-contact state at a predetermined drug diffusion interval D1, and the drug application surface 25 and the drug leveling edge 34 A guide space is provided between the two. That is, as shown in FIG. 3 and FIG. 4, the drug diffusion interval D <b> 1 is such that the drug C dropped or flown between the drug application surface 25 and the drug leveling edge 34 has the drug application surface 25 and drug leveling. It is a distance that can be brought into contact with both edges 34 by surface tension. Therefore, the medicine C that has moved to the guide space provided between the medicine leveling edge 34 and the medicine application surface 25 flows into the guide space due to surface tension and travels along the guide space to the medicine leveling edge 34. In the extending direction (the left-right direction of the drug application surface 25). The drug diffusion interval D1 is preferably set to 0.1 mm or less in order to expand the drug C by surface tension between the drug application surface 25 and the drug leveling end 34.

また、薬剤拡張部材Ｓ１における操作部３０の上面後部には、該薬剤拡張部材Ｓ１の前記上方停止位置において前記第１受面１７Ａと整合すると共に、前記薬剤均し縁部３４に連通するよう左右方向へ拡開する第２受面１７Ｂが形成されている。第２受面１７Ｂは、薬剤均し縁部３４に隣接して設けられることで、受滴部１７に滴下された薬剤Ｃを一次的に停留させ得ると共に、前記薬剤均し縁部３４と薬剤付与面２５との間へ該薬剤Ｃを案内する。なお、図４および図５(ａ)が第１受面１７Ａと第２受面１７Ｂとの整合状態であり、図５(ｂ)が第１受面１７Ａと第２受面１７Ｂとの非整合状態である。   In addition, the upper rear portion of the operation portion 30 of the medicine expansion member S1 is aligned with the first receiving surface 17A at the upper stop position of the medicine expansion member S1 and is connected to the medicine leveling edge 34 so as to communicate with the left and right sides. A second receiving surface 17B that expands in the direction is formed. The second receiving surface 17B is provided adjacent to the medicine leveling edge 34 so that the medicine C dropped on the droplet receiving part 17 can be temporarily stopped, and the medicine leveling edge 34 and the medicine The medicine C is guided to the application surface 25. 4 and 5A show the alignment state between the first receiving surface 17A and the second receiving surface 17B, and FIG. 5B shows the non-alignment between the first receiving surface 17A and the second receiving surface 17B. State.

更に、薬剤拡張部材Ｓ１における操作部３０の下面後部には、図１および図２に示すように、携帯電話Ｔの上部分を当て受ける第２スペーサ(支持手段)３５が、左右方向へ延在して下方へ延出した状態で形成されている。従って、図１および図２に示すように、携帯電話Ｔの下部分を前記第１スペーサ１８に前側から当接させると共に、該携帯電話Ｔの上部分を前記第２スペーサ３５に前側から当接させて立壁部１１に立て掛けることで、当該携帯電話Ｔが本体Ｆ１の機器セット部Ｈ１にセットされる。そして、機器セット部Ｈ１にセットした携帯電話Ｔは、前記薬剤付与プレートＢ１の薬剤付与面２５とは非接触状態に保持され、該携帯電話Ｔの薬剤付与面２５に対向する外面(被抗菌処理部分)と該薬剤付与面２５との間には、所定の抗菌処理間隔Ｄ２が形成されている。なお、携帯電話Ｔの上部分、中間部分、下部分において前記抗菌処理間隔Ｄ２の大きさが異なっているが、この抗菌処理間隔Ｄ２は、０ｍｍ＜Ｄ２≦２０ｍｍの範囲内で設定されている。この抗菌処理間隔Ｄ２の数値範囲は、本願発明者が行なった後述の実験により得られたものであり、該抗菌処理間隔Ｄ２を０ｍｍ＜Ｄ２≦２０ｍｍとすることで、薬剤付与面２５に付与された薬剤Ｃの気化した抗菌成分から形成された抗菌成分浮遊領域内において、機器セット部Ｈ１にセットした携帯電話Ｔの外面における被抗菌処理部分が該抗菌成分浮遊領域に正対するようになる。これにより、薬剤Ｃの気化した抗菌成分が携帯電話Ｔの被抗菌処理部分と効率的に接触して、該携帯電話Ｔの抗菌処理が適切に行なわれる。   Further, as shown in FIGS. 1 and 2, a second spacer (supporting means) 35 for receiving the upper portion of the mobile phone T extends in the left-right direction at the rear surface of the lower surface of the operation unit 30 in the medicine expansion member S1. And formed in a state of extending downward. Accordingly, as shown in FIGS. 1 and 2, the lower part of the mobile phone T is brought into contact with the first spacer 18 from the front side, and the upper part of the mobile phone T is brought into contact with the second spacer 35 from the front side. The cellular phone T is set in the device setting portion H1 of the main body F1 by leaning on the standing wall portion 11. The mobile phone T set in the device setting section H1 is held in a non-contact state with the drug application surface 25 of the drug application plate B1, and the outer surface (antibacterial treatment) of the mobile phone T is opposed to the drug application surface 25. A predetermined antibacterial treatment interval D2 is formed between the portion) and the drug application surface 25. In addition, although the magnitude | size of the said antibacterial treatment space | interval D2 differs in the upper part of the mobile phone T, an intermediate | middle part, and a lower part, this antibacterial treatment space | interval D2 is set in the range of 0 mm <D2 <= 20mm. The numerical range of the antibacterial treatment interval D2 is obtained by an experiment described later by the inventor of the present application. By setting the antibacterial treatment interval D2 to 0 mm <D2 ≦ 20 mm, the antibacterial treatment interval D2 is applied to the drug application surface 25. In the antibacterial component floating region formed from the vaporized antibacterial component of the medicine C, the antibacterial treatment portion on the outer surface of the mobile phone T set in the device setting portion H1 directly faces the antibacterial component floating region. Thereby, the antibacterial component which the chemical | medical agent C vaporized contacts efficiently with the to-be-antibacterial process part of the mobile phone T, and the antibacterial process of this mobile phone T is performed appropriately.

前記シールド部材３６は、図２に示すように、本体Ｆ１の機器セット部Ｈ１にセットした携帯電話Ｔおよび薬剤拡張手段としての薬剤拡張部材Ｓ１を被覆して、端縁部が前記立壁部１１の前面外周縁に沿って当接する形状に形成されている。このシールド部材３６は、実施例１の抗菌装置Ｍ１の運用中または保管中に、薬剤付与面２５およびその周囲に塵埃が進入して堆積するのを防止するためのものである。なお、実施例１の抗菌装置Ｍ１では、前述した如く、薬剤拡張部材Ｓ１で薬剤Ｃを拡張した薬剤付与面２５に対向させて携帯電話Ｔの抗菌処理を行なうので、シールド部材３６で閉成された雰囲気内で携帯電話Ｔの抗菌処理を行なう必要はなく、よって該シールド部材３６を装備しなくてもよい。   As shown in FIG. 2, the shield member 36 covers the mobile phone T set in the device setting portion H1 of the main body F1 and the drug expansion member S1 as the drug expansion means, and an edge portion of the standing wall portion 11 is covered. It is formed in a shape that abuts along the front outer periphery. This shield member 36 is for preventing dust from entering and depositing on the drug application surface 25 and its surroundings during operation or storage of the antibacterial device M1 of the first embodiment. In the antibacterial device M1 of the first embodiment, as described above, since the antibacterial treatment of the mobile phone T is performed facing the drug application surface 25 in which the drug C is expanded by the drug expansion member S1, it is closed by the shield member 36. It is not necessary to carry out the antibacterial treatment of the mobile phone T in an atmosphere, and therefore the shield member 36 may not be provided.

なお、実施例１の抗菌装置Ｍ１では、本体Ｆ１の立壁部１１に対して携帯電話Ｔを立て掛けた状態で抗菌処理を行ない得るので、抗菌処理中であっても該携帯電話Ｔの液晶画面や操作部等を目視することが可能である。また、携帯電話の充電端子を、本体Ｆ１のベース部１０に設けて、充電しながら携帯電話Ｔの抗菌処理を行なうことも可能である。   In the antibacterial device M1 of the first embodiment, the antibacterial treatment can be performed in a state where the mobile phone T is leaned against the standing wall portion 11 of the main body F1, so that even during the antibacterial treatment, the liquid crystal screen of the mobile phone T It is possible to visually check the operation unit and the like. It is also possible to provide the mobile phone charging terminal on the base portion 10 of the main body F1 so that the antibacterial treatment of the mobile phone T can be performed while charging.

薬剤Ｃは、抗菌成分が含有されると共に揮発性を有する液状の精油(エッセンシャルオイル)等が好適に使用される。また薬剤Ｃは、表面張力が３０ｍＮ／ｍ以下のものであれば、薬剤付与面２５に広がり易くするうえで好適である。このような薬剤Ｃは、具体的に、ローズウッドオイル、パルマローザオイル、ゼラニウムオイル、ラベンダーティートゥリーオイル、バジルリナロールオイル、マジョラムオイル、シトロネラオイル、ラバディンオイル、スパイクラベンダーオイル、ペパーミントオイル、スペアミントオイル、薄荷オイル、ラベンダーオイル、ベルガモットオイル、レモングラスオイル、レモンオイル、ローズオットーオイル、ユーカリオイル、ティトゥリーオイル、サイプレスオイル、ローズマリーオイル、サンダルウッドオイル、ジュニパーオイル、グレープフルーツオイル等が実施可能である。また、無水エタノール、ヒノキチオール、抗菌有効成分のみを生成したもの(シトロネロール等)、除菌電解ミスト等であってもよい。前記各薬剤Ｃのうち、ローズウッドオイル、ペパーミントオイル、ラベンダーティートゥリーオイル、マジョラムオイル、スパイクラベンダーオイルが好ましく、特にローズウッドオイル、ペパーミントオイル、ラベンダーティートゥリーオイルが好適である。なお、芳香成分を有する薬剤Ｃを使用した場合には、抗菌処理した携帯電話Ｔには該薬剤Ｃの香りが付着するが、日時の経過により該香りが弱くなることで、再抗菌処理の時期の目安にできる利点がある。   As the medicine C, liquid essential oil (essential oil) having an antibacterial component and having volatility is preferably used. In addition, if the drug C has a surface tension of 30 mN / m or less, it is suitable for easily spreading on the drug application surface 25. Specific examples of such drugs C include rosewood oil, palmarosa oil, geranium oil, lavender tea tree oil, basil linalool oil, marjoram oil, citronella oil, lavadin oil, spike lavender oil, peppermint oil, spearmint oil, Light oil, lavender oil, bergamot oil, lemongrass oil, lemon oil, rose otto oil, eucalyptus oil, tituri oil, cypress oil, rosemary oil, sandalwood oil, juniper oil, grapefruit oil, etc. can be implemented. Also, absolute ethanol, hinokitiol, those produced only with antibacterial active ingredients (citronellol etc.), sterilized electrolytic mist, etc. may be used. Of each of the above drugs C, rosewood oil, peppermint oil, lavender tea tree oil, marjoram oil, and spike lavender oil are preferable, and rosewood oil, peppermint oil, and lavender tea tree oil are particularly preferable. In addition, when the medicine C having an fragrance component is used, the scent of the medicine C adheres to the mobile phone T subjected to antibacterial treatment, but the scent becomes weaker with the passage of time, so that the timing of re-antibacterial treatment There is an advantage that can be used as a guide.

前述した各薬剤Ｃは、抗菌成分の気化温度が薬剤毎に異なっているから、抗菌装置Ｍ１が設置された周囲の温度に合わせて適切なものを使用するのが好ましい。例えば、抗菌装置Ｍ１の周囲温度が高い夏期や高温の地域等では、抗菌成分の気化温度が高い薬剤Ｃでも効果的に抗菌効果が得られるが、抗菌装置Ｍ１の周囲温度が低くなる冬期や低温の地域等では、抗菌成分の気化温度が高い薬剤Ｃでは抗菌効果が低下する場合がある。従って、使用される季節毎や地域毎に、使用する薬剤Ｃを変更するようにすることが望ましい。なお薬剤Ｃは、１滴の滴下量が０.０５ｍｌとなるように設定された密封可能なボトル状の容器に収納保管されて変質や劣化が防止され、抗菌装置で抗菌処理を行なう際に１回の抗菌処理に必要とされる量だけが使用される。   Since each of the above-mentioned drugs C has a different vaporization temperature of the antibacterial component, it is preferable to use an appropriate one according to the ambient temperature where the antibacterial device M1 is installed. For example, in summer or high temperature areas where the ambient temperature of the antibacterial device M1 is high, an antibacterial effect can be effectively obtained even with the medicine C having a high vaporization temperature of the antibacterial component, but in winter and low temperatures when the ambient temperature of the antibacterial device M1 is low. In such areas, the antibacterial effect may be lowered with the drug C having a high vaporization temperature of the antibacterial component. Therefore, it is desirable to change the medicine C to be used for each season or region used. The medicine C is stored and stored in a sealable bottle-shaped container set so that the amount of one drop is 0.05 ml, and is prevented from being altered or deteriorated. Only the amount required for a single antimicrobial treatment is used.

そして、実施例１の抗菌装置Ｍ１では、薬剤付与プレートＢ１のソリッドとなった薬剤付与面２５に液状の薬剤Ｃを広げるため、該薬剤付与面２５の面積に対する該薬剤Ｃの付与量は、１００ｍｍ２当たり０.０００９ｍｌ〜０.００１１ｍｌが適量とされている。例えば、携帯電話Ｔの被抗菌処理部分に対応して、薬剤付与プレートＢ１の薬剤付与面２５のサイズを１００ｍｍ×５０ｍｍに設定した場合では、１回の抗菌処理のために薬剤付与面２５に付与される薬剤Ｃは０.０４５ｍｌ〜０.０５５ｍｌとされる。 And in antibacterial device M1 of Example 1, in order to spread the liquid chemical | medical agent C on the chemical | medical agent provision surface 25 used as the solid of chemical | medical agent provision plate B1, the application amount of this chemical | medical agent C with respect to the area of this chemical | medical agent application surface 25 is 100 mm. An appropriate amount is 0.0009 ml to 0.0001 ml per two . For example, when the size of the drug application surface 25 of the drug application plate B1 is set to 100 mm × 50 mm corresponding to the antibacterial process portion of the mobile phone T, it is applied to the drug application surface 25 for one antibacterial process. The drug C to be added is 0.045 ml to 0.055 ml.

(実施例１の抗菌装置による抗菌方法)
前述のように構成された実施例１の抗菌装置Ｍ１による抗菌方法は、次のような操作により携帯電話Ｔの抗菌処理を実行する。先ず、図５(ａ)に示すように、シールド部材３６を開放させたもとで、薬剤付与プレートＢ１における薬剤付与面２５に、該薬剤付与面２５の面積に応じた適量(１回の抗菌処理に必要とされる量)の薬剤Ｃを、薬剤均し縁部３４に隣接する前記受滴部１７へ滴状に滴下する。この際に、受滴部１７の第１受面１７Ａと第２受面１７Ｂとが整合しており、滴下した薬剤Ｃは、薬剤均し縁部３４と薬剤付与面２５との間に設けた案内空間内へ流れ込み、表面張力により該薬剤均し縁部３４の延在方向(薬剤拡張部材Ｓ１のスライド変位方向と交差する方向)へ伝って移動して拡散し、該薬剤付与面２５に線状に付与される。 (Antimicrobial method using the antimicrobial device of Example 1)
In the antibacterial method using the antibacterial device M1 according to the first embodiment configured as described above, the antibacterial treatment of the mobile phone T is executed by the following operation. First, as shown in FIG. 5A, with the shield member 36 opened, an appropriate amount (for one antibacterial treatment) is applied to the drug application surface 25 of the drug application plate B1 according to the area of the drug application surface 25. The required amount of medicine C is dropped into the drop receiving section 17 adjacent to the medicine leveling edge 34. At this time, the first receiving surface 17A and the second receiving surface 17B of the droplet receiving unit 17 are aligned, and the dropped drug C is provided between the drug leveling edge 34 and the drug application surface 25. It flows into the guide space, moves along the extending direction of the medicine leveling edge 34 by the surface tension (direction intersecting the sliding displacement direction of the medicine expansion member S1), diffuses, and lines to the medicine application surface 25. It is given to the shape.

次いで、図５(ｂ)に示すように、前記薬剤拡張部材Ｓ１の操作部３０を指先等で上方から押圧して、上方停止位置に停止していた該薬剤拡張部材Ｓ１を、下方停止位置に向けてゆっくりと下降させる。この際に、薬剤均し縁部３４に沿って拡散した薬剤Ｃが、該薬剤付与面２５に対して薬剤拡張部材Ｓ１のスライド変位方向へ薄膜状に付与されていく。   Next, as shown in FIG. 5 (b), the operation part 30 of the medicine expansion member S1 is pressed from above with a fingertip or the like, and the medicine expansion member S1 stopped at the upper stop position is moved to the lower stop position. Slowly move down. At this time, the drug C diffused along the drug leveling edge 34 is applied to the drug application surface 25 in the form of a thin film in the slide displacement direction of the drug expansion member S1.

薬剤拡張部材Ｓ１が下方停止位置まで下降すると、薬剤Ｃは広がりながら薬剤付与面２５に付与される。そして、薬剤拡張部材Ｓ１が下方停止位置まで下降したら、操作部３０に対する押圧を解除または緩め、スプリング１４の弾性力を利用して該薬剤拡張部材Ｓ１を上方停止位置まで上昇させる。従って、薬剤付与面２５に付与された薬剤Ｃは、前記薬剤拡散間隔Ｄ１に相当する厚さで均される。   When the drug expansion member S1 is lowered to the lower stop position, the drug C is applied to the drug application surface 25 while spreading. When the medicine expansion member S1 is lowered to the lower stop position, the pressure on the operation unit 30 is released or loosened, and the medicine expansion member S1 is raised to the upper stop position using the elastic force of the spring 14. Accordingly, the drug C applied to the drug application surface 25 is leveled by a thickness corresponding to the drug diffusion interval D1.

薬剤拡張部材Ｓ１が上方停止位置まで上昇したら、図５(ｃ)に示すように、携帯電話Ｔを機器セット部Ｈ１へセットする。この際に、携帯電話Ｔの下部分を第１スペーサ１８に当接させると共に、該携帯電話Ｔの上部分を第２スペーサ３５に当接させる。これにより、薬剤Ｃが付与された薬剤付与面２５と携帯電話Ｔとの間に所定の抗菌処理間隔Ｄ２が確保され、該携帯電話Ｔの外面における被抗菌処理部分が抗菌成分浮遊領域に正対する。なお、携帯電話Ｔを機器セット部Ｈ１にセットしてある場合には、薬剤拡張部材Ｓ１を下方へ移動させることができないので、抗菌処理中に該薬剤拡張部材Ｓ１を誤って動かすことを防止し得る。また、薬剤拡張部材Ｓ１を昇降移動させて薬剤Ｃを薬剤付与面２５に拡散させている際には、機器セット部Ｈ１へ携帯電話Ｔをセットすることが不可能である。   When the medicine expansion member S1 rises to the upper stop position, as shown in FIG. 5C, the mobile phone T is set in the device setting unit H1. At this time, the lower part of the mobile phone T is brought into contact with the first spacer 18 and the upper part of the mobile phone T is brought into contact with the second spacer 35. Accordingly, a predetermined antibacterial treatment interval D2 is secured between the medicine application surface 25 to which the medicine C is applied and the mobile phone T, and the antibacterial treatment portion on the outer surface of the mobile phone T faces the antibacterial component floating region. . In addition, when the mobile phone T is set in the device setting unit H1, the drug expansion member S1 cannot be moved downward, so that the drug expansion member S1 is prevented from being erroneously moved during the antibacterial treatment. obtain. Further, when the medicine expansion member S1 is moved up and down to spread the medicine C on the medicine application surface 25, it is impossible to set the mobile phone T in the device setting section H1.

そして、携帯電話Ｔを機器セット部Ｈ１にセットした後、シールド部材３６を閉成して３０分〜６０分間待機することで(図５ではシールド部材３６を図示省略してある)、薬剤付与面２５から空気中に気化した薬剤Ｃの抗菌成分が携帯電話Ｔの被抗菌処理部分に接触して、該携帯電話Ｔにおける前記薬剤付与面２５との距離が２０ｍｍ未満にある該被抗菌処理部分の抗菌処理がなされる。なお、薬剤付与面２５に付与された薬剤Ｃは、当該の抗菌処理を実行する際に殆どが該薬剤付与面２５から気化し、該薬剤付与面２５には気化成分は残らない。   Then, after the mobile phone T is set in the device setting portion H1, the shield member 36 is closed, and waiting for 30 to 60 minutes (the shield member 36 is not shown in FIG. 5), the drug application surface The antibacterial component of the drug C vaporized in the air from 25 contacts the antibacterial treatment part of the mobile phone T, and the distance between the mobile phone T and the drug application surface 25 is less than 20 mm. Antibacterial treatment is made. Note that most of the drug C applied to the drug application surface 25 is vaporized from the drug application surface 25 when the antibacterial treatment is performed, and no vaporized component remains on the drug application surface 25.

従って、実施例１に係る抗菌装置Ｍ１によれば、次のような作用効果を奏する。
(１)受滴部１７に滴下して、薬剤拡張部材Ｓ１の薬剤均し縁部３４により該薬剤拡張部材Ｓ１のスライド変位方向と交差する方向へ拡張させながら薬剤付与プレートＢ１の薬剤付与面２５に付与した液状の薬剤Ｃを、薬剤付与面２５に浸透させることなく、前記薬剤拡張部材Ｓ１のスライド変位により該薬剤付与面２５へ簡易かつ適切に広げることができる。そして、第１スペーサ１８および第２スペーサ３５を利用して機器セット部Ｈ１に携帯電話Ｔをセットすることで、薬剤付与面２５に広げた薬剤Ｃの抗菌成分浮遊領域に対して被抗菌処理部分を前記抗菌処理間隔Ｄ２で正対させ得るので、気化した薬剤Ｃの抗菌成分を該被抗菌処理部分に適切に接触させることができ、携帯電話Ｔの抗菌処理を効率的に行なうことを可能とする。
(２)薬剤拡張部材Ｓ１は、指先で押すだけの簡単な操作で昇降移動するので、薬剤Ｃを薬剤付与面２５に簡単かつ適切に付与することができる。また、スプリング１４の付勢力により薬剤拡張部材Ｓ１の操作スピードを制御し得ると共に、操作途中に指を離せば該スプリング１４により薬剤拡張部材Ｓ１は上方停止位置へ戻る。
(３)薬剤付与面２５に広げた薬剤Ｃが該薬剤付与面２５に浸透しないので、該薬剤Ｃの気化を促進することを可能とすると共に、抗菌処理毎に必要とされる薬剤Ｃの量を少なくしてランニングコストを抑えて電子機器の抗菌処理を低コストで行なうことを可能とし、薬剤Ｃの無駄を防止できて経済的である。
(４)抗菌装置Ｍ１に多量の薬剤Ｃを補給せず、１回の抗菌処理毎に薬剤付与面２５に付与した薬剤Ｃを使い切るので、抗菌処理後の薬剤Ｃが該薬剤付与面２５に残って劣化することを抑制でき、薬剤Ｃの無駄を防止できると共に次回の薬剤拡張の阻害を抑制できて抗菌処理を適切に行ない得る。
(５)抗菌処理を実施する毎に、抗菌効果が高い(抗菌効果が低下していない)新しい薬剤Ｃを使用するので、常に安定した抗菌処理を適切に行ない得る。
(６)薬剤付与プレートＢ１に多量の薬剤Ｃを拡張させる構成ではないから、薬剤付与プレートＢ１のサイズが大きくならず、よって抗菌装置Ｍ１が大型になることがない。
(７)機器セット部Ｈ１にセットした携帯電話Ｔが液状の薬剤Ｃと接触しないので、該薬剤Ｃが携帯電話Ｔ内へ侵入することによる該携帯電話Ｔの故障を防止し得る。
(８)抗菌装置Ｍ１による抗菌処理が終了した携帯電話Ｔは、該抗菌装置Ｍ１から取り外して直ちに使用することができ、使用に支障を来たすことは殆どない。 Therefore, according to the antibacterial device M1 according to the first embodiment, the following operational effects can be obtained.
(1) The drug application surface 25 of the drug application plate B1 is dropped onto the droplet receiving part 17 and expanded in the direction intersecting the slide displacement direction of the drug expansion member S1 by the drug leveling edge 34 of the drug expansion member S1. The liquid medicine C applied to the medicine application surface 25 can be easily and appropriately spread on the medicine application surface 25 by the slide displacement of the medicine expansion member S1 without penetrating the medicine application surface 25. Then, by using the first spacer 18 and the second spacer 35 to set the mobile phone T in the device setting unit H1, the antibacterial treatment portion is applied to the antibacterial component floating region of the drug C spread on the drug application surface 25. Can be brought into direct contact with the antibacterial treatment interval D2, so that the antibacterial component of the vaporized medicine C can be brought into appropriate contact with the antibacterial treatment part and the antibacterial treatment of the mobile phone T can be efficiently performed. To do.
(2) Since the drug expansion member S1 moves up and down by a simple operation that is simply pushed with the fingertip, the drug C can be applied to the drug application surface 25 easily and appropriately. Further, the operation speed of the drug expansion member S1 can be controlled by the urging force of the spring 14, and the drug expansion member S1 returns to the upper stop position by the spring 14 when the finger is released during the operation.
(3) Since the drug C spread on the drug application surface 25 does not penetrate into the drug application surface 25, it is possible to promote the vaporization of the drug C and the amount of the drug C required for each antibacterial treatment Therefore, the running cost can be reduced, the antibacterial treatment of the electronic device can be performed at a low cost, and the waste of the medicine C can be prevented, which is economical.
(4) A large amount of the drug C is not replenished to the antibacterial device M1, and the drug C applied to the drug application surface 25 is used up every time the antibacterial treatment is performed. Therefore, the drug C after the antibacterial treatment remains on the drug application surface 25 Deterioration can be suppressed, the waste of the drug C can be prevented, and inhibition of the next drug expansion can be suppressed, so that the antibacterial treatment can be appropriately performed.
(5) Since a new medicine C having a high antibacterial effect (an antibacterial effect is not lowered) is used every time an antibacterial treatment is performed, stable antibacterial treatment can always be appropriately performed.
(6) Since it is not the structure which expands a lot of chemical | medical agents C to chemical | medical agent provision plate B1, the size of chemical | medical agent provision plate B1 does not become large, Therefore, antibacterial device M1 does not become large sized.
(7) Since the mobile phone T set in the device setting unit H1 does not come into contact with the liquid medicine C, it is possible to prevent the mobile phone T from being broken due to the medicine C entering the mobile phone T.
(8) The mobile phone T that has been subjected to the antibacterial treatment by the antibacterial device M1 can be used immediately after being removed from the antibacterial device M1, and the use is hardly hindered.

また、実施例１の抗菌装置Ｍ１による抗菌方法によれば、次のような作用効果を奏する。
(１)薬剤付与プレートＢ１の薬剤付与面２５に付与した液状の薬剤Ｃを、薬剤付与面２５に浸透させることなく薬剤拡張部材Ｓ１で該薬剤付与面２５に広げて、薬剤付与面２５に広げた薬剤Ｃに被抗菌処理部分が非接触で正対するよう携帯電話Ｔを支持するようにしたので、気化した薬剤Ｃの抗菌成分を該被抗菌処理部分に適切に接触させて携帯電話Ｔの抗菌処理を効率的に行なうことができる。
(２)薬剤付与面２５に付与された薬剤Ｃは、薬剤拡張部材Ｓ１をスライド移動させるだけで、該薬剤付与面２５へ簡易かつ適切に広げることができる。
(３)薬剤付与面２５に広げた薬剤Ｃが該薬剤付与面２５に浸透しないので、該薬剤Ｃの気化を促進することができると共に、抗菌処理毎に必要とされる薬剤Ｃの量が少なくなってランニングコストが抑えられるので電子機器の抗菌処理を低コストで行なうことができる。
(４)抗菌装置Ｍ１に多量の薬剤Ｃを補給せず、１回の抗菌処理毎に薬剤付与面２５に付与した薬剤Ｃを使い切るので、抗菌処理後の薬剤Ｃが該薬剤付与面２５に残って劣化することを抑制でき、薬剤Ｃの無駄を防止できると共に次回の薬剤拡張の阻害を抑制できて抗菌処理を適切に行ない得る。
(５)抗菌処理を実施する毎に、抗菌効果が高い(抗菌効果が低下していない)新しい薬剤Ｃを使用するので、常に安定した抗菌処理を適切に行ない得る。
(６)薬剤Ｃは、専用の密封可能な容器に収納して保管されて、抗菌処理毎に必要とされる量だけを使用するので、長期間に亘って抗菌効果を維持できる。
(７)機器セット部Ｈ１にセットした携帯電話Ｔを液状の薬剤Ｃと接触させないので、該薬剤Ｃが携帯電話Ｔ内へ侵入することによる該携帯電話Ｔの故障を防止し得る。 In addition, according to the antibacterial method using the antibacterial device M1 of Example 1, the following operational effects can be obtained.
(1) The liquid drug C applied to the drug application surface 25 of the drug application plate B1 is spread on the drug application surface 25 by the drug expansion member S1 without penetrating the drug application surface 25, and is spread on the drug application surface 25. Since the mobile phone T is supported so that the antibacterial treatment portion faces the non-contact portion of the antibacterial agent C, the antibacterial component of the mobile phone T is appropriately brought into contact with the antibacterial component of the vaporized drug C. Processing can be performed efficiently.
(2) The medicine C applied to the medicine application surface 25 can be easily and appropriately spread onto the medicine application surface 25 only by sliding the medicine expansion member S1.
(3) Since the drug C spread on the drug application surface 25 does not penetrate into the drug application surface 25, vaporization of the drug C can be promoted, and the amount of the drug C required for each antibacterial treatment is small. Thus, the running cost can be suppressed, so that the antibacterial treatment of the electronic device can be performed at a low cost.
(4) A large amount of the drug C is not replenished to the antibacterial device M1, and the drug C applied to the drug application surface 25 is used up every time the antibacterial treatment is performed. Therefore, the drug C after the antibacterial treatment remains on the drug application surface 25 Deterioration can be suppressed, the waste of the drug C can be prevented, and inhibition of the next drug expansion can be suppressed, so that the antibacterial treatment can be appropriately performed.
(5) Since a new medicine C having a high antibacterial effect (an antibacterial effect is not lowered) is used every time an antibacterial treatment is performed, stable antibacterial treatment can always be appropriately performed.
(6) Since the medicine C is stored and stored in a dedicated sealable container and uses only the amount required for each antibacterial treatment, the antibacterial effect can be maintained over a long period of time.
(7) Since the mobile phone T set in the device setting unit H1 is not brought into contact with the liquid medicine C, it is possible to prevent the mobile phone T from being broken due to the medicine C entering the mobile phone T.

(実施例２)
図６は、実施例２に係る電子機器の抗菌装置Ｍ２の概略斜視図、図７は、図６に示す抗菌装置Ｍ２の平面図、図８は、図６に示す抗菌装置Ｍ２の右側面図である。実施例２の抗菌装置Ｍ２は、電子機器である携帯電話Ｔの抗菌処理を行なうものである。この抗菌装置Ｍ２は、携帯電話Ｔが着脱可能にセットされる本体Ｆ２と、抗菌成分を含む液状の薬剤Ｃが付与される薬剤付与面５０を有した薬剤付与プレート(薬剤付与部)Ｂ２と、前記薬剤Ｃを、薬剤付与面５０に広げる薬剤拡張端部(薬剤拡張手段)Ｓ２とを備える。また抗菌装置Ｍ２は、本体Ｆ２にセットする携帯電話Ｔを、薬剤付与面５０から離した姿勢で支持するリブ４２(支持手段)を備えている。なお実施例２では、図６に示すように、抗菌装置Ｍ２を卓上等の水平面に置いた使用状態において、垂直方向を抗菌装置Ｍ２の「上下方向」、前記薬剤付与面５０に沿う水平方向を抗菌装置Ｍ２の「左右方向」、この左右方向と水平に直交する方向を抗菌装置Ｍ２の「前後方向」と指称する。そして携帯電話Ｔは、その幅方向を抗菌装置Ｍ２の左右方向に整合させ、長さ方向を抗菌装置Ｍ２の前後方向に整合させた姿勢で本体Ｆ２にセットされる。 (Example 2)
6 is a schematic perspective view of the antibacterial device M2 of the electronic apparatus according to the second embodiment, FIG. 7 is a plan view of the antibacterial device M2 shown in FIG. 6, and FIG. 8 is a right side view of the antibacterial device M2 shown in FIG. It is. The antibacterial device M2 of Example 2 performs an antibacterial treatment of the mobile phone T that is an electronic device. The antibacterial device M2 includes a main body F2 on which the mobile phone T is detachably set, a drug application plate (medicine application unit) B2 having a drug application surface 50 to which a liquid drug C containing an antibacterial component is applied, A drug expansion end (drug expansion means) S2 that spreads the drug C on the drug application surface 50 is provided. The antibacterial device M2 includes a rib 42 (support means) that supports the mobile phone T set in the main body F2 in a posture away from the medicine application surface 50. In Example 2, as shown in FIG. 6, when the antibacterial device M2 is placed on a horizontal surface such as a desktop, the vertical direction is the “vertical direction” of the antibacterial device M2, and the horizontal direction along the drug application surface 50 is The “left-right direction” of the antibacterial device M2 and the direction perpendicular to the left-right direction are referred to as “front-back direction” of the antibacterial device M2. The mobile phone T is set on the main body F2 in a posture in which the width direction is aligned with the left-right direction of the antibacterial device M2, and the length direction is aligned with the front-rear direction of the antibacterial device M2.

本体Ｆ２は、図６〜図８に示すように、上方および右側方へ開口した第１本体部材４０と、第１本体部材４０の右側に装着された第２本体部材４１とからなり、第１本体部材４０に対して第２本体部材４１を組付けることで上方に開口した矩形の有底箱体状となっている。そして、本体Ｆ２の上部に、携帯電話Ｔを載置する機器セット部Ｈ２が設けられている。この機器セット部Ｈ２は、フラップタイプの携帯電話Ｔを安定的に載置し得るように、本体Ｆ２の前後方向における略中間部分で屈曲していると共に該中間部分が陥凹した形状となっている。すなわち、前記中間屈曲部より後側は略水平であり、該中間屈曲部より前側は前下がりの傾斜状となっている。なお、本体Ｆ２の上部開口には、左右方向へ延在する複数のリブ(支持手段)４２が、前後方向に適宜間隔毎に形成されている。これらリブ４２は、機器セット部Ｈ２に載置する携帯電話Ｔを下方から支持すると共に、該携帯電話Ｔと薬剤付与プレートＢ２の薬剤付与面５０とに間に所定の抗菌処理間隔Ｄ２を確保する。   As shown in FIGS. 6 to 8, the main body F <b> 2 includes a first main body member 40 that opens upward and rightward, and a second main body member 41 that is mounted on the right side of the first main body member 40. The second main body member 41 is assembled to the main body member 40 to form a rectangular bottomed box that opens upward. And the apparatus set part H2 which mounts the mobile telephone T is provided in the upper part of the main body F2. The device set portion H2 is bent at a substantially intermediate portion in the front-rear direction of the main body F2 so that the flap type mobile phone T can be stably placed, and the intermediate portion is recessed. Yes. That is, the rear side of the intermediate bent portion is substantially horizontal, and the front side of the intermediate bent portion is inclined downward. In the upper opening of the main body F2, a plurality of ribs (supporting means) 42 extending in the left-right direction are formed at appropriate intervals in the front-rear direction. These ribs 42 support the mobile phone T placed on the device setting portion H2 from below, and secure a predetermined antibacterial treatment interval D2 between the mobile phone T and the drug application surface 50 of the drug application plate B2. .

また本体Ｆ２の右側面には、図６〜図８に示すように、前記薬剤付与プレートＢ２の挿通を許容するスライド挿通口４３が、前記機器セット部Ｈ２の屈曲形状に合わせて略「へ」字形に形成されている。本体Ｆ２の内部における前壁内側と後壁内側には、左右方向に延在すると共に前記スライド挿通口４３に整合するガイドレール(スライド手段)４４,４４が設けられている。これらガイドレール４４,４４は、前端縁および後端縁が係合した前記薬剤付与プレートＢ２のスライド移動を案内するためのものである。また、本体Ｆ２の右側面には２つの凹部４５,４５が形成されており、薬剤付与プレートＢ２のスライド量を減らすと共に、薬剤付与プレートＢ２の薬剤付与面５０に対する薬剤Ｃの付与作業を行ない易くなっている。   Also, on the right side surface of the main body F2, as shown in FIG. 6 to FIG. 8, a slide insertion port 43 that allows insertion of the medicine application plate B2 is substantially “f” according to the bent shape of the device set portion H2. It is formed in a letter shape. Guide rails (sliding means) 44, 44 extending in the left-right direction and aligned with the slide insertion opening 43 are provided on the inner side of the front wall and the inner side of the rear wall in the main body F 2. These guide rails 44, 44 are for guiding the sliding movement of the medicine applying plate B2 engaged with the front end edge and the rear end edge. In addition, two concave portions 45, 45 are formed on the right side surface of the main body F2, and the amount of slide of the drug application plate B2 is reduced, and the application operation of the drug C to the drug application surface 50 of the drug application plate B2 is easy. It has become.

薬剤付与プレートＢ２は、図６〜図８に示すように、前記本体Ｆ２にスライド移動可能に配設された略矩形状の部材であり、機器セット部Ｈ２に臨む上面が、本体Ｆ２の前後方向において縦長の薬剤付与面５０とされ、前後方向の中間部位で折曲している。この薬剤付与プレートＢ２は、少なくとも薬剤付与面５０となる上面部分に液状の薬剤Ｃが浸透していく空隙を有さないソリッドとなっており、薬剤付与面５０に付与された薬剤Ｃが該薬剤付与プレートＢ２の内部へ浸透することが不可能となっている。薬剤付与面５０は、携帯電話Ｔの外面における被抗菌処理部分(実施例では、携帯電話Ｔの液晶表示面およびキー操作面)の大きさおよび形状に基づき、該被抗菌処理部分より一回り大きく設定されている。そして薬剤付与プレートＢ２は、側面形状が前記スライド挿通口４３と同一の略「へ」字形となっており、該スライド挿通口４３を介して該本体Ｆ２内に挿入され得る。本体Ｆ２内へ挿入された薬剤付与プレートＢ２は、該薬剤付与プレートＢ２の前端縁および後端縁が係合したガイドレール４４,４４で該本体Ｆ２に支持される。また薬剤付与プレートＢ２は、本体Ｆ２内に収納されて薬剤付与面５０を機器セット部Ｈ２の携帯電話Ｔに臨ませた収容位置(対向位置)(図６)と、スライド挿通口４３を介して本体Ｆ２の右方向へ引出して薬剤付与面５０を携帯電話Ｔから離間させた引出し位置(退避位置)(図７)との間で、ガイドレール４４,４４に沿って本体Ｆ２の左右方向(薬剤付与面５０の幅方向)へのスライド移動が可能となっている。   As shown in FIGS. 6 to 8, the drug application plate B2 is a substantially rectangular member that is slidably disposed on the main body F2, and the upper surface facing the device setting portion H2 is the front-rear direction of the main body F2. Is a vertically long medicine application surface 50 and is bent at an intermediate portion in the front-rear direction. The drug application plate B2 is a solid that does not have a gap through which the liquid drug C permeates at least on the upper surface portion that becomes the drug application surface 50, and the drug C applied to the drug application surface 50 is the drug. It is impossible to penetrate into the inside of the application plate B2. The medicine application surface 50 is slightly larger than the antibacterial treatment portion based on the size and shape of the antibacterial treatment portion (in the embodiment, the liquid crystal display surface and the key operation surface of the mobile phone T) on the outer surface of the mobile phone T. Is set. The drug application plate B <b> 2 has a substantially “h” -shaped side surface that is the same as the slide insertion port 43, and can be inserted into the main body F <b> 2 through the slide insertion port 43. The drug application plate B2 inserted into the main body F2 is supported by the main body F2 by guide rails 44, 44 engaged with the front and rear edges of the drug application plate B2. Further, the medicine application plate B2 is housed in the main body F2 so that the medicine application surface 50 faces the mobile phone T of the device setting unit H2 (opposite position) (FIG. 6) and the slide insertion port 43. Between the drawer position (retracted position) (FIG. 7) in which the medicine application surface 50 is pulled out to the right of the main body F2 and separated from the mobile phone T (FIG. 7), the left and right direction of the main body F2 (the medicine) A sliding movement in the width direction of the application surface 50 is possible.

薬剤付与プレートＢ２の右端中央には、指先等で把持可能な取っ手５１が形成されている。また、薬剤付与プレートＢ２の左端には、前後方向に離間して２つの膨出部５２,５２が形成されている。更に、薬剤付与プレートＢ２の薬剤付与面５０において、前記各膨出部５２,５２に対応した部位には、薬剤Ｃの滴下位置を示すマーキング５３,５３が形成されている。これらマーキング５３,５３は、図７に示すように、薬剤付与プレートＢ２の引出し位置において、本体Ｆ２の前記凹部４５,４５に隣接する位置となる。   A handle 51 that can be gripped with a fingertip or the like is formed at the center of the right end of the medicine application plate B2. In addition, two bulging portions 52, 52 are formed at the left end of the medicine application plate B2 so as to be separated in the front-rear direction. Further, markings 53 and 53 indicating the dropping position of the medicine C are formed on the medicine application surface 50 of the medicine application plate B2 at portions corresponding to the bulging portions 52 and 52, respectively. As shown in FIG. 7, the markings 53 and 53 are positioned adjacent to the concave portions 45 and 45 of the main body F <b> 2 at the drawing position of the drug application plate B <b> 2.

薬剤拡張端部Ｓ２は、図７および図８に示すように、本体Ｆ２の第２本体部材４１において、前記スライド挿通口４３の開口上縁に沿って形成されている。すなわち薬剤拡張端部Ｓ２は、本体Ｆ２における薬剤付与プレートＢ２の移動経路上に設けられ、薬剤付与面５０に対向し、かつ薬剤付与プレートＢ２の移動方向と交差する方向(前後方向)へ延在する薬剤均し端部５５を有している。従って薬剤拡張端部Ｓ２は、薬剤付与プレートＢ２がスライド挿通口４３を介してスライド移動する際に、薬剤付与面５０の前後方向に亘って延在するようになる。そして、薬剤拡張端部Ｓ２の薬剤均し端部５５と薬剤付与プレートＢ２の薬剤付与面５０とは、所定の薬剤拡散間隔Ｄ１で非接触状態に対向しており、これら薬剤付与面５０と薬剤均し端部５５との間に案内空間が設けられている。すなわち薬剤拡散間隔Ｄ１は、図９(ａ)に示すように、薬剤付与面５０に滴下した前記薬剤Ｃの薬滴の厚さより狭くなっている。従って薬剤Ｃは、薬剤均し端部５５側へ薬剤付与プレートＢ２を移動した際に、表面張力により該薬剤均し端部５５と薬剤付与面５０との間の案内空間内へ流れ込み、該案内空間を伝わって薬剤均し端部５５の延在方向(薬剤付与面５０の前後方向)へ移動するようになる。なお薬剤拡散間隔Ｄ１は、薬剤付与面５０に薬剤Ｃを薄膜状に付与させるため、具体的には０.１ｍｍ以下に設定するのが望ましい。   As shown in FIGS. 7 and 8, the drug expansion end S <b> 2 is formed along the upper edge of the opening of the slide insertion port 43 in the second main body member 41 of the main body F <b> 2. That is, the drug expansion end S2 is provided on the movement path of the drug application plate B2 in the main body F2, faces the drug application surface 50, and extends in a direction (front-rear direction) intersecting the moving direction of the drug application plate B2. The medicine leveling end portion 55 is provided. Therefore, when the medicine application plate B2 slides through the slide insertion port 43, the medicine expansion end S2 extends in the front-rear direction of the medicine application surface 50. The drug leveling end 55 of the drug expansion end S2 and the drug application surface 50 of the drug application plate B2 face each other in a non-contact state at a predetermined drug diffusion interval D1, and these drug application surface 50 and drug A guide space is provided between the leveling end 55. That is, the drug diffusion interval D1 is narrower than the thickness of the drug drop of the drug C dropped on the drug application surface 50 as shown in FIG. Therefore, when the medicine C moves the medicine application plate B2 toward the medicine leveling end 55, the medicine C flows into the guide space between the medicine leveling end 55 and the medicine application surface 50 due to surface tension. It travels through the space and moves in the extending direction of the medicine leveling end 55 (front-rear direction of the medicine application surface 50). The drug diffusion interval D1 is preferably set to 0.1 mm or less in order to apply the drug C to the drug application surface 50 in a thin film.

機器セット部Ｈ２に載置した携帯電話Ｔと収容位置の薬剤付与プレートＢ２の薬剤付与面５０との間には、前記リブ４２により、所定の抗菌処理間隔Ｄ２が形成されている。この抗菌処理間隔Ｄ２は、携帯電話Ｔの薬剤付与面５０と対向している外面(被抗菌処理部分)における上部分、中間部分、下部分において多少の差異はあるが、０ｍｍ＜Ｄ２≦２０ｍｍの範囲内で設定されている。この抗菌処理間隔Ｄ２の数値範囲は、本願発明者が行なった後述の実験により得られたものである。すなわち、抗菌処理間隔Ｄ２を０ｍｍ＜Ｄ２≦２０ｍｍとすることで、薬剤Ｃが携帯電話Ｔに直接接触して該携帯電話Ｔが濡れるのを防止したもとで、薬剤付与面５０に付与された薬剤Ｃの気化した抗菌成分から形成された抗菌成分浮遊領域内において、機器セット部Ｈ２にセットした携帯電話Ｔの外面における被抗菌処理部分が該抗菌成分浮遊領域に臨むようになる。これにより、薬剤Ｃの気化した抗菌成分が携帯電話Ｔの被抗菌処理部分に効率的に接触して、該携帯電話Ｔの抗菌処理が適切に行なわれる。   A predetermined antibacterial treatment interval D2 is formed by the rib 42 between the mobile phone T placed on the device setting unit H2 and the medicine application surface 50 of the medicine application plate B2 in the accommodation position. This antibacterial treatment interval D2 is slightly different in the upper part, the middle part, and the lower part on the outer surface (antibacterial treatment part) facing the drug application surface 50 of the mobile phone T, but 0 mm <D2 ≦ 20 mm. It is set within the range. This numerical range of the antibacterial treatment interval D2 is obtained by an experiment described later conducted by the inventor of the present application. That is, by setting the antibacterial treatment interval D2 to 0 mm <D2 ≦ 20 mm, the medicine C was applied to the medicine application surface 50 while preventing the mobile phone T from coming into direct contact with the mobile phone T and getting wet. In the antibacterial component floating region formed from the vaporized antibacterial component of the medicine C, the antibacterial treatment portion on the outer surface of the mobile phone T set in the device setting portion H2 faces the antibacterial component floating region. Thereby, the antibacterial component which the chemical | medical agent C vaporized contacts the antibacterial process part of the mobile phone T efficiently, and the antibacterial process of this mobile phone T is performed appropriately.

(実施例２の抗菌装置による抗菌方法)
前述のように構成された実施例２の抗菌装置Ｍ２による抗菌方法は、次のような操作により携帯電話Ｔの抗菌処理を実行する。先ず、図９(ａ)に示すように、薬剤付与プレートＢ２を本体Ｆ２から右外方へスライドさせて引出し位置としたもとで、実施例１で説明した如く、薬剤付与プレートＢ２における薬剤付与面５０に、該薬剤付与面５０の面積に応じた適量(１回の抗菌処理に必要とされる量)の薬剤Ｃを、前記各マーキング５３,５３の位置へ滴状に滴下する。 (Antimicrobial method using the antimicrobial device of Example 2)
In the antibacterial method using the antibacterial device M2 of the second embodiment configured as described above, the antibacterial treatment of the mobile phone T is executed by the following operation. First, as shown in FIG. 9 (a), the medicine application plate B2 is slid outwardly from the main body F2 to the right-out position, and the medicine application on the medicine application plate B2 is performed as described in the first embodiment. An appropriate amount (the amount required for one antibacterial treatment) of the drug C corresponding to the area of the drug application surface 50 is dropped onto the surface 50 in the form of droplets at the positions of the markings 53 and 53.

次いで、図９(ｂ)に示すように、前記薬剤付与プレートＢ２を、本体Ｆ２内へゆっくりとスライド移動させる。この際に、薬剤付与面５０へ滴下した各薬剤Ｃは、スライド挿通口４３に臨む薬剤均し端部５５まで移動すると案内空間内へ流れ込み、表面張力により該薬剤均し端部５５の延在方向(薬剤付与プレートＢ２のスライド変位方向と交差する方向)へ伝って移動して拡散する。そして、薬剤付与プレートＢ２を前記収容位置に向けてゆっくりと押し込むと、薬剤均し端部５５に沿って拡散した薬剤Ｃが、薬剤付与面５０に対して薬剤付与プレートＢ２のスライド変位方向へ薄膜状に付与されていく。   Next, as shown in FIG. 9B, the drug application plate B2 is slowly slid into the main body F2. At this time, each drug C dropped onto the drug application surface 50 flows into the guide space when it moves to the drug leveling end 55 facing the slide insertion port 43, and the drug leveling end 55 extends due to surface tension. It moves in the direction (direction intersecting with the slide displacement direction of the drug application plate B2) and diffuses. Then, when the medicine application plate B2 is slowly pushed toward the accommodation position, the medicine C diffused along the medicine leveling end portion 55 becomes a thin film in the slide displacement direction of the medicine application plate B2 with respect to the medicine application surface 50. It is given to the shape.

薬剤付与プレートＢ２が収容位置までスライド移動すると、図９(ｃ)に示すように、薬剤Ｃは、薬剤付与面５０に広がりながら該薬剤付与面５０に付与される。すなわち、薬剤付与面５０に付与された薬剤Ｃは、前記薬剤拡散間隔Ｄ１に相当する厚さで均される。   When the medicine application plate B2 slides to the accommodation position, the medicine C is applied to the medicine application surface 50 while spreading on the medicine application surface 50 as shown in FIG. That is, the drug C applied to the drug application surface 50 is leveled by a thickness corresponding to the drug diffusion interval D1.

なお図９では、携帯電話Ｔを機器セット部Ｈ２へ載置した状態で、薬剤Ｃを薬剤付与面５０に付与する場合を例示したが、前記薬剤Ｃの付与が完了した後に、携帯電話Ｔを機器セット部Ｈ２に載置するようにしてもよい。そして、携帯電話Ｔを機器セット部Ｈ２にセットし、薬剤Ｃが付与された薬剤付与面５０と携帯電話Ｔとの間に所定の抗菌処理間隔Ｄ２を確保したもとで、該携帯電話Ｔの外面における被抗菌処理部分を抗菌成分浮遊領域に正対させる。そして、この状態で３０分〜６０分間待機することで、薬剤付与面５０から空気中に気化した薬剤Ｃが携帯電話Ｔの被抗菌処理部分に接触して、該携帯電話Ｔにおける前記薬剤付与面５０との距離が２０ｍｍ未満にある該被抗菌処理部分の抗菌処理がなされる。なお、薬剤付与面５０に付与された薬剤Ｃは、当該の抗菌処理を実行する際に、その殆どが該薬剤付与面５０から気化し、該薬剤付与面５０には気化成分は残らない。   In FIG. 9, the case where the medicine C is applied to the medicine application surface 50 in a state where the mobile phone T is placed on the device setting unit H2 is illustrated. However, after the application of the medicine C is completed, the mobile phone T is You may make it mount in the apparatus set part H2. Then, the mobile phone T is set in the device setting unit H2, and a predetermined antibacterial treatment interval D2 is secured between the medicine application surface 50 to which the medicine C is applied and the mobile phone T. The antibacterial treatment portion on the outer surface is directly opposed to the antibacterial component floating region. And by waiting for 30 minutes to 60 minutes in this state, the medicine C vaporized in the air from the medicine application surface 50 comes into contact with the antibacterial treatment portion of the mobile phone T, and the medicine application surface in the mobile phone T The antibacterial treatment is performed on the portion to be antibacterial treatment having a distance from 50 of less than 20 mm. Note that most of the drug C applied to the drug application surface 50 is vaporized from the drug application surface 50 when the antibacterial treatment is performed, and no vaporized component remains on the drug application surface 50.

従って、実施例２に係る抗菌装置Ｍ２によれば、薬剤付与プレートＢ２のマーキング５３が形成された位置に滴下して、薬剤拡張端部Ｓ２の薬剤均し端部５５により該薬剤付与プレートＢ２のスライド変位方向と交差する方向へ拡張させた液状の薬剤Ｃを、薬剤付与面５０に浸透させることなく、前記薬剤付与プレートＢ２のスライド変位により該薬剤付与面５０に簡易かつ適切に広げることができる。そして、本体Ｆ２の機器セット部Ｈ２に携帯電話Ｔをセットすることで、薬剤付与面５０に広げた薬剤Ｃの抗菌成分浮遊領域に対して被抗菌処理部分を前記抗菌処理間隔Ｄ２で正対させ得るので、気化した薬剤Ｃの抗菌成分を該被抗菌処理部分に適切に接触させることができ、携帯電話Ｔの抗菌処理を効率的に行なうことを可能とする。従って、実施例２の抗菌装置Ｍ２によれば、実施例１の抗菌装置Ｍ１と同等の作用効果が得られる。   Therefore, according to the antibacterial device M2 according to the second embodiment, the medicine application plate B2 is dropped at the position where the marking 53 is formed on the medicine application plate B2, and the medicine application plate B2 of the medicine application end portion S2 of the medicine application end B2 The liquid medicine C expanded in the direction intersecting the slide displacement direction can be easily and appropriately spread on the medicine application surface 50 by the slide displacement of the medicine application plate B2 without penetrating the medicine application surface 50. . Then, by setting the mobile phone T in the device setting unit H2 of the main body F2, the antibacterial treatment portion is opposed to the antibacterial component floating region of the medicine C spread on the medicine application surface 50 at the antibacterial treatment interval D2. Therefore, the antibacterial component of the vaporized medicine C can be appropriately brought into contact with the antibacterial treatment part, and the cell phone T can be efficiently subjected to the antibacterial treatment. Therefore, according to the antibacterial device M2 of the second embodiment, an operational effect equivalent to that of the antibacterial device M1 of the first embodiment is obtained.

また、実施例２の抗菌装置Ｍ２による抗菌方法によれば、薬剤付与プレートＢ２の薬剤付与面５０に付与した液状の薬剤Ｃを、薬剤付与面５０に浸透させることなく薬剤拡張端部Ｓ２で該薬剤付与面５０に広げて、薬剤付与面５０に広げた薬剤Ｃに被抗菌処理部分が非接触で正対するよう携帯電話Ｔを支持するようにしたので、気化した薬剤Ｃの抗菌成分を該被抗菌処理部分に適切に接触させて携帯電話Ｔの抗菌処理を効率的に行なうことができる。従って、実施例２の抗菌装置Ｍ２による抗菌方法によれば、実施例１の抗菌装置Ｍ１による抗菌方法と同等の作用効果が得られる。   Further, according to the antibacterial method using the antibacterial device M2 of Example 2, the liquid drug C applied to the drug application surface 50 of the drug application plate B2 is not penetrated into the drug application surface 50 at the drug expansion end S2. Since the mobile phone T is supported so that the antibacterial treatment portion faces the drug C spread on the drug application surface 50 in a non-contact manner, the antibacterial component of the vaporized drug C is applied to the target. The antibacterial treatment of the mobile phone T can be efficiently performed by appropriately contacting the antibacterial treatment portion. Therefore, according to the antibacterial method using the antibacterial device M2 of the second embodiment, the same effects as the antibacterial method using the antibacterial device M1 of the first embodiment can be obtained.

(実施例３)
図１０は、実施例３に係る電子機器の抗菌装置Ｍ３の概略斜視図、図１１は、図１０に示す抗菌装置Ｍ３の左側面図である。実施例３の抗菌装置Ｍ３は、矩形箱状の電子機器Ｔの抗菌処理を行なうものである。この抗菌装置Ｍ３は、電子機器Ｔが着脱可能にセットされる本体Ｆ３と、抗菌成分を含む薬剤Ｃが付与される薬剤付与面７０を有し、前記薬剤付与面７０を電子機器Ｔに向けた状態となるように本体Ｆ３に配設された薬剤付与プレート(薬剤付与部)Ｂ３と、前記薬剤Ｃを、薬剤付与面７０に広げる押付プレート(薬剤拡張手段)Ｓ３とを備える。また抗菌装置Ｍ３は、本体Ｆ３にセットする電子機器Ｔを、薬剤付与面７０からから離した姿勢で支持する支持手段を備えている。なお実施例３では、図１０に示すように、抗菌装置Ｍ３を卓上等の水平面に置いた使用状態において、垂直方向を抗菌装置Ｍ３の「上下方向」、前記薬剤付与面７０に沿う水平方向を抗菌装置Ｍ３の「左右方向」、この左右方向と水平に直交する方向を抗菌装置Ｍ３の「前後方向」と指称する。 Example 3
FIG. 10 is a schematic perspective view of the antibacterial device M3 of the electronic apparatus according to the third embodiment, and FIG. 11 is a left side view of the antibacterial device M3 shown in FIG. The antibacterial device M3 of Example 3 performs an antibacterial treatment of the rectangular box-shaped electronic device T. The antibacterial device M3 includes a main body F3 on which the electronic device T is detachably set, and a drug application surface 70 to which a drug C containing an antibacterial component is applied, and the drug application surface 70 faces the electronic device T. A drug application plate (medicine application part) B3 disposed in the main body F3 so as to be in a state and a pressing plate (medicine expansion means) S3 that spreads the drug C on the drug application surface 70 are provided. The antibacterial device M3 includes support means for supporting the electronic device T set in the main body F3 in a posture away from the medicine application surface 70. In Example 3, as shown in FIG. 10, when the antibacterial device M3 is placed on a horizontal surface such as a desktop, the vertical direction is the “vertical direction” of the antibacterial device M3, and the horizontal direction along the medicine application surface 70 is The “left-right direction” of the antibacterial device M3 and the direction perpendicular to the left-right direction are referred to as “front-back direction” of the antibacterial device M3.

本体Ｆ３は、図１０および図１１に示すように、前方へ延出した第１本体部６０と、第１本体部６０の後端から上方へ立設した第２本体部６１とからなり、側面から見て略「Ｌ」字型に形成されている。そして、本体Ｆ３の前側上方に、電子機器Ｔを載置する機器セット部Ｈ３が設けられている。この機器セット部Ｈ３は、第１本体部６０の上面に垂直に立設した４本の支持部材(支持手段)６２と、第２本体部６１の前面から水平前方へ延出した２の当接部材(支持手段)６３とからなる。各支持部材６２は、電子機器Ｔを下方から支持して、該電子機器Ｔと押付プレートＳ３の押付面７５との間に所定の抗菌処理間隔Ｄ２を確保する。また各当接部材６３は、電子機器Ｔを後方から支持して、該電子機器Ｔと薬剤付与プレートＢ３の薬剤付与面７０との間に所定の抗菌処理間隔Ｄ２を確保する。なお、第２本体部６１の左右中間には、薬剤付与プレートＢ３を前方へ臨ませるため、薬剤付与プレートＢ３の左右方向の長さより幅が狭い凹部６４が形成されている。また、本体Ｆ３の第２本体部６１における前記凹部６４の下端には、図１１に示すように、左右方向へ延在する枢支軸(回転支持手段)６５が架設されている。   As shown in FIGS. 10 and 11, the main body F <b> 3 includes a first main body portion 60 extending forward and a second main body portion 61 erected upward from the rear end of the first main body portion 60. When viewed from above, it is formed in a substantially “L” shape. And the apparatus set part H3 which mounts the electronic device T is provided above the front side of the main body F3. The device setting portion H3 includes four support members (supporting means) 62 that are erected vertically on the upper surface of the first main body portion 60, and two abutments that extend horizontally forward from the front surface of the second main body portion 61. And a member (support means) 63. Each support member 62 supports the electronic device T from below, and ensures a predetermined antibacterial treatment interval D2 between the electronic device T and the pressing surface 75 of the pressing plate S3. Each abutting member 63 supports the electronic device T from behind, and secures a predetermined antibacterial treatment interval D2 between the electronic device T and the drug application surface 70 of the drug application plate B3. In addition, in the middle of the left and right sides of the second main body 61, a concave portion 64 having a width narrower than the length in the left-right direction of the drug application plate B3 is formed in order to face the drug application plate B3 forward. Further, as shown in FIG. 11, a pivot shaft (rotation support means) 65 extending in the left-right direction is installed at the lower end of the concave portion 64 in the second main body portion 61 of the main body F3.

薬剤付与プレートＢ３は、図１０および図１１に示すように、前記本体Ｆ３の第２本体部６１に回転可能に配設された略矩形状の部材であり、前面が薬剤付与面７０とされている。この薬剤付与プレートＢ３は、少なくとも薬剤付与面７０となる外面部分が、液状の薬剤Ｃが浸透していく空隙を有さないソリッドとなっており、薬剤付与面７０に付与された薬剤Ｃが該薬剤付与プレートＢ３の内部へ浸透することが不可能となっている。薬剤付与面７０は、電子機器Ｔの外面における被抗菌処理部分の大きさおよび形状に基づき、該被抗菌処理部分より一回り大きく設定されている。そして、薬剤付与プレートＢ３の下端には、前記枢支軸６５が左右方向へ挿通するボス部７１が形成されている。   As shown in FIGS. 10 and 11, the drug application plate B3 is a substantially rectangular member rotatably disposed on the second main body portion 61 of the main body F3, and the front surface is a drug application surface 70. Yes. In the drug application plate B3, at least the outer surface portion that becomes the drug application surface 70 is a solid that does not have a gap through which the liquid drug C permeates, and the drug C applied to the drug application surface 70 is It is impossible to penetrate into the inside of the drug application plate B3. The medicine application surface 70 is set to be slightly larger than the antibacterial treatment portion based on the size and shape of the antibacterial treatment portion on the outer surface of the electronic device T. And the boss | hub part 71 which the said pivot shaft 65 penetrates in the left-right direction is formed in the lower end of chemical | medical agent provision plate B3.

押付プレートＳ３は、図１０および図１１に示すように、前記本体Ｆ３の第２本体部６１に回転可能に配設された略矩形状の部材である。そして、押付プレートＳ３の上面には、薬剤付与プレートＢ３の薬剤付与面７０と全面的に対向する押付面７５が形成されている。この押付プレートＳ３は、押付面７５となる外面部分および薬剤付与プレートＢ３の薬剤付与面７０とが、液状の薬剤Ｃが浸透していく空隙を有さないソリッドとなっており、押付面７５に付着した薬剤Ｃが該押付プレートＳ３の内部へ浸透することが不可能ととなっている。押付プレートＳ３の後端には、前記枢支軸６５が左右方向へ挿通するボス部７６が形成されている。従って押付プレートＳ３は、枢支軸６５を中心として後端側が本体Ｆ３に枢支され、前方へ延出した前方水平位置(図１１)と、後方へ１８０°回転して後方へ延出した後方水平位置(図１２(ｂ))との間で回転移動が可能となっている。すなわち押付プレートＳ３は、本体Ｆ３の凹部６４より左右方向の寸法が小さく形成されていて、該凹部６４を介して本体Ｆ３の後方へ回転変位することが許容される。なお、図１０中の符号７７は、押付プレートＳ３が前方水平位置にある場合に、第１本体部６０の上面に当接して該押付プレートＳ３を前方水平位置に保持する支持片である。   As shown in FIGS. 10 and 11, the pressing plate S3 is a substantially rectangular member that is rotatably disposed on the second main body portion 61 of the main body F3. A pressing surface 75 is formed on the upper surface of the pressing plate S3 so as to entirely face the drug application surface 70 of the drug application plate B3. In this pressing plate S3, the outer surface portion that becomes the pressing surface 75 and the drug application surface 70 of the drug application plate B3 are solid without a gap through which the liquid drug C penetrates. It is impossible for the adhered medicine C to penetrate into the pressing plate S3. A boss portion 76 through which the pivot shaft 65 is inserted in the left-right direction is formed at the rear end of the pressing plate S3. Therefore, the pressing plate S3 is pivotally supported by the main body F3 with the pivot shaft 65 as a center, the front horizontal position (FIG. 11) extending forward, and the rear extending 180 ° rearward. A rotational movement between the horizontal position (FIG. 12B) is possible. That is, the pressing plate S3 is formed with a dimension in the left-right direction smaller than the concave portion 64 of the main body F3, and is allowed to be rotationally displaced rearward of the main body F3 via the concave portion 64. In addition, the code | symbol 77 in FIG. 10 is a support piece which contacts the upper surface of the 1st main-body part 60, and hold | maintains this pressing plate S3 in a front horizontal position, when the pressing plate S3 exists in a front horizontal position.

薬剤付与プレートＢ３の下端には、図１１に示すように、前方へ延出した係止爪部７２が形成されている。この係止爪部７２は、薬剤付与プレートＢ３の垂直位置において、前方水平位置の押付プレートＳ３における下面後端に係止するようになっている。従って、図１２(ａ)に示すように、薬剤付与プレートＢ３を垂直位置から後方水平位置へ回転させる際に、係止爪部７２が押付プレートＳ３に係止して、該押付プレートＳ３を前方水平位置から垂直状態まで追従回転させる。   As shown in FIG. 11, a locking claw portion 72 extending forward is formed at the lower end of the medicine application plate B3. This locking claw 72 is configured to be locked to the lower rear end of the pressing plate S3 at the front horizontal position in the vertical position of the medicine application plate B3. Accordingly, as shown in FIG. 12 (a), when the medicine application plate B3 is rotated from the vertical position to the rear horizontal position, the locking claw 72 is locked to the pressing plate S3, and the pressing plate S3 is moved forward. Follow and rotate from horizontal position to vertical position.

そして、図１２(ｂ)に示すように、薬剤付与プレートＢ３を後方水平位置に回転させたもとで、押付プレートＳ３を後方水平位置まで回転させると、押付プレートＳ３の押付面７５が、該薬剤付与プレートＢ３の薬剤付与面７０に対して、該薬剤付与面７０に滴下した薬剤の液滴の高さより狭い薬剤拡散間隔Ｄ１を設けて対向するようになっている。なお薬剤拡散間隔Ｄ１は、０.１ｍｍ以下となっている。従って、後方水平位置の薬剤付与プレートＢ３の薬剤付与面７０に薬剤Ｃを滴下させた状態で、押付プレートＳ３を後方水平位置まで回転させると、薬剤付与面７０と押付面７５とで挟圧された薬剤Ｃは、前記隙間内を移動して薬剤付与面７０の全体に広がるようになっている。   Then, as shown in FIG. 12 (b), when the pressing plate S3 is rotated to the rear horizontal position while the drug applying plate B3 is rotated to the rear horizontal position, the pressing surface 75 of the pressing plate S3 is applied with the drug application. The drug application surface 70 of the plate B3 is opposed to the drug application surface 70 with a drug diffusion interval D1 narrower than the height of the drug droplet dropped on the drug application surface 70. The drug diffusion interval D1 is 0.1 mm or less. Accordingly, when the pressing plate S3 is rotated to the rear horizontal position while the drug C is dropped on the drug application surface 70 of the drug application plate B3 at the rear horizontal position, the drug application surface 70 and the pressing surface 75 are sandwiched between the pressures. The medicine C moves in the gap and spreads over the whole medicine application surface 70.

(実施例３の抗菌装置による抗菌方法)
前述のように構成された実施例３の抗菌装置Ｍ３による抗菌方法は、次のような操作により電子機器Ｔの抗菌処理を実行する。先ず、図１２(ａ)に示すように、薬剤付与プレートＢ３を後方水平位置に回転させたもとで、薬剤付与プレートＢ３における薬剤付与面７０に、該薬剤付与面７０の面積に応じた適量(１回の抗菌処理に必要とされる量)の薬剤Ｃを、該薬剤付与面７０の中央付近に滴状に滴下する。 (Antimicrobial method using the antimicrobial device of Example 3)
In the antibacterial method using the antibacterial device M3 of Example 3 configured as described above, the antibacterial treatment of the electronic device T is executed by the following operation. First, as shown in FIG. 12A, an appropriate amount (1) corresponding to the area of the drug application surface 70 is applied to the drug application surface 70 of the drug application plate B3 while the drug application plate B3 is rotated to the rear horizontal position. The amount of the medicine C required for the antibacterial treatment in one time is dropped in the vicinity of the center of the medicine application surface 70.

次いで、図１２(ｂ)に示すように、前記押付プレートＳ３を後方水平位置に向けて回転させる。この際に、薬剤付与面７０へ滴下した薬剤Ｃが、該薬剤付与面７０と押付面７５とで挟圧され、該薬剤Ｃは両面７０,７５の隙間内で広がる。従って薬剤Ｃは、薬剤付与面７０に薄膜状に付与されると共に、押付面７５にも薄膜状に付与される。   Next, as shown in FIG. 12B, the pressing plate S3 is rotated toward the rear horizontal position. At this time, the drug C dropped onto the drug application surface 70 is sandwiched between the drug application surface 70 and the pressing surface 75, and the drug C spreads in the gap between the both surfaces 70 and 75. Accordingly, the drug C is applied to the drug application surface 70 in a thin film shape, and is also applied to the pressing surface 75 in a thin film shape.

薬剤付与プレートＢ３と押付プレートＳ３は、薬剤Ｃにより吸着された状態となっているので、図１２(ｃ)に示すように、両プレートＢ３,Ｓ３を一体的に垂直状態まで回転させる。そして、薬剤付与プレートＢ３が本体Ｆ３の第２本体部６１に当接した状態で押付プレートＳ３のみを更に前方へ押すと、両プレートＢ３,Ｓ３の吸着が解除されるので、該押付プレートＳ３を前方水平位置まで回転させる。これにより、薬剤付与プレートＢ３の薬剤付与面７０および押付プレートＳ３の押付面７５には、薬剤Ｃが薄膜状に広がって付与される。   Since the medicine application plate B3 and the pressing plate S3 are in a state of being adsorbed by the medicine C, both the plates B3 and S3 are integrally rotated to the vertical state as shown in FIG. Then, if only the pressing plate S3 is pushed further forward while the medicine applying plate B3 is in contact with the second main body portion 61 of the main body F3, the adsorption of both the plates B3 and S3 is released. Rotate to front horizontal position. Thereby, the medicine C is spread and applied to the medicine application surface 70 of the medicine application plate B3 and the pressing surface 75 of the pressing plate S3.

次いで、機器セット部Ｈ３に電子機器Ｔをセットし、薬剤Ｃが付与された薬剤付与面７０および押付面７５と電子機器Ｔとの間に所定の抗菌処理間隔Ｄ２を確保したもとで、該電子機器Ｔの外面における被抗菌処理部分を抗菌成分浮遊領域に正対させる。そして、この状態で３０分〜６０分間待機することで、薬剤付与面７０および押付面７５から空気中に気化した薬剤Ｃの抗菌成分が電子機器Ｔの被抗菌処理部分に接触して、該電子機器Ｔの抗菌処理がなされる。特に実施例３では、電子機器Ｔの押付面７５に対向する被抗菌処理部分および薬剤付与面７０に対向する被抗菌処理部分の２面を、１回の処理で同時に抗菌処理することが可能である。なお、薬剤付与面７０に付与された薬剤Ｃおよび押付面７５に付着した薬剤Ｃは、当該の抗菌処理を実行する際に、その抗菌成分の殆どが効率よく気化し、該薬剤付与面７０および押付面７５には気化成分は残らない。   Next, the electronic device T is set in the device setting unit H3, and a predetermined antibacterial treatment interval D2 is secured between the drug application surface 70 to which the drug C is applied and the pressing surface 75 and the electronic device T. The antibacterial treatment portion on the outer surface of the electronic device T is directly opposed to the antibacterial component floating region. And by waiting for 30 to 60 minutes in this state, the antibacterial component of the medicine C vaporized in the air from the medicine application surface 70 and the pressing surface 75 comes into contact with the antibacterial treatment portion of the electronic device T, and the electronic The antibacterial treatment of the device T is performed. In particular, in Example 3, it is possible to simultaneously perform antibacterial treatment on two surfaces of the antibacterial treatment part facing the pressing surface 75 of the electronic device T and the antibacterial treatment part facing the drug application surface 70 in one treatment. is there. It should be noted that most of the antibacterial components of the medicine C applied to the medicine application surface 70 and the medicine C attached to the pressing surface 75 are efficiently vaporized when the antibacterial treatment is performed. No vaporizing component remains on the pressing surface 75.

従って、実施例３に係る抗菌装置Ｍ３によれば、薬剤付与面７０に滴下した液状の薬剤Ｃを、該薬剤付与面７０に浸透させることなく、押付プレートＳ３を回転変位させて薬剤付与プレートＢ３に押付けることで、該薬剤付与面７０および押付面７５に簡易かつ適切に広げることができる。そして、本体Ｆ３の機器セット部Ｈ３に電子機器Ｔをセットすることで、薬剤付与面７０および押付面７５に広げた薬剤Ｃの抗菌成分浮遊領域に対して被抗菌処理部分を前記抗菌処理間隔Ｄ２で正対させ得るので、気化した薬剤Ｃの抗菌成分を該被抗菌処理部分に適切に接触させることができ、電子機器Ｔの抗菌処理を効率的に行なうことを可能とする。従って、実施例３の抗菌装置Ｍ３によれば、前記実施例１の抗菌装置Ｍ１と同等の作用効果が得られる。なお、実施例３の抗菌装置Ｍ３では、薬剤付与面７０および押付面７５の２面に薬剤Ｃが付与されるので、電子機器Ｔの２面を同時に抗菌処理し得る利点がある。   Therefore, according to the antibacterial device M3 according to Example 3, the pressing plate S3 is rotationally displaced without causing the liquid drug C dropped on the drug application surface 70 to permeate the drug application surface 70, thereby causing the drug application plate B3. Can be easily and appropriately spread on the medicine applying surface 70 and the pressing surface 75. Then, by setting the electronic device T in the device setting portion H3 of the main body F3, the antibacterial treatment interval D2 is placed on the antibacterial component floating region of the drug C spread on the drug application surface 70 and the pressing surface 75. Therefore, the antibacterial component of the vaporized medicine C can be appropriately brought into contact with the antibacterial treatment part, and the antibacterial treatment of the electronic device T can be efficiently performed. Therefore, according to the antibacterial device M3 of the third embodiment, the same effects as the antibacterial device M1 of the first embodiment can be obtained. In the antibacterial device M3 of Example 3, since the medicine C is applied to the two surfaces of the medicine application surface 70 and the pressing surface 75, there is an advantage that the two surfaces of the electronic device T can be subjected to the antibacterial treatment simultaneously.

また、実施例３の抗菌装置Ｍ３による抗菌方法によれば、薬剤付与面７０に付与した液状の薬剤Ｃを、押付プレートＳ３の回転変位により薬剤付与面７０および押付面７５に浸透させることなく広げて、薬剤付与面７０および押付面７５に広げた薬剤Ｃの薬剤成分浮遊領域に被抗菌処理部分が非接触で正対するよう電子機器Ｔを支持するようにしたので、気化した薬剤Ｃの抗菌成分を該被抗菌処理部分に適切に接触させて電子機器Ｔの抗菌処理を効率的に行なうことができる。従って、実施例３の抗菌装置Ｍ３による抗菌方法によれば、前記実施例１の抗菌装置Ｍ１による抗菌方法と同等の作用効果が得られる。   Further, according to the antibacterial method using the antibacterial device M3 of Example 3, the liquid medicine C applied to the medicine application surface 70 is spread without penetrating the medicine application surface 70 and the pressing surface 75 by the rotational displacement of the pressing plate S3. In addition, since the electronic device T is supported so that the antibacterial treatment portion faces the non-contact portion of the drug component floating region of the drug C spread on the drug application surface 70 and the pressing surface 75, the antibacterial component of the vaporized drug C Thus, the antibacterial treatment of the electronic device T can be performed efficiently by appropriately contacting the portion to be treated. Therefore, according to the antibacterial method using the antibacterial device M3 of the third embodiment, the same effects as the antibacterial method using the antibacterial device M1 of the first embodiment can be obtained.

(実施例４)
図１３は、実施例４に係る電子機器の抗菌装置Ｍ４の概略斜視図、図１４は、図１３に示す抗菌装置Ｍ４の側断面図、図１５は、図１３に示す抗菌装置Ｍ４の平面図である。実施例４の抗菌装置Ｍ４は、電子機器である携帯電話Ｔの抗菌処理を行なうものである。この抗菌装置Ｍ４は、携帯電話Ｔが着脱可能にセットされる本体Ｆ４と、抗菌成分を含む液状の薬剤Ｃが付与される薬剤付与面８０を有した薬剤付与シート(薬剤付与部)Ｂ４と、本体Ｆ４にセットする携帯電話Ｔを、薬剤付与面８０から離した姿勢で支持する支持手段としてのシート押え部材８１および支持バー８２を備えている。また薬剤付与シートＢ４は、前記薬剤Ｃを薬剤付与面８０に広げる薬剤拡張凹凸(薬剤拡張手段)Ｓ４を備えている。すなわち、実施例４の抗菌装置Ｍ４は、前記実施例１〜３の抗菌装置Ｍ１〜Ｍ３と異なり、本体Ｆ４とは別体の薬剤付与シートＢ４を備えると共に、この薬剤付与シートＢ４に薬剤拡張手段としての薬剤拡張凹凸Ｓ４を備えている。なお実施例４では、図１３に示すように、抗菌装置Ｍ４を卓上等の水平面に置いた使用状態において、垂直方向を抗菌装置Ｍ４の「上下方向」、本体Ｆ４に装着した薬剤付与シートＢ４の前記薬剤付与面８０に沿う水平方向を抗菌装置Ｍ４の「左右方向」、この左右方向と水平に直交する方向を抗菌装置Ｍ４の「前後方向」と指称する。そして携帯電話Ｔは、その幅方向を抗菌装置Ｍ４の左右方向に整合させ、長さ方向を抗菌装置Ｍ４の前後方向に整合させた姿勢で本体Ｆ４にセットされる。 Example 4
13 is a schematic perspective view of an antibacterial device M4 of an electronic apparatus according to a fourth embodiment, FIG. 14 is a side sectional view of the antibacterial device M4 shown in FIG. 13, and FIG. 15 is a plan view of the antibacterial device M4 shown in FIG. It is. The antibacterial device M4 of the fourth embodiment performs an antibacterial treatment of the mobile phone T that is an electronic device. The antibacterial device M4 includes a main body F4 on which the mobile phone T is detachably set, a drug application sheet (medicine application part) B4 having a drug application surface 80 to which a liquid drug C containing an antibacterial component is applied, A sheet pressing member 81 and a support bar 82 are provided as support means for supporting the mobile phone T set on the main body F4 in a posture away from the medicine application surface 80. The drug application sheet B4 includes a drug expansion unevenness (drug expansion means) S4 that spreads the drug C on the drug application surface 80. That is, unlike the antibacterial devices M1 to M3 of the first to third embodiments, the antibacterial device M4 of the fourth embodiment includes a drug application sheet B4 that is separate from the main body F4, and the drug application sheet B4 has a drug expansion means. The medicine expansion unevenness S4 is provided. In Example 4, as shown in FIG. 13, when the antibacterial device M4 is placed on a horizontal surface such as a table, the vertical direction is the “vertical direction” of the antibacterial device M4, and the drug application sheet B4 attached to the main body F4 is The horizontal direction along the medicine application surface 80 is referred to as “left-right direction” of the antibacterial device M4, and the direction perpendicular to the left-right direction is referred to as “front-back direction” of the antibacterial device M4. The mobile phone T is set on the main body F4 in a posture in which the width direction is aligned with the left-right direction of the antibacterial device M4 and the length direction is aligned with the front-rear direction of the antibacterial device M4.

本体Ｆ４は、図１３〜図１５に示すように、前後方向における中間部分が上方へ突出した山形形状に形成されて、複数の部材から組み立てられた合成樹脂製の成形部材である。そして、本体Ｆ４の上面には、長矩形状の薬剤付与シートＢ４をセットするシートセット部８３が設けられている。すなわちシートセット部８３は、本体Ｆ４の前後中間部分が最も高くなっており、この中間部分から前側が前下がりの平坦状に形成され、該中間部分から後側が後下がりの平坦状に形成され、側面視において略「へ」字形となっている。従って薬剤付与シートＢ４は、図１３および図１４に示すように、シートセット部８３に沿ってセットすると、側面視で略「へ」字形に折曲げられる。また前記支持バー８２は、本体Ｆ４の前後中間部分における最上部において、左右方向へ水平に架設されている。なお、本体Ｆ４の底部に形成された開口部には、必要に応じて底板８５が着脱可能に装着されると共に、該本体Ｆ４の内部には、予備の薬剤付与シートＢ４等を収容可能な収容空間が画成されている(図１４)。   As shown in FIGS. 13 to 15, the main body F <b> 4 is a synthetic resin molded member that is formed in a chevron shape in which an intermediate portion in the front-rear direction protrudes upward and is assembled from a plurality of members. And on the upper surface of the main body F4, a sheet setting portion 83 for setting a long rectangular drug application sheet B4 is provided. That is, the sheet set portion 83 has the highest front and rear intermediate portion of the main body F4, the front side is formed in a flat shape with a front lowering from the intermediate portion, the rear side is formed in a flat shape with a rear lowering from the intermediate portion, In the side view, it has a generally “h” shape. Therefore, as shown in FIGS. 13 and 14, when the drug application sheet B4 is set along the sheet setting portion 83, the drug application sheet B4 is bent into a substantially “h” shape in a side view. The support bar 82 is horizontally extended in the left-right direction at the uppermost portion of the front-rear intermediate portion of the main body F4. In addition, a bottom plate 85 is detachably attached to the opening formed in the bottom of the main body F4 as required, and the main body F4 can accommodate a spare medicine-applying sheet B4 and the like. A space is defined (FIG. 14).

前記シート押え部材８１は、図１３および図１５に示すように、略「日」字形に形成された枠体であり、本体Ｆ４の前側および後側に夫々１つずつが配設されている。本体Ｆ４の前側に配設されたシート押え部材８１は、図１３に示すように、前端部が本体Ｆ４に対してヒンジ８４で回転可能に取り付けられ、シートセット部８３に倒伏した姿勢および本体Ｆ４から起立した姿勢との間で姿勢変位が可能となっている(図１６(ａ))。同様に、本体Ｆ４の後側に配設されたシート押え部材８１は、後端部が本体Ｆ４に対してヒンジ８４で回転可能に取り付けられ、シートセット部８３に倒伏した姿勢および本体Ｆ４から起立した姿勢との間で姿勢変位が可能となっている(図１６(ａ))。従って、シートセット部８３に薬剤付与シートＢ４をセットしたもとで、各シート押え部材８１,８１を倒伏姿勢に変位させることで、該薬剤付与シートＢ４の前側および後側をシートセット部８３から浮き上がらないように保持し得る。なお、倒伏した姿勢から起立した姿勢に姿勢変位したシート押え部材８１が該姿勢から更に過回転するのを防止する回転規制手段(図示せず)が、本体Ｆ４に設けられている。   As shown in FIGS. 13 and 15, the sheet pressing member 81 is a frame formed in a substantially “day” shape, and one is provided on each of the front side and the rear side of the main body F <b> 4. As shown in FIG. 13, the sheet pressing member 81 disposed on the front side of the main body F4 is rotatably attached to the main body F4 with a hinge 84 at the front end portion, and the body F4 is inclined to the sheet setting portion 83. The posture can be displaced between the posture and the posture standing up from (Fig. 16 (a)). Similarly, the sheet pressing member 81 disposed on the rear side of the main body F4 is attached to the main body F4 so as to be rotatable by a hinge 84 with respect to the main body F4. The posture can be changed between the postures shown in FIG. 16 (a). Accordingly, with the medicine application sheet B4 set in the sheet setting section 83, the front and rear sides of the medicine application sheet B4 are moved from the sheet setting section 83 by displacing the sheet pressing members 81, 81 to the lying posture. It can be held so that it does not rise. Note that a rotation restricting means (not shown) is provided in the main body F4 to prevent the sheet pressing member 81 whose posture has been displaced from the lying posture to the posture in which it has stood up from the posture.

そして、実施例４の抗菌装置Ｍ４では、前記支持バー８２と、前後の各シート押え部材８１,８１とにより、フラップタイプの携帯電話Ｔを折り曲げた状態で支持する機器セット部Ｈ４が構成される。そして、前記支持バー８２および各シート押え部材８１,８１は、図１４に示すように、携帯電話Ｔと薬剤付与シートＢ４の薬剤付与面８０とに間に所定の抗菌処理間隔Ｄ２を確保する。この抗菌処理間隔Ｄ２は、携帯電話Ｔの薬剤付与面８０と対向している外面(被抗菌処理部分)における上部分、中間部分、下部分において多少の差異はあるが、０ｍｍ＜Ｄ２≦２０ｍｍの範囲内で設定されている。この抗菌処理間隔Ｄ２の数値範囲は、本願発明者が行なった後述の実験により得られたものである。すなわち、抗菌処理間隔Ｄ２を０ｍｍ＜Ｄ２≦２０ｍｍとすることで、薬剤Ｃが携帯電話Ｔに直接接触して該携帯電話Ｔが濡れるのを防止したもとで、薬剤付与面８０に付与された薬剤Ｃの気化した抗菌成分から形成された抗菌成分浮遊領域内において、機器セット部Ｈ４にセットした携帯電話Ｔの外面における被抗菌処理部分が該抗菌成分浮遊領域に正対するようになる。これにより、薬剤Ｃの気化した抗菌成分が効率的に接触して、該携帯電話Ｔの抗菌処理が適切に行なわれる。   In the antibacterial device M4 according to the fourth embodiment, the support bar 82 and the front and rear sheet pressing members 81 and 81 constitute a device set portion H4 that supports the flap type mobile phone T in a folded state. . And as shown in FIG. 14, the said support bar 82 and each sheet | seat pressing member 81,81 ensure the predetermined | prescribed antibacterial treatment space | interval D2 between the mobile telephone T and the chemical | medical agent provision surface 80 of chemical | medical agent provision sheet B4. The antibacterial treatment interval D2 is slightly different in the upper part, the middle part, and the lower part on the outer surface (antibacterial treatment part) facing the drug application surface 80 of the mobile phone T, but 0 mm <D2 ≦ 20 mm. It is set within the range. This numerical range of the antibacterial treatment interval D2 is obtained by an experiment described later conducted by the inventor of the present application. That is, by setting the antibacterial treatment interval D2 to 0 mm <D2 ≦ 20 mm, the medicine C was applied to the medicine application surface 80 while preventing the mobile phone T from coming into direct contact with the mobile phone T and getting wet. In the antibacterial component floating region formed from the vaporized antibacterial component of the medicine C, the antibacterial treatment portion on the outer surface of the mobile phone T set in the device setting unit H4 directly faces the antibacterial component floating region. Thereby, the antimicrobial component which the chemical | medical agent C vaporized contacts efficiently, and the antimicrobial treatment of this mobile phone T is performed appropriately.

薬剤付与シートＢ４は、図１３に示すように、本体Ｆ４のシートセット部８３の大きさおよび形状に合致する長矩形状に形成されたシート材であり、携帯電話Ｔの被抗菌処理部分より一回り大きいサイズに設定されている。そして、薬剤付与シートＢ４の薬剤付与面８０は、ＪＩＳ Ｒ６０１０に準拠したＰ２４０〜Ｐ８００の粒度の凹凸で構成される薬剤拡張凹凸Ｓ４が設けられている。従って実施例４では、図１７(ａ)に示すように、薬剤付与シートＢ４として、ＪＩＳ Ｒ６０１０に準拠したＰ２４０〜Ｐ８００の粒度を有する研磨布紙(拡張紙)が使用されている。この薬剤付与シートＢ４として実施される研磨布紙は、布または紙からなる最下層の基材８６と、多数の研磨材８９を保持するメークコート８７と、研磨材８９を脱離し難くする共に柔軟性を高めて薬剤付与面８０を構成するサイズコート８８とからなり、各研磨材８９の先端部分がサイズコート８８から僅かに突出していることで、薬剤付与面８０に凹凸をなす薬剤拡張凹凸Ｓ４が構成される。なお、薬剤Ｃの気化速度が該薬剤Ｃの前記サイズコート８８への浸透速度より大きいため、薬剤付与面８０に付与された薬剤Ｃが該薬剤付与シートＢ４の内部(基材８６)へ浸透することは、実質的に不可能となっている。   As shown in FIG. 13, the medicine application sheet B4 is a sheet material formed in a long rectangular shape that matches the size and shape of the sheet set portion 83 of the main body F4, and is slightly more than the antibacterial treatment portion of the mobile phone T. It is set to a large size. And the chemical | medical agent provision surface 80 of the chemical | medical agent provision sheet B4 is provided with the chemical | medical agent expansion unevenness | corrugation S4 comprised by the unevenness | corrugation of the particle size of P240-P800 based on JISR6010. Therefore, in Example 4, as shown in FIG. 17A, abrasive cloth paper (expanded paper) having a particle size of P240 to P800 conforming to JIS R6010 is used as the drug application sheet B4. The abrasive cloth implemented as the medicine-applying sheet B4 includes a base material 86 of a lowermost layer made of cloth or paper, a make coat 87 that holds a large number of abrasives 89, and makes the abrasives 89 difficult to detach and is flexible. The drug-enhancing unevenness S <b> 4 is formed on the drug-applying surface 80 by making the tip part of each abrasive material 89 slightly protrude from the size-coating 88. Is configured. In addition, since the vaporization rate of the medicine C is higher than the penetration speed of the medicine C into the size coat 88, the medicine C applied to the medicine application surface 80 penetrates into the inside of the medicine application sheet B4 (base material 86). That is virtually impossible.

図１３における符号９０は、薬剤Ｃの滴下ポイントを示すマーキングである。これらマーキング９０,９０は、本体Ｆ４のシートセット部８３にセットした薬剤付与シートＢ４の傾斜部分における上方に位置している。従って、図１７(ｂ)に示すように、薬剤付与シートＢ４の各マーキング９０部分に、１回の抗菌処理に必要とされる量の薬剤Ｃを滴下すると、滴下された該薬剤Ｃは、表面張力および重力により薬剤拡張凹凸Ｓ４の隣接する凸部へ順次引き付けられて薬剤付与面８０の全体に広がる。   Reference numeral 90 in FIG. 13 is a marking indicating a dropping point of the medicine C. These markings 90 and 90 are located above the inclined portion of the medicine application sheet B4 set in the sheet setting portion 83 of the main body F4. Therefore, as shown in FIG. 17 (b), when the amount of medicine C required for one antibacterial treatment is dropped on each marking 90 portion of the medicine application sheet B4, the dropped medicine C The drug is gradually attracted to adjacent convex portions of the drug expansion unevenness S4 by tension and gravity and spreads over the entire drug application surface 80.

なお、図１３に示すように、本体Ｆ４の上部には、機器セット部Ｈ４を被覆するシールド部材９２が、本体Ｆ４に着脱可能に装着されるようになっている。前記シールド部材９２は、携帯電話Ｔの抗菌処理時には本体Ｆ４から取り外される。すなわちシールド部材９２は、抗菌処理を行なわない保管時に、シートセット部８３や該シートセット部８３にセットした薬剤付与シートＢ４の薬剤付与面８０に埃が付着するのを防止するためのものである。また、本体Ｆ４の左右側壁における上端縁には、シートセット部８３にセットした薬剤付与シートＢ４の側端および機器セット部Ｈ４にセットした携帯電話Ｔの側部に指先を掛け得るようにする凹部９１が形成されており、薬剤付与シートＢ４および携帯電話Ｔをシートセット部８３や機器セット部Ｈ４から取り外し易くなっている。   As shown in FIG. 13, a shield member 92 covering the device setting portion H4 is detachably attached to the main body F4 on the upper portion of the main body F4. The shield member 92 is removed from the main body F4 during the antibacterial treatment of the mobile phone T. That is, the shield member 92 is for preventing dust from adhering to the sheet setting portion 83 and the drug application surface 80 of the drug application sheet B4 set in the sheet setting unit 83 during storage without performing antibacterial treatment. . In addition, the upper edge of the left and right side walls of the main body F4 is a recess that allows a fingertip to be placed on the side edge of the medicine application sheet B4 set in the sheet setting portion 83 and the side portion of the mobile phone T set in the device setting portion H4. 91 is formed, and it is easy to remove the drug application sheet B4 and the mobile phone T from the sheet setting unit 83 and the device setting unit H4.

(実施例４の抗菌装置による抗菌方法)
前述のように構成された実施例４の抗菌装置Ｍ４による抗菌方法は、次のような操作により携帯電話Ｔの抗菌処理を実行する。先ず、図１６(ａ)に示すように、薬剤付与シートＢ４の長手方向における一方端部を、支持バー８２とシートセット部８３との間に差し込んで、該薬剤付与シートＢ４をシートセット部８３にセットし、該薬剤付与シートＢ４を各シート押え部材８１,８１で保持する。次いで、薬剤付与シートＢ４における薬剤付与面８０に、該薬剤付与面８０の面積に応じた適量(１回の抗菌処理に必要とされる量)の薬剤Ｃを、薬剤付与シートＢ４の前記各マーキング９０,９０の位置へ滴状に滴下する(図１６(ｂ))。滴下された薬剤Ｃは、薬剤拡張凹凸Ｓ４によって作用する表面張力および重力により、薬剤付与面８０の全体に亘って広がる(図１７(ｂ))。 (Antimicrobial method using the antimicrobial device of Example 4)
In the antibacterial method using the antibacterial device M4 according to the fourth embodiment configured as described above, the antibacterial treatment of the mobile phone T is executed by the following operation. First, as shown in FIG. 16 (a), one end portion in the longitudinal direction of the medicine application sheet B4 is inserted between the support bar 82 and the sheet setting section 83, and the medicine application sheet B4 is inserted into the sheet setting section 83. The medicine application sheet B4 is held by the sheet pressing members 81, 81. Next, an appropriate amount (the amount required for one antibacterial treatment) of the drug C according to the area of the drug application surface 80 is applied to the drug application surface 80 of the drug application sheet B4. It is dropped in the form of droplets at positions 90 and 90 (FIG. 16 (b)). The dropped medicine C spreads over the whole medicine application surface 80 due to surface tension and gravity acting by the medicine expansion unevenness S4 (FIG. 17B).

次いで、携帯電話Ｔを機器セット部Ｈ４にセットし、薬剤Ｃが付与された薬剤付与面８０と携帯電話Ｔとの間に所定の抗菌処理間隔Ｄ２を確保したもとで、該携帯電話Ｔの外面における被抗菌処理部分を抗菌成分浮遊領域に正対させる。そして、この状態で３０分〜６０分間待機することで、薬剤付与面８０から空気中に気化した薬剤Ｃが携帯電話Ｔの被抗菌処理部分に接触して、該携帯電話Ｔの抗菌処理がなされる。なお、薬剤付与面８０に付与された薬剤Ｃは、当該の抗菌処理を実行する際に、その抗菌成分の殆どが該薬剤付与面８０から気化し、該薬剤付与面８０には気化成分は残らない。   Next, the mobile phone T is set in the device setting unit H4, and a predetermined antibacterial treatment interval D2 is secured between the medicine application surface 80 to which the medicine C is applied and the mobile phone T. The antibacterial treatment portion on the outer surface is directly opposed to the antibacterial component floating region. Then, by waiting for 30 to 60 minutes in this state, the medicine C vaporized in the air from the medicine application surface 80 comes into contact with the antibacterial treatment portion of the mobile phone T, and the antibacterial treatment of the mobile phone T is performed. The It should be noted that most of the antibacterial components of the drug C applied to the drug application surface 80 are vaporized from the drug application surface 80 when the antibacterial treatment is performed, and the vaporized component remains on the drug application surface 80. Absent.

従って、実施例４に係る抗菌装置Ｍ４によれば、薬剤付与シートＢ４における薬剤付与面８０のマーキング９０が形成された位置に滴下した液状の薬剤Ｃを、該薬剤付与面８０に浸透させることなく、該薬剤付与シートＢ４に設けた薬剤拡張凹凸Ｓ４により該滴下した薬剤Ｃを自立的に拡張するので、ユーザーが薬剤を拡張させる操作をしなくても該薬剤付与面８０の全体に薬剤Ｃを簡易かつ適切に広げることができる。そして、本体Ｆ４の機器セット部Ｈ４に携帯電話Ｔをセットすることで、薬剤付与面８０に広げた薬剤Ｃの抗菌成分浮遊領域に対して被抗菌処理部分を前記抗菌処理間隔Ｄ２で正対させ得るので、気化した薬剤Ｃの抗菌成分を該被抗菌処理部分に適切に接触させることができ、携帯電話Ｔの抗菌処理を効率的に行なうことを可能とする。従って、実施例４の抗菌装置Ｍ４によれば、前記実施例１の抗菌装置Ｍ１と同等の作用効果が得られる。   Therefore, according to the antibacterial device M4 according to Example 4, the liquid medicine C dripped at the position where the marking 90 of the medicine application surface 80 in the medicine application sheet B4 is formed does not penetrate the medicine application surface 80. Since the dropped drug C is independently expanded by the drug expansion unevenness S4 provided on the drug application sheet B4, the drug C is applied to the entire drug application surface 80 without the user performing an operation of expanding the drug. It can be spread easily and appropriately. Then, by setting the mobile phone T in the device setting portion H4 of the main body F4, the antimicrobial treatment portion is directly opposed to the antimicrobial component floating region of the medicine C spread on the medicine application surface 80 at the antimicrobial treatment interval D2. Therefore, the antibacterial component of the vaporized medicine C can be appropriately brought into contact with the antibacterial treatment part, and the cell phone T can be efficiently subjected to the antibacterial treatment. Therefore, according to the antibacterial device M4 of the fourth embodiment, the same effects as the antibacterial device M1 of the first embodiment can be obtained.

また、実施例４の抗菌装置Ｍ４による抗菌方法によれば、薬剤付与シートＢ４のマーキング９０が形成された位置に滴下した液状の薬剤Ｃを、該薬剤付与シートＢ４の薬剤付与面８０に浸透させることなく、薬剤拡張凹凸Ｓ４により薬剤付与面８０に広げて、薬剤付与面８０に広げた薬剤Ｃに被抗菌処理部分が非接触で正対するよう携帯電話Ｔを支持するようにしたので、気化した薬剤Ｃの抗菌成分を該被抗菌処理部分に適切に接触させて携帯電話Ｔの抗菌処理を効率的に行なうことができる。従って、実施例４の抗菌装置Ｍ４による抗菌方法によれば、前記実施例１の抗菌装置Ｍ１による抗菌方法と同等の作用効果が得られる。   Further, according to the antibacterial method using the antibacterial device M4 of Example 4, the liquid medicine C dripped at the position where the marking 90 of the medicine application sheet B4 is formed is permeated into the medicine application surface 80 of the medicine application sheet B4. Without expanding the medicine application surface 80 by the medicine expansion unevenness S4, the mobile phone T is supported so that the antibacterial treatment part faces the medicine C spread on the medicine application surface 80 in a non-contact manner. The antibacterial component of the medicine C can be appropriately brought into contact with the portion to be antibacterial treated so that the antibacterial treatment of the mobile phone T can be performed efficiently. Therefore, according to the antibacterial method using the antibacterial device M4 of the fourth embodiment, the same effects as the antibacterial method using the antibacterial device M1 of the first embodiment can be obtained.

(実験例)
本願の抗菌装置は、前述した如く、薬剤付与面に広げて付与する１回の抗菌処理に必要とされる量の薬剤Ｃと電子機器(携帯電話)とを非接触状態で対向させ、該薬剤の空気中に気化した抗菌成分により該電子機器(携帯電話)の抗菌処理を行なうものである。そこで本願発明者は、次の実験１〜実験６を行ない、本願の抗菌装置および該抗菌装置による抗菌方法が好適な抗菌効果を現出することを検証すると共に、好適な抗菌効果が得られる条件を確認した。 (Experimental example)
As described above, the antibacterial device of the present application is such that the amount of medicine C required for one antibacterial treatment spread and applied to the medicine application surface is opposed to an electronic device (cell phone) in a non-contact state. The antibacterial component of the electronic device (mobile phone) is subjected to antibacterial treatment with the antibacterial component vaporized in the air. Therefore, the inventor of the present application performs the following Experiment 1 to Experiment 6 to verify that the antibacterial device of the present application and the antibacterial method using the antibacterial device exhibit a suitable antibacterial effect, and conditions under which a suitable antibacterial effect is obtained. It was confirmed.

(実験１) 抗菌成分浮遊領域の形成態様検証
実験１は、図２０に示すように、ＪＩＳ Ｒ６０１０に準拠したＰ４００の粒度の拡張紙上に付与した薬剤Ｃに、電子機器Ｃを代用する被抗菌処理物品９６を対向させて、所定の抗菌処理時間に亘って抗菌処理を行なう場合に、該薬剤Ｃの抗菌効果が現出する抗菌成分浮遊領域がどのような態様で形成されるかを検証する実験である。すなわち、所定時間に亘って抗菌処理を行なった場合に、被抗菌処理物品９６の表面において菌が増殖しない部分が抗菌成分浮遊領域であると認定し得る。なお、以下は実験条件の概要である。
＜条件＞
・被抗菌処理物品９６：大腸菌(ＮＢＲＣ３３０１)を含むスラッジＥを表面に塗布した寒天培地
・薬剤Ｃ：ローズウッドオイル(０.０４１ｍｌ)
・抗菌処理間隔Ｄ２：５ｍｍ
・抗菌処理時間：１時間
・周囲温度：２５℃
・開放状態 (Experiment 1) Forming mode verification of antibacterial component floating region Experiment 1 is an antibacterial treatment in which the electronic device C is substituted for the medicine C applied on the expanded paper of P400 particle size conforming to JIS R6010 as shown in FIG. Experiment for verifying in what manner the antimicrobial component floating region where the antimicrobial effect of the drug C appears is formed when antimicrobial treatment is performed for a predetermined antimicrobial treatment time with the article 96 facing each other. It is. That is, when the antibacterial treatment is performed for a predetermined time, it can be recognized that the portion where the bacteria do not grow on the surface of the antibacterial treatment article 96 is the antibacterial component floating region. The following is an outline of the experimental conditions.
<Conditions>
-Antibacterial article 96: Agar medium coated with sludge E containing E. coli (NBRC3301)-Drug C: Rosewood oil (0.041 ml)
・ Antimicrobial treatment interval D2: 5 mm
-Antibacterial treatment time: 1 hour-Ambient temperature: 25 ° C
・ Open state

すなわち、図２０に示すように、シャーレ９５に入れた寒天培地の表面にスラッジＥを塗布して該表面を下向きに配置した被抗菌処理物品９６に対して、拡張紙９７上に付与した薬剤Ｃを抗菌処理間隔Ｄ２＝５ｍｍで垂直に対向配置させ、密封シート９８により密閉状態として、被抗菌処理物品９６の表面と拡張紙９７上の薬剤Ｃとの間に気流が生ずるのを防止した。そして、図２０の状態で１時間に亘って抗菌処理を行なった後、被抗菌処理物品９６を拡張紙９７から外して抗菌処理を終了し、この抗菌処理終了からインキュベータ内で２４時間培養させて、被抗菌処理物品９６における菌の増殖状況を観察した。なお、薬剤Ｃの付与態様としては、直径８ｍｍの拡張紙(以降「小径の拡張紙」という)９７上に０.０４１ｍｌのローズウッドオイルを滴下して該小径の拡張紙９７の全面に薬剤Ｃが付与された拡張面積が小さいのもの(図２１(ａ)参照)と、直径７０ｍｍの拡張紙(以降「大径の拡張紙」という)９７上に０.０４１ｍｌのローズウッドオイルを滴下して該大径の拡張紙９７の全面に薬剤Ｃを広げた拡張面積が大きいもの(図２１(ｂ)参照)との２種類を準備して、夫々に関して抗菌処理を行ない試料１および試料２を得た。   That is, as shown in FIG. 20, the drug C applied on the expansion paper 97 to the antibacterial treatment article 96 in which the sludge E is applied to the surface of the agar medium placed in the petri dish 95 and the surface is disposed downward. Were placed vertically opposite to each other with an antibacterial treatment interval D2 = 5 mm and sealed with a sealing sheet 98 to prevent airflow from occurring between the surface of the antibacterial treatment article 96 and the drug C on the expansion paper 97. Then, after the antibacterial treatment is performed for 1 hour in the state of FIG. 20, the antibacterial treatment article 96 is removed from the expansion paper 97 to end the antibacterial treatment, and after this antibacterial treatment is completed, the cells are cultured in the incubator for 24 hours. Then, the state of bacterial growth in the antimicrobial treatment article 96 was observed. As an application mode of the medicine C, 0.041 ml of rosewood oil is dropped on an expansion paper (hereinafter referred to as “small-diameter expansion paper”) 97 having a diameter of 8 mm, and the medicine C is applied to the entire surface of the small-diameter expansion paper 97. Drop of 0.041 ml of rosewood oil onto a paper with a small expansion area (see FIG. 21A) and a paper with a diameter of 70 mm (hereinafter referred to as “large diameter paper”). Two types are prepared, one having a large expanded area obtained by spreading the medicine C over the entire surface of the large-diameter expansion paper 97 (see FIG. 21B), and antibacterial treatment is performed on each of them to obtain Sample 1 and Sample 2. It was.

図２２(ａ)は、図２１(ａ)に示した小径の拡張紙９７に付与した薬剤Ｃによる抗菌処理で得られた試料１の写真であり、図２２(ｂ)は、図２１(ｂ)に示した大径の拡張紙９７に付与した薬剤Ｃによる抗菌処理で得られた試料２の写真である。試料１では、被抗菌処理物品９６の表面略中央において略円形の部分では菌が増殖せず、これ以外の部分では菌が増殖していることが確認できる。なお、菌が増殖していない円形の部分は、小径の拡張紙９７上に円形に付与した薬剤Ｃの拡張面積より大きくなっていると共に輪郭が不明瞭になっているが、これは図２１(ａ)から明らかなように、薬剤Ｃが小径の拡張紙９７上に保持されずに一部が周囲に溢れて広がったためである。従って、菌が増殖していない円形の部分は、該薬剤Ｃの広がった面積と略同じサイズであり、かつ該薬剤Ｃと垂直に対向する部分であった。また試料２では、被抗菌処理物品９６の略全面において菌が増殖していないことが確認できる。これは、図２１(ｂ)に示す大径の拡張紙９７の直径がシャーレ９５の直径と略同じであり、薬剤Ｃの拡張面積が被抗菌処理物品９６の直径と略同じだったためである。   FIG. 22 (a) is a photograph of Sample 1 obtained by antibacterial treatment with the medicine C applied to the small-diameter expansion paper 97 shown in FIG. 21 (a). FIG. 22 (b) is a photograph of FIG. 2 is a photograph of Sample 2 obtained by antibacterial treatment with the medicine C applied to the large-diameter expansion paper 97 shown in FIG. In the sample 1, it can be confirmed that the bacteria do not grow in the substantially circular portion at the substantially center of the surface of the antibacterial treatment article 96 and the bacteria grow in other portions. In addition, although the circular part which the microbe does not multiply is larger than the expansion area of the medicine C given to the circular shape on the small-diameter expansion paper 97 and the outline is unclear, this is shown in FIG. As is clear from a), the drug C was not held on the small-diameter expansion paper 97 and partly overflowed and spread. Therefore, the circular portion where the bacteria did not grow was a portion that was approximately the same size as the area where the drug C spread and was perpendicular to the drug C. Moreover, in the sample 2, it can be confirmed that the bacteria have not grown on the substantially entire surface of the antibacterial treatment article 96. This is because the diameter of the large-diameter expansion paper 97 shown in FIG. 21B is substantially the same as the diameter of the petri dish 95, and the expanded area of the medicine C is substantially the same as the diameter of the antibacterial treatment article 96.

前記実験１の結果から、拡張紙９７上に付与した薬剤Ｃと垂直に対向する部分に、該薬剤Ｃの輪郭形状・サイズと略同じ形状・サイズの抗菌成分浮遊領域が形成され、被抗菌処理物品９６の該抗菌成分浮遊領域に対向する表面においては菌の増殖抑止効果が顕著に現出することが確認できた。しかも、図２１(ａ)に示した小径の拡張紙９７に付与した薬剤Ｃと図２１(ｂ)に示した大径の拡張紙９７に付与した薬剤Ｃとは、付与量が何れも０.０４１ｍｌと同量であるにも拘わらず、図２１(ｂ)に示した大径の拡張紙９７のほうが菌の増殖抑止効果が現出する面積が広くなっている。すなわち、薬剤Ｃによる抗菌効果は、薬剤Ｃの付与量によるものではなく、薬剤Ｃの付与面積に依存することが確認された。従って、本願の抗菌方法においては、薬剤付与部(薬剤付与プレート、薬剤付与シート)の薬剤付与面に、１回の抗菌処理に必要とされる量の薬剤Ｃを付与し、電子機器(携帯電話)の薬剤付与面に対向する被抗菌処理部分と少なくとも同じ広さに該薬剤Ｃを広げ、この広げた薬剤と電子機器(携帯電話)の被抗菌処理部分とを対向させることで好適な抗菌効果が得られるものである。   From the result of the experiment 1, an antibacterial component floating region having a shape and size substantially the same as the contour shape and size of the drug C is formed in a portion perpendicular to the drug C applied on the expansion paper 97, and the antibacterial treatment It was confirmed that the effect of inhibiting the growth of bacteria appeared remarkably on the surface of the article 96 facing the antimicrobial component floating region. Moreover, the amount of the medicine C applied to the small-diameter expansion paper 97 shown in FIG. 21A and the medicine C applied to the large-diameter expansion paper 97 shown in FIG. Despite being the same amount as 041 ml, the large-diameter expansion paper 97 shown in FIG. 21 (b) has a larger area where the effect of inhibiting the growth of bacteria appears. That is, it was confirmed that the antibacterial effect of the drug C is not based on the applied amount of the drug C but depends on the applied area of the drug C. Therefore, in the antibacterial method of the present application, an amount of the drug C required for one antibacterial treatment is applied to the drug application surface of the drug application unit (drug application plate, drug application sheet), and the electronic device (cell phone ) The antibacterial effect suitable by spreading the drug C to at least the same area as the antibacterial treatment part facing the drug application surface of the electronic device (cell phone). Is obtained.

(実験２) 抗菌処理間隔に基づく抗菌効果検証
実験２は、拡張紙９７上に塗布した薬剤Ｃに、図２３に示すように、電子機器Ｃを代用する被抗菌処理物品９６を対向させて、所定の抗菌処理時間に亘って抗菌処理を行なう場合に、薬剤Ｃと被抗菌処理物品９６との対向間隔である抗菌処理間隔Ｄ２と抗菌効果との関連を検証する実験である。なお、以下は実験条件の概要である。
＜条件＞
・被抗菌処理物品９６：一般家庭の風呂場の排水溝より採取したスラッジＥ´を表面に塗布した寒天培地
・薬剤Ｃ：ペパーミントオイル、レモングラスオイル
(四角形(３０×３０ｍｍ)の拡張紙９７上に０.０５ｍｌを付与)
・抗菌処理間隔Ｄ２：５ｍｍ、１０ｍｍ、１５ｍｍ、２０ｍｍ、２２ｍｍ、３０ｍｍ
・抗菌処理時間：１時間
・周囲温度：２５℃ (Experiment 2) Antibacterial Effect Verification Based on Antibacterial Treatment Interval Experiment 2 is performed by making an antibacterial treatment article 96 substituting the electronic device C as shown in FIG. This is an experiment for verifying the relationship between the antibacterial effect and the antibacterial treatment interval D2, which is the distance between the drug C and the antibacterial treatment article 96, when the antibacterial treatment is performed for a predetermined antibacterial treatment time. The following is an outline of the experimental conditions.
<Conditions>
-Antibacterial treatment article 96: Agar medium coated with sludge E 'collected from the drainage channel of a general household bathroom-Drug C: Peppermint oil, lemongrass oil
(Apply 0.05 ml on quadrilateral (30 x 30 mm) expansion paper 97)
-Antibacterial treatment interval D2: 5 mm, 10 mm, 15 mm, 20 mm, 22 mm, 30 mm
-Antibacterial treatment time: 1 hour-Ambient temperature: 25 ° C

すなわち、図２３に示すように、シャーレ９５に入れた寒天培地の表面にスラッジＥ´をスプレー塗布した被抗菌処理物品９６に対して、四角形の拡張紙９７上に付与した薬剤Ｃを、Ｌ型のピン状支持台Ｐに載せて抗菌処理間隔Ｄ２で対向配置させ、１時間に亘って抗菌処理を行なった後、抗菌処理終了から２４時間定置させて、被抗菌処理物品９６における菌の増殖状態を観察した。なお抗菌処理間隔Ｄ２は、前述の如く６通りとすると共に、薬剤Ｃはペパーミントオイルおよびレモングラスオイルを採用した。   That is, as shown in FIG. 23, the drug C applied on the rectangular expansion paper 97 is applied to the antibacterial treatment article 96 in which the sludge E ′ is spray-coated on the surface of the agar medium placed in the petri dish 95. The antimicrobial treatment interval D2 is placed on the pin-shaped support stand P2 and the antibacterial treatment is performed for 1 hour, and then placed for 24 hours from the end of the antibacterial treatment. Was observed. The antibacterial treatment interval D2 was set to 6 as described above, and peppermint oil and lemongrass oil were used as the medicine C.

なお、携帯電話等の電子機器は、使用中にその外表面に皮脂や汚れ等が付着し易く、該皮脂や汚れの上に菌が付着、増殖した状態で使用されるものである。そこで本願発明者は、実験２に関する実験結果を次のように評価することとした。すなわち、寒天培地の表面にスラッジＥ´をスプレー塗布して、薬剤Ｃによる抗菌処理を行なわない物品(非抗菌処理物品９６’)に増殖した菌のコロニーにおいて(図２４参照)、前記拡張紙９７上に３０×３０ｍｍの広さに拡張した薬剤Ｃの塗布エリアの正面部位から外れた部位で増殖した菌のコロニーの面積をＲ１とし(図２４(ａ)の黒塗り部分)、該薬剤Ｃの塗布エリアの正面部位内で増殖した菌のコロニーの面積をＲ１’とする(図２４(ｂ)の黒塗り部分)。また、薬剤Ｃによる抗菌処理を行なった被抗菌処理物品９６に増殖した菌コロニーにおいて(図２５参照)、前記拡張紙９７上に３０×３０ｍｍの広さに拡張した薬剤Ｃの塗布エリアの正面部位から外れた部位で増殖した菌のコロニーの面積をＲ２とし(図２５(ａ)の黒塗り部分)、該薬剤Ｃの塗布エリアの正面部位内で増殖した菌のコロニーの面積をＲ３とする(図２５(ｂ)の黒塗り部分)。そして、非抗菌処理物品９６’における菌のコロニーの面積Ｒ１,Ｒ１’を夫々基準として(１００％として)、被抗菌処理物品９６における菌のコロニーの面積Ｒ２,Ｒ３が、非抗菌処理物品９６’における菌のコロニーの面積Ｒ１,Ｒ１’の７０％以下である場合には、菌の増殖抑止効果が十分にあって抗菌装置での抗菌効果があると判定した。また、被抗菌処理物品９６における菌のコロニーの面積Ｒ２,Ｒ３が、非抗菌処理物品９６’における菌のコロニーの面積Ｒ１,Ｒ１’の７０％より大きい場合には、菌の増殖抑止効果が僅かで抗菌装置での抗菌効果がないと判定した。なお、前記「７０％」での評価は、被抗菌処理物品９６における菌のコロニーの面積Ｒ２およびＲ３の傾向から考量した。   An electronic device such as a mobile phone is used in a state in which sebum or dirt easily adheres to the outer surface during use, and bacteria adhere to and grow on the sebum or dirt. Therefore, the inventor of the present application decided to evaluate the experimental result related to Experiment 2 as follows. That is, in the colony of fungi grown on an article (non-antibacterial treated article 96 ′) that is not subjected to the antibacterial treatment with the medicine C by applying sludge E ′ on the surface of the agar medium (see FIG. 24), the expansion paper 97 The area of the colony of the fungus that has grown at a site deviating from the front part of the application area of the drug C expanded to a size of 30 × 30 mm is defined as R1 (the black area in FIG. 24 (a)). The area of the colony of the fungus that has grown in the front part of the application area is defined as R1 ′ (the black portion in FIG. 24B). Further, in a fungal colony grown on the antibacterial treatment article 96 subjected to the antibacterial treatment with the drug C (see FIG. 25), the front part of the application area of the drug C expanded to a size of 30 × 30 mm on the expansion paper 97 The area of the colonies of the bacteria that grew at the site outside of the area was designated as R2 (the black area in FIG. 25 (a)), and the area of the colonies of the bacteria that grew within the front area of the application area of the drug C was designated as R3 ( FIG. 25 (b) shows a black portion). Then, the area R1, R1 ′ of the fungal colonies in the non-antibacterial treated article 96 ′ is set as a reference (100%), respectively, and the area R2, R3 of the fungal colonies in the antibacterial treated article 96 is the non-antibacterial treated article 96 ′. When the area was less than 70% of the area R1, R1 ′ of the fungus colonies, it was determined that the fungus growth inhibitory effect was sufficient and the antibacterial effect of the antibacterial device was obtained. In addition, when the area R2, R3 of the fungal colony in the antibacterial treated article 96 is larger than 70% of the area R1, R1 ′ of the fungal colony in the non-antibacterial treated article 96 ′, the effect of inhibiting the growth of the fungus is slight. It was determined that there was no antibacterial effect in the antibacterial device. The evaluation at “70%” was determined based on the tendency of the area R2 and R3 of the bacterial colonies in the antibacterial treatment article 96.

前述した実験２の結果に対する評価方法は、寒天培地の表面全体に増殖した菌のコロニー数をカウントする一般的な評価方法とは異なっている。本願の抗菌装置は、薬剤Ｃが付与されたエリアと対向する部位(抗菌成分浮遊領域)と、該対向する部位から外れた部位(抗菌成分浮遊領域から外れた部位)とでは、抗菌効果が著しく異なることが大きな特徴となっている。このため、薬剤Ｃの塗布エリアの正面部位において菌のコロニー数が少なかったとしても、薬剤Ｃの塗布エリアの正面から外れた部位において増殖したコロニーの数が多い場合には、前述した一般的な評価方法では抗菌効果が少ないと判定されることになる。そこで本願発明者は、形成された菌のコロニー数ではなく、コロニーの面積を抗菌効果の判定基準とした。   The evaluation method for the result of Experiment 2 described above is different from a general evaluation method for counting the number of colonies of bacteria that have grown on the entire surface of the agar medium. The antibacterial device of the present application has a remarkably antibacterial effect in a part (antibacterial component floating region) facing the area to which the medicine C is applied and a part (part separated from the antibacterial component floating region) away from the facing part. Differences are a major feature. For this reason, even if the number of colonies of the fungus is small in the front part of the application area of the medicine C, when the number of colonies grown in the part off the front of the application area of the medicine C is large, the above-described general In the evaluation method, it is determined that the antibacterial effect is small. Therefore, the inventor of the present application uses the area of the colony, not the number of colonies of the formed bacteria, as a criterion for the antibacterial effect.

表１は、薬剤Ｃとしてペパーミントオイルを使用した場合の実験の結果を示したものである。薬剤Ｃがペパーミントオイルの場合、薬剤Ｃの塗布エリアの正面部位では、抗菌処理間隔Ｄ２が２０ｍｍ以下において、被抗菌処理物品９６における菌のコロニーの面積Ｒ３が、非抗菌処理物品９６’における菌のコロニーの面積Ｒ１’の７０％以下となり、菌の増殖抑止効果があることが確認された。特に、抗菌処理間隔Ｄ２が５ｍｍでは菌の増殖が全く見られず、抗菌処理間隔Ｄ２が１０ｍｍでは菌の増殖が１７％に留まり、１５ｍｍでも菌の増殖が４８％と非抗菌処理時に比べて半減している。なお、抗菌処理間隔Ｄ２が２０ｍｍを超えると菌の増殖が評価基準の７０％を超えてしまうが、菌の増殖が極端に増加するものではなく、２０ｍｍを超えても菌の増殖抑止効果はあることが確認できた。一方、薬剤Ｃの塗布エリアの正面部位から外れた部位では、抗菌処理間隔Ｄ２が５ｍｍにおいて、被抗菌処理物品９６における菌のコロニーの面積Ｒ２が、非抗菌処理物品９６’における菌のコロニーの面積Ｒ１の３９％となり、菌の増殖抑止効果があることが確認された。しかし、抗菌処理間隔Ｄ２が１０ｍｍとなると、被抗菌処理物品９６における菌のコロニーの面積Ｒ２が、非抗菌処理物品９６’における菌のコロニーの面積Ｒ１の８４％まで急増してしまい、菌の増殖抑止効果が殆どなくなることが確認された。従って、ペパーミントオイルを薬剤Ｃとして使用した場合には、該薬剤Ｃの塗布エリアの正面部位においては、抗菌処理間隔Ｄ２が２０ｍｍ以下において菌の増殖抑止効果が十分にあることが確認できた。なお、薬剤Ｃの塗布エリアの正面部位から外れた部位においては、菌の増殖抑止効果があまり期待できず、前記実験１の実験結果を立証できた。   Table 1 shows the results of the experiment when peppermint oil was used as the medicine C. When the medicine C is peppermint oil, the area R3 of the bacteria colony in the antibacterial treatment article 96 is less than 20 mm in the antibacterial treatment interval D2 at the front part of the application area of the medicine C. It was 70% or less of the area R1 ′ of the colony, and it was confirmed that there was an effect of inhibiting the growth of bacteria. In particular, when the antibacterial treatment interval D2 is 5 mm, no bacterial growth is observed, and when the antibacterial treatment interval D2 is 10 mm, the bacterial growth is only 17%. Even at 15 mm, the bacterial growth is 48%, which is half that of the non-antibacterial treatment. doing. In addition, when the antibacterial treatment interval D2 exceeds 20 mm, the growth of the bacteria exceeds 70% of the evaluation standard, but the proliferation of the bacteria does not increase extremely, and even if it exceeds 20 mm, there is an effect of inhibiting the growth of the bacteria. I was able to confirm. On the other hand, in the part deviating from the front part of the application area of the medicine C, the area R2 of the fungal colonies in the antibacterial treated article 96 is equal to the area R2 of the fungal colonies in the non-antibacterial treated article 96 ′. It was 39% of R1, and it was confirmed that there was an effect of inhibiting the growth of bacteria. However, when the antibacterial treatment interval D2 is 10 mm, the area R2 of the fungal colonies in the antibacterial treated article 96 rapidly increases to 84% of the area R1 of the fungal colonies in the non-antibacterial treated article 96 ′, and the growth of the fungus is increased. It was confirmed that the deterrent effect was almost lost. Therefore, when peppermint oil was used as the medicine C, it was confirmed that the front part of the application area of the medicine C had a sufficient effect of inhibiting the growth of bacteria when the antibacterial treatment interval D2 was 20 mm or less. In addition, in the site | part which remove | deviated from the front site | part of the application | coating area of the chemical | medical agent C, the growth suppression effect of a microbe could not be expected so much, and the experimental result of the said experiment 1 was proved.

表２は、薬剤Ｃとしてレモングラスオイルを使用した場合の実験の結果を示したものである。薬剤Ｃがレモングラスオイルの場合、薬剤Ｃの塗布エリアの正面部位では、抗菌処理間隔Ｄ２が３０ｍｍであっても、被抗菌処理物品９６における菌のコロニーの面積Ｒ３が、非抗菌処理物品９６’における菌のコロニーの面積Ｒ１’の０.４％に留まり、菌の増殖抑止効果が極めて高いことが確認された。一方、薬剤Ｃの塗布エリアの正面部位から外れた部位では、抗菌処理間隔Ｄ２が３０ｍｍであっても、被抗菌処理物品９６における菌のコロニーの面積Ｒ２が、非抗菌処理物品９６’における菌のコロニーの面積Ｒ１の僅か０.３％に留まり、菌の増殖抑止効果が極めて高いことが確認された。従って、レモングラスオイルを薬剤Ｃとして使用した場合には、該薬剤Ｃの塗布エリアの正面部位においては、抗菌処理間隔Ｄ２が３０ｍｍ以下であれば菌の増殖抑止効果が十分にあることが確認された。なお、薬剤Ｃがレモングラスオイルの場合は、該薬剤Ｃの塗布エリアの正面部位から外れた部位において、抗菌処理間隔Ｄ２が３０ｍｍ以下であれば菌の増殖抑止効果が多少期待できることが確認された。しかし、薬剤Ｃの塗布エリアの正面部位および該正面部位から外れた部位とでは、菌の増殖抑止効果に違いが生ずることから、前記実験１の実験結果を立証することとなった。   Table 2 shows the results of the experiment when lemongrass oil was used as the medicine C. When the medicine C is lemongrass oil, the area R3 of the bacterial colonies in the antibacterial treatment article 96 is non-antibacterial treatment article 96 ′ even if the antibacterial treatment interval D2 is 30 mm at the front part of the application area of the medicine C. It was only 0.4% of the area R1 ′ of the fungal colonies in FIG. On the other hand, in the part deviating from the front part of the application area of the medicine C, even if the antibacterial treatment interval D2 is 30 mm, the area R2 of the fungal colony in the antibacterial treatment article 96 is less than that of the fungus in the non-antibacterial treatment article 96 ′. Only 0.3% of the area R1 of the colony was confirmed, and it was confirmed that the effect of inhibiting the growth of bacteria was extremely high. Therefore, when lemongrass oil is used as the medicine C, it is confirmed that the front part of the application area of the medicine C has a sufficient effect of inhibiting the growth of bacteria if the antibacterial treatment interval D2 is 30 mm or less. It was. In addition, when the medicine C was lemongrass oil, it was confirmed that the antiproliferation effect of the bacteria could be expected somewhat if the antibacterial treatment interval D2 was 30 mm or less at a site outside the front part of the application area of the medicine C. . However, since the difference in the effect of inhibiting the growth of bacteria occurs between the front part of the application area of the medicine C and the part away from the front part, the experimental result of Experiment 1 was proved.

図２６は、実験２に関連して、ローズウッドオイルを薬剤Ｃとした場合の試料写真であって、図２６(ａ)はコントロール(抗菌処理を行なっていない基準サンプル)であり、図２６(ｂ)〜図２６(ｄ)は抗菌処理間隔Ｄ２＝５ｍｍ、７ｍｍ、１０ｍｍでの実験結果を示している。各試料写真からも、抗菌処理間隔Ｄ２が２０ｍｍ以下であれば、菌の増殖抑止効果が十分にあることが確認できる。   FIG. 26 is a sample photograph in the case of using Rosewood oil as medicine C in relation to Experiment 2, and FIG. 26 (a) is a control (reference sample not subjected to antibacterial treatment), and FIG. b) to FIG. 26 (d) show the experimental results at the antibacterial treatment interval D2 = 5 mm, 7 mm, and 10 mm. Also from each sample photograph, if the antibacterial treatment interval D2 is 20 mm or less, it can be confirmed that there is a sufficient effect of inhibiting the growth of bacteria.

(実験３) 設置態様に基づく抗菌効果検証
実験３は、被抗菌処理物品９６と拡張紙９７(薬剤Ｃ)との設置態様の違いによる抗菌効果を検証するため、設置態様１、設置態様２および設置態様３の３態様につき、抗菌効果を確認したものである。すなわち設置態様１は、図２７(ａ)に示すように、被抗菌処理物品９６を、Ｌ型のピン状支持台Ｐに載せて寒天培地表面が下向きとなるように設置すると共に、拡張紙９７を薬剤Ｃ表面が上向きとなるように設置した垂直対向態様である(前記実験１、２の設置態様と同じ)。設置態様２は、図２７(ｂ)に示すように、被抗菌処理物品９６を寒天培地表面が上向きとなるように設置すると共に、拡張紙９７を薬剤Ｃ表面が下向きとなるように設置した垂直対向態様である。設置態様３は、図２７(ｃ)に示すように、被抗菌処理物品９６および拡張紙９７の両方を垂直にして、寒天培地表面と薬剤Ｃ表面とを水平方向で対向させた水平対向態様である。 (Experiment 3) Antibacterial Effect Verification Based on Installation Mode Experiment 3 is to verify the antibacterial effect due to the difference in installation mode between the antibacterial treated article 96 and the expansion paper 97 (drug C). The antibacterial effect was confirmed for the three aspects of the installation aspect 3. That is, in the installation mode 1, as shown in FIG. 27A, the antibacterial treated article 96 is placed on an L-shaped pin-shaped support P so that the surface of the agar medium is facing downward, and the extension paper 97 Is a vertically opposed mode in which the surface of the medicine C is faced upward (same as the installation mode of Experiments 1 and 2 above). In the installation mode 2, as shown in FIG. 27 (b), the antibacterial article 96 is installed so that the surface of the agar medium faces upward, and the expansion paper 97 is installed so that the surface of the medicine C faces downward. It is an opposite aspect. As shown in FIG. 27 (c), the installation mode 3 is a horizontal facing mode in which both the antibacterial article to be treated 96 and the expansion paper 97 are vertical and the agar medium surface and the drug C surface are opposed in the horizontal direction. is there.

表３は、設置態様２(図２７(ｂ))および設置態様３(図２７(ｃ))において、薬剤Ｃとしてペパーミントオイルを使用した場合で、薬剤Ｃの塗布エリアの正面部位における菌の増殖抑止効果を実験した結果を示したものである(設置態様１は表１参照)。薬剤Ｃがペパーミントオイルの場合、設置態様２および設置態様３の両態様において略同じ結果が得られ、薬剤Ｃの塗布エリアの正面部位では、抗菌処理間隔Ｄ２が２０ｍｍ以下において、被抗菌処理物品９６における菌のコロニーの面積Ｒ３が、非抗菌処理物品９６’における菌のコロニーの面積Ｒ１’の７０％以下となり、菌の増殖抑止効果があることが確認された。特に、抗菌処理間隔Ｄ２が５ｍｍでは菌の増殖が全く見られず、抗菌処理間隔Ｄ２が１０ｍｍでは菌の増殖が１５％に留まり、１５ｍｍでも菌の増殖が５０％と非抗菌処理時に比べて半減している。なお、抗菌処理間隔Ｄ２が２０ｍｍを超えると菌の増殖が評価基準の７０％を超えてしまうが、菌の増殖が極端に増加するものではなく、２０ｍｍを超えても菌の増殖抑止効果はあることが確認できた。また、表３の実験結果と表１の実験結果とを比較してみると、多少の誤差があるとしても、抗菌処理間隔Ｄ２が同じであれば略同じ結果が得られている。従って、薬剤Ｃとしてペパーミントオイルを使用した場合には、設置態様１、設置態様２および設置態様３の何れも略同じ増殖抑止効果が得られ、薬剤付与面に付与した薬剤Ｃと電子機器Ｔとがどのような配置関係にあっても同等の抗菌効果が得られることが確認できた。   Table 3 shows the growth of bacteria in the front part of the application area of the drug C when peppermint oil is used as the drug C in the installation mode 2 (FIG. 27 (b)) and the installation mode 3 (FIG. 27 (c)). The result of having experimented on the deterrent effect is shown (see Table 1 for installation mode 1). When the medicine C is peppermint oil, substantially the same results are obtained in both the installation mode 2 and the installation mode 3, and the antibacterial article 96 to be antibacterial treated when the antibacterial treatment interval D2 is 20 mm or less in the front part of the application area of the drug C The area R3 of the fungal colonies in the non-antibacterial treated article 96 ′ was 70% or less of the area R1 ′ of the fungal colonies, confirming that there was an effect of inhibiting the growth of the fungi. In particular, when the antibacterial treatment interval D2 is 5 mm, no bacterial growth is observed, and when the antibacterial treatment interval D2 is 10 mm, the bacterial growth is only 15%, and even at 15 mm, the bacterial growth is 50%, half that of the non-antibacterial treatment. doing. In addition, when the antibacterial treatment interval D2 exceeds 20 mm, the growth of the bacteria exceeds 70% of the evaluation standard, but the proliferation of the bacteria does not increase extremely, and even if it exceeds 20 mm, there is an effect of inhibiting the growth of the bacteria. I was able to confirm. Further, comparing the experimental results in Table 3 with the experimental results in Table 1, even if there are some errors, the same results are obtained as long as the antibacterial treatment interval D2 is the same. Therefore, when peppermint oil is used as the medicine C, the installation mode 1, the installation mode 2 and the installation mode 3 all have substantially the same growth inhibiting effect, and the drug C and the electronic device T applied to the drug application surface It was confirmed that the same antibacterial effect can be obtained regardless of the arrangement relationship.

なお、レモングラスオイルを４８時間定置した場合では、前記表１と同様の結果となった。また、その他の精油を用いた設置態様１での抗菌処理間隔Ｄ２が１０ｍｍの場合でも、表１の抗菌処理間隔Ｄ２が１０ｍｍと同様の結果となる。このことから、ペパーミントオイル以外での各配設態様毎の実験は行なっていないが、前述した何れの薬剤であっても略同様の結果が得られることが容易に予想できる。   In addition, when lemongrass oil was placed for 48 hours, the same results as in Table 1 were obtained. Further, even when the antibacterial treatment interval D2 in the installation mode 1 using other essential oils is 10 mm, the same result as that of the antibacterial treatment interval D2 in Table 1 is 10 mm is obtained. For this reason, experiments for each arrangement mode other than peppermint oil have not been performed, but it can be easily predicted that substantially the same results will be obtained with any of the aforementioned drugs.

(実験４) 抗菌処理時間に基づく抗菌効果検証
実験４は、抗菌処理時間の違いによる抗菌効果を検証するため、前記設置態様１(図２７(ａ))において、処理時間が異なる場合の抗菌効果を比較して確認したものである。なお、実験条件は次のようである。
＜条件＞
・薬剤：ローズウッドオイル
・薬剤量：０.０５ｍｌ
・薬剤付与面：直径７８ｍｍの円形
・設置態様：垂直対向・開放状態
・抗菌処理間隔Ｄ２：５ｍｍ
・周囲温度：２５℃
・抗菌処理時間：５秒、５分、１５分、３０分、４５分、６０分 (Experiment 4) Antibacterial effect verification based on antibacterial treatment time Experiment 4 is to verify the antibacterial effect due to the difference in antibacterial treatment time. In the installation mode 1 (Fig. 27 (a)), the antibacterial effect when the treatment time is different. It was confirmed by comparing. The experimental conditions are as follows.
<Conditions>
・ Drug: Rosewood oil ・ Drug volume: 0.05ml
・ Drug application surface: circular shape with a diameter of 78 mm ・ Installation mode: vertically opposed / open state ・ Antimicrobial treatment interval D2: 5 mm
・ Ambient temperature: 25 ℃
・ Antimicrobial treatment time: 5 seconds, 5 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes

図２８は、実験４における各抗菌処理時間で処理した６種類の試料を撮影した写真である。この試料から明らかなように、抗菌処理時間が５秒の場合では抗菌効果は全く確認できず(図２８ａ)、抗菌処理時間が５分の場合および１５分の場合でも顕著な抗菌効果が確認できない(図２８(ｂ)、図２８(ｃ))。しかし、抗菌処理時間が３０分の場合では、コロニー間の隙間が徐々に大きくなって抗菌効果が現れ始める(図２８(ｄ))。そして、抗菌処理時間が４５分の場合では、コロニーの形成されない範囲が徐々に大きくなり(図２８(ｅ))、更に抗菌処理時間が６０分の場合では、寒天培地の表面の全体でのコロニーの形成が抑えられることが判明した(図２８(ｆ))。従って抗菌処理時間は、少なくとも３０分以上に設定すれば抗菌効果が得られ、６０分に設定すれば良好な抗菌効果が得られるといえる。   FIG. 28 is a photograph of six samples processed in each antibacterial treatment time in Experiment 4. As is clear from this sample, no antibacterial effect was confirmed when the antibacterial treatment time was 5 seconds (FIG. 28a), and no significant antibacterial effect could be confirmed even when the antibacterial treatment time was 5 minutes or 15 minutes. (FIG. 28 (b), FIG. 28 (c)). However, when the antibacterial treatment time is 30 minutes, the gap between colonies gradually increases and the antibacterial effect begins to appear (FIG. 28 (d)). When the antibacterial treatment time is 45 minutes, the area where colonies are not formed gradually increases (FIG. 28 (e)), and when the antibacterial treatment time is 60 minutes, colonies on the entire surface of the agar medium are obtained. Was found to be suppressed (FIG. 28 (f)). Therefore, it can be said that when the antibacterial treatment time is set to at least 30 minutes or more, an antibacterial effect is obtained, and when it is set to 60 minutes, a good antibacterial effect is obtained.

(実験５) 抗菌処理環境に基づく抗菌効果検証
実験５は、被抗菌処理物品９６と拡張紙９７(薬剤Ｃ)とを、大気に開放した状態で対向設置した抗菌処理態様(図２９(ａ))と、密閉した状態で対向設置した抗菌処理態様(図２９(ｂ))における抗菌効果を検証するものである。すなわち、開放状態での抗菌処理は、前記実施例２、３、４に係る抗菌装置Ｍ２,Ｍ３,Ｍ４による電子機器(携帯電話)Ｔの抗菌処理を室内等で行なう使用状態を想定したものであり、密閉状態での抗菌処理は、シールド部材３６を備えた前記実施例１に係る抗菌装置Ｍ１による電子機器(携帯電話)Ｔの抗菌処理を行なう使用状態を想定したものである。なお、実験条件は次のようである。
＜条件＞
・薬剤：ローズウッドオイル、ラベンダーティートゥリーオイル
・薬剤量：０.０５ｍｌ
・シャーレ９５の内径：８８ｍｍ(外径９０ｍｍ、厚さ１ｍｍ)
・シャーレ９５の寒天培地を除く高さ：１１ｍｍ
・開放空間容積Ｇ１：１５,３６７,９６８ｍｍ３(ケースＫのサイズ ３９６×１９６×１９８ｍｍ)
・密閉空間容積Ｇ２：６６,８６９ｍｍ３(４３.５２×π×１１ｍｍ)
・抗菌処理間隔Ｄ２：５ｍｍ
・抗菌処理時間：１時間
・周囲温度：２５℃ (Experiment 5) Antibacterial effect verification based on antibacterial treatment environment Experiment 5 is an antibacterial treatment mode in which an antibacterial treatment article 96 and expansion paper 97 (drug C) are placed facing each other in an open state (FIG. 29 (a)). ) And the antibacterial effect in the antibacterial treatment mode (FIG. 29 (b)) placed opposite to each other in a sealed state. That is, the antibacterial treatment in the open state is assumed to be in a use state in which the antibacterial treatment of the electronic device (mobile phone) T by the antibacterial devices M2, M3, M4 according to Examples 2, 3, and 4 is performed indoors. In addition, the antibacterial treatment in the sealed state assumes a use state in which the antibacterial treatment of the electronic device (mobile phone) T by the antibacterial device M1 according to the first embodiment including the shield member 36 is performed. The experimental conditions are as follows.
<Conditions>
・ Drug: Rosewood oil, lavender tea tree oil ・ Drug volume: 0.05ml
・ Inner diameter of petri dish 95: 88 mm (outer diameter 90 mm, thickness 1 mm)
-Height excluding petri dish 95 agar: 11mm
・ Open space volume G1: 15,367,968 mm 3 (case K size 396 × 196 × 198 mm)
Sealed space volume G2: 66,869 mm 3 (43.5 2 × π × 11 mm)
・ Antimicrobial treatment interval D2: 5 mm
-Antibacterial treatment time: 1 hour-Ambient temperature: 25 ° C

図２９(ａ)は、大気に開放した状態での実験概要図であって、この実験では、２個の被抗菌処理物品９６,９６を、Ｌ型のピン状支持台Ｐに載せた状態で大型のケースＫ内に収容設置して、各々の被抗菌処理物品９６について抗菌処理を行なうものである。このように、ケースＫの内部に被抗菌処理物品９６を収容して抗菌処理を行なうのは気化した薬剤成分の濃度を測るためであるが、該ケースＫを大型とすることで室内に設置した状態に近い環境となっている。なお、前記開放空間容積Ｇ１を規定するケースＫの内容積は、前述したように１５,３６７,９６８ｍｍ３である。また図２９(ｂ)は、密閉状態での実験概要図であって、この実験では、シャーレ９５の開口を蓋で覆蓋することで、該シャーレ９５内が密閉となっている。なお、前記密閉空間容積Ｇ２を規定するシャーレ９５内の内容積は、６６,８６９ｍｍ３であり、前記開放空間容積Ｇ１は密閉空間容積Ｇ２の１１５倍となっている。 FIG. 29A is a schematic diagram of an experiment in a state opened to the atmosphere. In this experiment, two antibacterial treatment articles 96 and 96 are placed on an L-shaped pin-shaped support P. The antibacterial treatment is performed on each antibacterial treatment article 96 by being housed and installed in a large case K. As described above, the antibacterial treatment article 96 is accommodated in the case K and is subjected to the antibacterial treatment in order to measure the concentration of the vaporized drug component. The environment is close to the state. The internal volume of the case K that defines the open space volume G1 is 15,367,968 mm 3 as described above. FIG. 29B is a schematic diagram of an experiment in a sealed state. In this experiment, the inside of the petri dish 95 is sealed by covering the opening of the petri dish 95 with a lid. The internal volume in the petri dish 95 that defines the sealed space volume G2 is 66,869 mm 3 , and the open space volume G1 is 115 times the sealed space volume G2.

図３０は、実験５の実験結果を示す写真である。図３０(ａ)は、大気開放状態での抗菌処理結果を示す写真であり、図３０(ｂ)は、密閉状態での抗菌処理結果を示す写真である。両写真から明らかなように、薬剤Ｃがローズウッドオイルの場合では、大気開放状態および密閉状態での抗菌効果に殆ど違いが見られず、前記実験１における抗菌成分浮遊領域において薬剤Ｃの濃度が高く、これにより大気開放状態であっても十分な抗菌効果が現出することが確認された。一方、図３０(ｃ)は、ラベンダーティートゥリーオイルからなる薬剤Ｃの大気開放状態での抗菌処理結果を示す写真であり、図３０(ｄ)は、ラベンダーティートゥリーオイルからなる薬剤Ｃの密閉状態での抗菌処理結果を示す写真である。両写真から明らかなように、薬剤Ｃがラベンダーティートゥリーオイルの場合では、密閉状態より大気開放状態の方が抗菌効果が僅かに劣っているものの、大気開放状態においても十分な抗菌効果が得られることが確認できる。すなわち、ラベンダーティートゥリーオイルからなる薬剤Ｃの場合では、前記ローズウッドオイルからなる薬剤Ｃの場合と同様に、前記実験１における抗菌成分浮遊領域においての薬剤Ｃの濃度は、大気開放状態、密閉状態に拘わらず抗菌成分浮遊領域外の雰囲気中と比べて最も高く、これにより大気開放状態であっても十分な抗菌効果が現出することが確認された。従って、本願の抗菌方法では、密閉状態においては好適な抗菌効果が得られることは勿論、大気開放状態であっても密閉状態と同等の抗菌効果が得られることが確認できた。   FIG. 30 is a photograph showing the experimental results of Experiment 5. FIG. 30 (a) is a photograph showing the antibacterial treatment result in the open air state, and FIG. 30 (b) is a photograph showing the antibacterial treatment result in the sealed state. As is apparent from both photographs, when the drug C is rosewood oil, there is almost no difference in the antibacterial effect in the open atmosphere and the sealed state, and the concentration of the drug C in the antibacterial component floating region in the experiment 1 is It was confirmed that a sufficient antibacterial effect appeared even in an open state. On the other hand, FIG. 30 (c) is a photograph showing the antibacterial treatment result of the medicine C made of lavender tea tree oil in the open air state, and FIG. 30 (d) is a sealed state of the medicine C made of lavender tea tree oil. It is a photograph which shows the antibacterial processing result in. As is clear from both photographs, when the drug C is lavender tea tree oil, the antibacterial effect is slightly inferior in the open air state than in the sealed state, but a sufficient antibacterial effect is obtained even in the open air state. I can confirm that. That is, in the case of the medicine C made of lavender tea tree oil, the concentration of the medicine C in the antibacterial component floating region in the experiment 1 is in an open air state, a sealed state, as in the case of the medicine C made of the rosewood oil. Regardless of the antibacterial component, it was the highest compared to the atmosphere outside the floating region, and it was confirmed that a sufficient antibacterial effect appeared even in an open atmosphere. Therefore, in the antibacterial method of the present application, it was confirmed that a suitable antibacterial effect can be obtained in a sealed state, and that an antibacterial effect equivalent to that in a sealed state can be obtained even in an open atmosphere.

(実験６) 薬剤付与部の材質の違いによる抗菌効果検証
実験６は、薬剤付与部の材質の違いによる抗菌効果の現出の違いを検証するための実験で、図３１に示すように、３種類の薬剤付与部を準備して、各薬剤付与部に規定量の薬剤Ｃを付与した場合の抗菌効果を比較した。なお、実験条件は次のようである。
＜条件＞
・薬剤：ローズウッドオイル
・薬剤量：０.０４１ｍｌ
・設置態様：垂直対向・密閉状態
・薬剤付与部：大きさは３種類とも円形で、直径は７０ｍｍ
・研磨布紙(拡張紙)(Ｐ４００)
・濾紙(ＡＤＶＡＮＴＥＣ社製)
・フェルト(ポリエステル１００％)((株)大創産業社製)
・抗菌処理間隔Ｄ２：５ｍｍ
・周囲温度：２５℃ (Experiment 6) Antibacterial effect verification due to difference in material of drug application part Experiment 6 is an experiment for verifying the difference in appearance of the antibacterial effect due to difference in material of the drug application part. Different types of drug application units were prepared, and the antibacterial effects when a prescribed amount of drug C was applied to each drug application unit were compared. The experimental conditions are as follows.
<Conditions>
・ Drug: Rosewood oil ・ Drug volume: 0.041 ml
・ Installation mode: Vertically facing, sealed state ・ Drug application part: All three types are circular, and the diameter is 70 mm
・ Abrasive cloth (extended paper) (P400)
・ Filter paper (manufactured by ADVANTEC)
・ Felt (100% polyester) (manufactured by Daiso Sangyo Co., Ltd.)
・ Antimicrobial treatment interval D2: 5 mm
・ Ambient temperature: 25 ℃

図３１(ａ)は、抗菌成分を含まない精製水を研磨布紙に滴下した写真である。研磨布紙に滴下した精製水は、殆ど広がることなく滴下した状態のレンズ状となっている。図３２(ａ)は、図３１(ａ)に示す精製水が付与された研磨布紙を、被抗菌処理物品９６における寒天培地の表面に対向させて抗菌処理を行なった結果を示す写真である。この場合には、精製水に抗菌成分が含まれていないから、当然のことながら被抗菌処理物品９６における寒天培地の表面全体に菌のコロニーが形成される。なお、図３２(ａ)に示す被抗菌処理物品９６をコントロールとして、各薬剤付与部毎の抗菌効果を検証する。   FIG. 31 (a) is a photograph in which purified water containing no antibacterial component is dropped onto a polishing cloth. The purified water dripped onto the polishing cloth is in the form of a lens that is dripped almost without spreading. FIG. 32 (a) is a photograph showing the result of antibacterial treatment with the abrasive cloth paper provided with purified water shown in FIG. 31 (a) facing the surface of the agar medium in the antibacterial treatment article 96. . In this case, since the antibacterial component is not contained in the purified water, it is a matter of course that fungal colonies are formed on the entire surface of the agar medium in the antibacterial treatment article 96. Note that the antibacterial effect of each drug application unit is verified using the antibacterial article to be processed 96 shown in FIG. 32 (a) as a control.

図３１(ｂ)は、研磨布紙に薬剤Ｃを滴下した場合の写真であって、該研磨布紙に滴下した薬剤Ｃは、該研磨布紙の表面全体に広がっている。図３２(ｂ)は、図３１(ｂ)に示す薬剤Ｃが付与された研磨布紙を、被抗菌処理物品９６における寒天培地の表面に対向させて抗菌処理を行なった結果を示す写真である。図３１(ｂ)および図３２(ｂ)から明らかなように、寒天培地の表面において研磨布紙の薬剤Ｃが拡張された部分と対向する部分では抗菌効果が顕著に現出することが確認された。   FIG. 31 (b) is a photograph when the medicine C is dropped on the polishing cloth, and the medicine C dropped on the polishing cloth spreads over the entire surface of the polishing cloth. FIG. 32 (b) is a photograph showing the results of antibacterial treatment with the abrasive cloth paper to which the medicine C shown in FIG. 31 (b) is applied facing the surface of the agar medium in the antibacterial treatment article 96. . As is clear from FIG. 31 (b) and FIG. 32 (b), it was confirmed that the antibacterial effect appears remarkably in the portion of the surface of the agar medium facing the portion where the chemical C of the polishing cloth was expanded. It was.

図３１(ｃ)は、濾紙に薬剤Ｃを滴下した場合の写真であって、該濾紙に滴下した薬剤Ｃは、濾紙に吸収されるために該濾紙の半径の略半分程度までしか広がらない。図３２(ｃ)は、図３１(ｃ)に示す薬剤Ｃが付与された濾紙を、被抗菌処理物品９６における寒天培地の表面に対向させて抗菌処理を行なった結果を示す写真である。図３１(ｃ)および図３２(ｃ)から明らかなように、該寒天培地の表面において濾紙の薬剤Ｃが拡張された部分と対向する部分では抗菌効果が顕著に現出することが確認された。そして、寒天培地の表面において濾紙の薬剤Ｃが浸透した部分と対向しない部分では菌のコロニーが形成されている。すなわち、研磨布紙と比べて薬剤Ｃが広がり難いことで、抗菌効果が現出する広さが研磨布紙よりも狭くなっている。   FIG. 31 (c) is a photograph of the case where the medicine C is dropped on the filter paper. The medicine C dropped on the filter paper is absorbed by the filter paper and spreads only to about half of the radius of the filter paper. FIG. 32 (c) is a photograph showing the result of antibacterial treatment with the filter paper to which the medicine C shown in FIG. 31 (c) is applied facing the surface of the agar medium in the antibacterial treatment article 96. As is clear from FIG. 31 (c) and FIG. 32 (c), it was confirmed that the antibacterial effect appeared remarkably in the part of the surface of the agar medium facing the part of the filter paper where the drug C was expanded. . And the fungal colony is formed in the part which does not oppose the part which the chemical | medical agent C of the filter paper infiltrated on the surface of the agar medium. That is, since the medicine C is difficult to spread compared with the abrasive cloth, the area where the antibacterial effect appears is narrower than the abrasive cloth.

図３１(ｄ)は、フェルトに薬剤Ｃを滴下した場合の写真であって、該フェルトに滴下した薬剤Ｃは、該フェルトの生地に直ちに吸収されて径方向へは殆ど拡張しない。図３２(ｄ)は、図３１(ｄ)に示す薬剤Ｃが付与されたフェルトを、被抗菌処理物品９６における寒天培地の表面に対向させて抗菌処理を行なった結果を示す写真である。図３１(ｄ)および図３２(ｄ)から明らかなように、該寒天培地の表面においてフェルトの薬剤Ｃが浸透した部分と対向する部分では顕著な抗菌効果が現出することが確認された。そして、寒天培地の表面においてフェルトの薬剤Ｃが浸透した部分と対向しない部分では菌のコロニーが形成されている。すなわち、研磨布紙や濾紙と比べて薬剤Ｃが広がり難いことで、抗菌効果が現出する広さが研磨布紙や濾紙よりも狭くなっている。   FIG. 31 (d) is a photograph of the case where the medicine C is dropped onto the felt. The medicine C dropped onto the felt is immediately absorbed by the felt fabric and hardly expands in the radial direction. FIG. 32 (d) is a photograph showing the result of antibacterial treatment with the felt to which the medicine C shown in FIG. 31 (d) is applied facing the surface of the agar medium in the antibacterial treatment article 96. As is clear from FIGS. 31 (d) and 32 (d), it was confirmed that a remarkable antibacterial effect appeared in the portion of the surface of the agar medium facing the portion where the felt drug C penetrated. And, on the surface of the agar medium, a fungal colony is formed in a portion not facing the portion where the felt drug C penetrates. That is, since the medicine C is difficult to spread compared with abrasive cloth paper and filter paper, the area where the antibacterial effect appears is narrower than that of abrasive cloth paper and filter paper.

従って、前記各実験の結果を纏めると、次のような事項が判明し、この実験結果に基づいて抗菌装置を構成すると共に抗菌方法を実行することで、好適な抗菌効果が得られる。
（A）薬剤付与面に付与した薬剤Ｃによる抗菌効果が現出する抗菌成分浮遊領域は、該薬剤付与面に付与した薬剤Ｃの付与量に依存するものではなく、薬剤付与面に対する該薬剤Ｃの付与面積に依存するものである。従って、薬剤付与面に対して、１回の抗菌処理に必要とされる量の薬剤Ｃを広げて付与することで、電子機器Ｔの抗菌処理を効率的に行なうことができる（実験１）。
（B）薬剤付与部は、薬剤Ｃが浸透しないソリットタイプの薬剤付与面を備えたものが、少ない薬剤Ｃで適切な抗菌効果を得るために有用である(実験６)。
（C）薬剤Ｃを付与した薬剤付与面と電子機器Ｔとの抗菌処理間隔Ｄ２は、２０ｍｍ以下とすることで抗菌装置において十分な抗菌効果が期待できる。特に、抗菌処理間隔Ｄ２を１５ｍｍ以下とすることで、効率的かつ適切な抗菌処理を行なうことができる(実験２)。
（D）薬剤Ｃを付与した薬剤付与面と電子機器Ｔとの配置は、垂直対向および水平対向の何れでも略同等の抗菌効果が得られる(実験３)。
（E）薬剤Ｃによる抗菌処理時間は、３０分〜６０分に設定することで抗菌効果を得ることができ、望ましくは６０分とすることで良好な抗菌効果が得られる(実験４)。
（F）室内等の気流が穏やかな場所に抗菌装置を置いて抗菌処理を行なう場合であれば、大気に開放した状態であっても好適な抗菌処理を行なうことが可能である。なお、密閉状態で抗菌処理を行なえば、抗菌処理装置自体を移動させながらでも(持ち運びの最中でも)良好な抗菌効果を得ることができる(実験５)。 Therefore, when the results of the experiments are summarized, the following matters are found, and a suitable antibacterial effect can be obtained by configuring the antibacterial device and executing the antibacterial method based on the experimental result.
(A) The antibacterial component floating region where the antibacterial effect due to the drug C applied to the drug application surface appears does not depend on the applied amount of the drug C applied to the drug application surface, and the drug C against the drug application surface Depends on the application area. Therefore, the antibacterial treatment of the electronic device T can be efficiently performed by spreading and applying the amount of the medicine C required for one antibacterial treatment to the medicine application surface (Experiment 1).
(B) A drug application unit having a solit type drug application surface that does not penetrate drug C is useful for obtaining an appropriate antibacterial effect with less drug C (Experiment 6).
(C) A sufficient antibacterial effect can be expected in the antibacterial device by setting the antibacterial treatment interval D2 between the drug application surface to which the drug C is applied and the electronic device T to 20 mm or less. In particular, by setting the antibacterial treatment interval D2 to 15 mm or less, efficient and appropriate antibacterial treatment can be performed (Experiment 2).
(D) The arrangement of the drug application surface to which the drug C is applied and the electronic device T can provide substantially the same antibacterial effect both in the vertical and horizontal directions (Experiment 3).
(E) The antibacterial effect can be obtained by setting the antibacterial treatment time with the drug C to 30 to 60 minutes, and preferably 60 minutes to obtain a good antibacterial effect (Experiment 4).
(F) If antibacterial treatment is performed by placing an antibacterial device in a place where airflow is gentle, such as indoors, it is possible to perform suitable antibacterial treatment even in a state where it is open to the atmosphere. If the antibacterial treatment is performed in a sealed state, a good antibacterial effect can be obtained even while the antibacterial treatment apparatus itself is moved (during carrying) (Experiment 5).

（変更例）
本願に係る電子機器の抗菌装置は、前記各実施例に例示の形態に限らず、様々に変更することが可能である。
(１)実施例１および実施例２では、複数の薬剤付与プレートＢ１,Ｂ２を備えるようにしてもよい。このように複数の薬剤付与プレートを設けた場合には、電子機器Ｔを複数の方向から同時に抗菌処理することができ、抗菌処理の効率化を図り得る。
(２)前記薬剤拡散間隔Ｄ１は、薬剤Ｃの滴下量や粘性等の条件により適宜変更してもよい。
(３)別体に構成された薬剤拡張手段と薬剤付与部とが相対的にスライド変位する形態(実施例１、２)では、前記薬剤拡散間隔Ｄ１を保持しながらスライド変位して薬剤Ｃを薬剤付与面へ適切に広げることができれば、実施例１または２に例示した構成に限定されるものではない。また、別体に構成された薬剤拡張手段と薬剤付与部とが相対的に近接・離間する形態(実施例３)では、薬剤拡張手段と薬剤付与部とが前記薬剤拡散間隔Ｄ１まで互いに近接して薬剤Ｃを薬剤付与面へ適切に広げることができれば、実施例３に示した回転変位する構成に限定されず、例えば薬剤拡張手段と薬剤付与部とが平行な姿勢で直線移動しながら近接・離間する構成であってもよい。
(４)実施例１では、第１スペーサ１８を本体Ｆ１に設けると共に、第２スペーサ３５を薬剤拡張部材Ｓ１に設けたが、これら第１スペーサ１８および第２スペーサ３５の両方を本体Ｆ１に設けてもよい。また、第１スペーサ１８および第２スペーサ３５は、薬剤付与プレートＢ１に設けてもよい。
(５)実施例３では、押付プレートＳ３を後方水平位置に回転させた際に、押付面７５が薬剤付与面７０が完全に当接するようにしてもよい。この場合でも、薬剤付与面７０と押付面７５とで薬剤Ｃを挟圧して、該薬剤Ｃを該薬剤付与面７０に広げて付与することが可能である。
(６)実施例４の抗菌装置Ｍ４では、図１８に示すように、本体Ｆ４のシートセット部８３の傾斜角度が大きい場合に、薬剤付与シートＢ４を該シートセット部８３に装着した後に薬剤Ｃを滴下すると、該薬剤Ｃが左右方向へ広がる拡散速度より該薬剤Ｃが下方向へ流下する流動速度が大きくなって、薬剤付与面８０の左右方向へ薬剤Ｃが十分に広がらないおそれがある。そこで、シートセット部８３の傾斜角度が大きい抗菌装置Ｍ４では、本体Ｆ４から起立させた両シート押え部材８１,８１の先端に薬剤付与シートＢ４の長手方向における両端部近傍を載せて、該薬剤付与シートＢ４の傾斜を緩やかにしたもとで薬剤Ｃを薬剤付与面８０に滴下するようにしてもよい。そして、薬剤Ｃを薬剤付与面８０の左右方向に広がらせた後に、薬剤付与シートＢ４をシート押え部材８１,８１でシートセット部８３へセットする。
(７)実施例４では、薬剤付与部である薬剤付与シートＢ４として、ＪＩＳ Ｒ６０１０に準拠したＰ２４０〜Ｐ８００の粒度の研磨布紙を例示したが、該薬剤付与シートＢ４は該研磨布紙に限定されない。すなわち、薬剤付与面８０が前記薬剤拡張凹凸Ｓ４と同等の粒度(ＪＩＳ Ｒ６０１０に準拠したＰ２４０〜Ｐ８００の粒度)の凹凸から構成され、かつ薬剤付与面８０から薬剤Ｃが浸透しないシート材であればよい。
(８)実施例４の薬剤付与シートＢ４は、ＪＩＳ Ｒ６０１０に準拠したＰ２４０〜Ｐ８００における単一粒度の研磨布紙やシート材に限らず、薬剤Ｃの滴下ポイントであるマーキング９０からの距離に応じて粒度を変化させた所謂「複合粒度」の研磨布紙やシート材であってもよい。薬剤付与面８０に滴下した薬剤Ｃの下方向への流動速度は、粒度が細かいほど速く、粒度が粗いほど遅くなることが実験により判っている。すなわち、拡張に有利なのは粒度が細かいものであるので、図１９(ａ)に示すように、薬剤付与面８０の薬剤拡張凹凸Ｓ４を、薬剤付与シートＢ４の折曲部分と長手方向の端部との中間部分を境界として、マーキング９０に近い部分は粗い粒度とし、該マーキング９０から遠い部分は細かい粒度としたものを提案し得る。また、図１９(ｂ)に示すように、マーキング９０を中心として、該マーキング９０が形成された部位は粗い粒度とし、該マーキング９０から遠ざかるほど漸次細かい粒度となるようにして、該マーキング９０を中心として同心円状に粒度を変化させたものも提案し得る。このように、薬剤付与面８０における薬剤拡張凹凸Ｓ４の粒度を、マーキング９０の位置を基準として変化させることにより、薬剤Ｃの種類や気温等による該薬剤Ｃの流動速度の変化に柔軟に対応することが可能となる。なお、粒度を変化させるパターンは、図１９(ａ)および図１９(ｂ)に示したものに限らず、様々に変更可能である。
(９)薬剤Ｃは、精油に限定されず、段落（００３５）に示したものが実施可能である。
(１０)前記実施例１〜４では、電子機器または該電子機器の一つである携帯電話Ｔを抗菌処理対象とした抗菌装置Ｍ１〜Ｍ４を例示したが、前記抗菌装置Ｍ１〜Ｍ４は、電子機器以外の物品、例えば指輪、時計、ネックレス等の貴金属類やアクセサリー類等の抗菌処理を行なうことも可能である。 (Example of change)
The antibacterial device of the electronic device according to the present application is not limited to the form illustrated in each of the embodiments, and can be variously changed.
(1) In Example 1 and Example 2, you may make it provide several chemical | medical agent provision plate B1, B2. Thus, when a some chemical | medical agent provision plate is provided, the electronic device T can be simultaneously antibacterial-treated from a plurality of directions, and the efficiency of the antibacterial treatment can be improved.
(2) The drug diffusion interval D1 may be appropriately changed depending on conditions such as the dripping amount and viscosity of the drug C.
(3) In the form (Examples 1 and 2) in which the medicine expanding means and the medicine applying section configured separately are slid relative to each other (Examples 1 and 2), the medicine C is slid and displaced while holding the medicine diffusion interval D1. The configuration is not limited to the configuration exemplified in Example 1 or 2 as long as it can be appropriately spread on the medicine application surface. Further, in the form (Example 3) in which the drug expansion means and the drug application section configured separately are relatively close to each other (Example 3), the drug expansion means and the drug application section are close to each other up to the drug diffusion interval D1. If the medicine C can be properly spread on the medicine application surface, the configuration is not limited to the rotational displacement shown in the third embodiment. For example, the medicine expansion means and the medicine application section move close to each other while moving linearly in a parallel posture. The structure which separates may be sufficient.
(4) In Example 1, while providing the 1st spacer 18 in the main body F1, and providing the 2nd spacer 35 in chemical | medical agent expansion member S1, both these 1st spacer 18 and 2nd spacer 35 are provided in the main body F1. May be. Moreover, you may provide the 1st spacer 18 and the 2nd spacer 35 in chemical | medical agent provision plate B1.
(5) In the third embodiment, when the pressing plate S3 is rotated to the rear horizontal position, the pressing surface 75 may be completely in contact with the medicine applying surface 70. Even in this case, the medicine C can be sandwiched between the medicine application surface 70 and the pressing surface 75 and the medicine C can be spread and applied to the medicine application surface 70.
(6) In the antibacterial device M4 of Example 4, as shown in FIG. 18, when the inclination angle of the sheet set part 83 of the main body F4 is large, the drug C is applied after the drug application sheet B4 is mounted on the sheet set part 83. Is dropped, the flow rate at which the drug C flows downward is greater than the diffusion rate at which the drug C spreads in the left-right direction, and the drug C may not spread sufficiently in the left-right direction of the drug application surface 80. Therefore, in the antibacterial device M4 having a large inclination angle of the sheet setting portion 83, the vicinity of both ends in the longitudinal direction of the drug application sheet B4 is placed on the tips of both sheet pressing members 81, 81 raised from the main body F4, and the drug application is performed. The medicine C may be dropped onto the medicine application surface 80 with the sheet B4 inclined gently. Then, after spreading the medicine C in the left-right direction of the medicine application surface 80, the medicine application sheet B4 is set to the sheet setting portion 83 by the sheet pressing members 81, 81.
(7) In Example 4, as the drug application sheet B4 which is the drug application unit, an example of the abrasive cloth paper having a particle size of P240 to P800 based on JIS R6010 is illustrated. However, the drug application sheet B4 is limited to the abrasive cloth paper. Not. That is, if the drug application surface 80 is composed of irregularities having the same particle size (particle size of P240 to P800 according to JIS R6010) as the drug expansion unevenness S4, and the drug material C does not penetrate the drug C, Good.
(8) The drug application sheet B4 of Example 4 is not limited to single-grain abrasive cloth or sheet material in P240 to P800 in accordance with JIS R6010, but according to the distance from the marking 90 that is the dropping point of the drug C It is also possible to use a so-called “composite particle size” abrasive cloth or sheet material in which the particle size is changed. Experiments have shown that the downward flow rate of the drug C dripped onto the drug application surface 80 is faster as the particle size is finer and slower as the particle size is coarser. That is, since the particle size is advantageous for the expansion, as shown in FIG. 19 (a), the drug expansion unevenness S4 of the drug application surface 80 is formed with a bent portion and a longitudinal end of the drug application sheet B4. A portion close to the marking 90 can be proposed with a coarse particle size, and a portion far from the marking 90 can be provided with a fine particle size. Further, as shown in FIG. 19 (b), with the marking 90 as the center, the portion where the marking 90 is formed has a coarse particle size, and the particle size gradually becomes finer as the distance from the marking 90 increases. It can also be proposed to change the particle size concentrically as the center. In this way, by changing the particle size of the drug expansion unevenness S4 on the drug application surface 80 with reference to the position of the marking 90, it is possible to flexibly cope with changes in the flow rate of the drug C depending on the type of the drug C, the temperature, and the like. It becomes possible. The pattern for changing the granularity is not limited to those shown in FIGS. 19A and 19B, and can be variously changed.
(9) The medicine C is not limited to essential oil, and the one shown in paragraph (0035) can be implemented.
(10) In the first to fourth embodiments, the antibacterial devices M1 to M4 that are the target of the antibacterial treatment of the electronic device or the mobile phone T that is one of the electronic devices are exemplified, but the antibacterial devices M1 to M4 are electronic devices. It is also possible to perform antibacterial treatment of articles other than equipment, for example, precious metals such as rings, watches, necklaces, and accessories.

１６ ガイドレール(スライド手段)，１８ 第１スペーサ(支持手段)
２５,５０,７０,８０ 薬剤付与面，３３ 突部(スライド手段)，３４ 薬剤均し縁部
３５ 第２スペーサ(支持手段)，４２ リブ(支持手段)
４４ ガイドレール(スライド手段)，５５ 薬剤均し端部，６２ 支持部材(支持手段)
６３ 当接部材(支持手段)，６５ 枢支軸(回転支持手段)，７５ 押付面，Ｃ 薬剤
Ｄ２ 抗菌処理間隔(間隔)，Ｆ１,Ｆ２,Ｆ３,Ｆ４ 本体
Ｂ１,Ｂ２,Ｂ３ 薬剤付与プレート(薬剤付与部)，Ｂ４ 薬剤付与シート(薬剤付与部)
Ｔ 携帯電話(電子機器)，Ｓ１ 薬剤拡張部材(薬剤拡張手段)
Ｓ２ 薬剤拡張端部(薬剤拡張手段)，Ｓ３ 押付プレート(薬剤拡張手段)
Ｓ４ 薬剤拡張凹凸(薬剤拡張手段)
８１ シート押え部材(支持手段)，８２ 支持バー８２(支持手段)
８３ シートセット部 16 Guide rail (sliding means), 18 First spacer (supporting means)
25, 50, 70, 80 Drug application surface, 33 Projection (slide means), 34 Drug leveling edge 35 Second spacer (support means), 42 Rib (support means)
44 guide rail (sliding means), 55 drug leveling end, 62 support member (support means)
63 abutting member (support means), 65 pivot shaft (rotation support means), 75 pressing surface, C medicine D2 antibacterial treatment interval (interval), F1, F2, F3, F4 main body B1, B2, B3 medicine application plate ( Drug application unit), B4 Drug application sheet (Drug application unit)
T mobile phone (electronic device), S1 drug expansion member (drug expansion means)
S2 drug expansion end (drug expansion means), S3 pressing plate (drug expansion means)
S4 Drug expansion unevenness (drug expansion means)
81 Sheet pressing member (support means), 82 Support bar 82 (support means)
83 Sheet set part

Claims (11)

電子機器を抗菌処理する抗菌装置であって、
本体に配設され、抗菌成分を含む液状の薬剤の浸透が不能な薬剤付与面を有する薬剤付与部と、
前記本体および前記薬剤付与部の少なくとも一方に設けられ、前記電子機器を前記薬剤付与面から離して該薬剤付与面に正対するよう支持する支持手段と、
前記薬剤付与部とは別体に構成され、前記薬剤を前記薬剤付与面に広げる薬剤拡張手段とを備え、
前記薬剤付与部は、前記支持手段で支持された前記電子機器に前記薬剤付与面が対向するよう前記本体に配設され、
前記薬剤拡張手段は、前記薬剤付与面と対面可能な押付面を有し、回転支持手段により、前記薬剤付与面に滴下した薬剤の液滴より狭い案内空間を設けて該薬剤付与面に該押付面が対向する近接位置と、該押付面が該薬剤付与面から離間した退避位置との間で回転変位可能に前記本体に配設され、
前記薬剤拡張手段は、前記薬剤付与面に滴下した薬剤を、前記回転支持手段による該薬剤拡張手段の前記近接位置への回転変位により、薬剤付与面と前記押付面とで挟圧して該薬剤付与面へ広げるよう構成し、
前記薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、前記支持手段で支持した前記電子機器を抗菌処理するよう構成した
ことを特徴とする電子機器の抗菌装置。 An antibacterial device for antibacterial treatment of electronic equipment,
A drug application portion disposed on the main body and having a drug application surface incapable of penetrating a liquid drug containing an antibacterial component;
A support means provided on at least one of the main body and the drug application section, and supporting the electronic device so as to face the drug application surface away from the drug application surface;
The drug application unit is configured separately from the drug application unit, and includes a drug expansion unit that spreads the drug on the drug application surface ,
The drug application part is disposed in the main body so that the drug application surface faces the electronic device supported by the support means,
The drug expansion means has a pressing surface that can face the drug application surface, and the rotation support means provides a guide space that is narrower than a drug droplet dropped on the drug application surface, thereby pressing the drug application surface. Disposed on the main body so as to be rotationally displaceable between a proximity position where the surfaces face each other and a retreat position where the pressing surface is separated from the drug application surface;
The drug expanding means is configured to apply the drug by dropping the drug dropped on the drug applying surface between the drug applying surface and the pressing surface by rotational displacement of the drug expanding means to the proximity position by the rotation support means. Configured to spread to the surface,
An antibacterial device for an electronic device, wherein the antibacterial component contained in the drug vaporized from the drug spread on the drug application surface is subjected to an antibacterial treatment on the electronic device supported by the support means . 電子機器を抗菌処理する抗菌装置であって、
本体の上面に設けられたシートセット部と、
前記本体と別体のシート状に形成されると共に、抗菌成分を含む液状の薬剤の浸透が不能な薬剤付与面を有し、該薬剤付与面が傾斜するように前記シートセット部に沿わせて配設される薬剤付与部と、
前記本体に設けられ、前記電子機器を、前記シートセット部に沿わせて配設された前記薬剤付与部の薬剤付与面から離して該薬剤付与面に正対するよう支持する支持手段と、
前記薬剤付与面に設けられたＪＩＳ Ｒ６０１０に準拠したＰ２４０〜Ｐ８００の粒度の凹凸で構成され、薬剤付与面の傾斜上部に滴下される前記薬剤を該薬剤付与面に広げる薬剤拡張手段とを備え、
前記支持手段は、
前記本体における前記シートセット部の傾斜上部に設けられ、該シートセット部との間に前記薬剤付与部を挟んで該薬剤付与部の上部を保持する支持バーと、
シートセット部と重なるように倒伏してシートセット部に沿って配設された薬剤付与部を保持する倒伏姿勢と、シートセット部から起立した起立姿勢との間で姿勢変位可能な枠状のシート押え部材とを備え、
起立姿勢の前記シート押え部材で前記薬剤付与部を支持して、前記シートセット部に沿って配設された薬剤付与部の薬剤付与面の傾斜よりも緩い傾斜で該薬剤付与面を保持して、薬剤付与面の傾斜上部に前記薬剤を滴下可能に構成され、
前記シートセット部に沿わせて配設された前記薬剤付与部の前記薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、前記支持バーおよび倒伏姿勢のシート押え部材で支持した前記電子機器を抗菌処理するよう構成した
ことを特徴とする電子機器の抗菌装置。 An antibacterial device for antibacterial treatment of electronic equipment,
A sheet set portion provided on the upper surface of the main body,
Formed in a separate sheet form from the main body, and has a drug application surface that is incapable of penetrating a liquid drug containing an antibacterial component, along the sheet set portion so that the drug application surface is inclined A drug application unit disposed;
Support means provided on the main body and supporting the electronic device so as to face the drug application surface away from the drug application surface of the drug application unit disposed along the sheet set unit;
It consists of pre-Symbol granularity of P240~P800 conforming to JIS R6010 provided in drug imparting surface irregularities, and a drug expansion means to expand the agent to be dropped on the inclined upper portion of the drug applied surface agent imparting surface ,
The support means is
A support bar that is provided on an inclined upper portion of the sheet set portion in the main body, and holds the upper portion of the drug application portion with the drug application portion sandwiched between the sheet set portion;
A frame-like sheet whose posture is displaceable between a lying posture that holds the medicine application portion disposed so as to overlap the sheet setting portion and that is disposed along the sheet setting portion, and a standing posture that stands up from the sheet setting portion A holding member,
The medicine application part is supported by the sheet pressing member in a standing posture, and the medicine application surface is held with an inclination gentler than the inclination of the medicine application surface of the medicine application part disposed along the sheet set part. , Configured to be able to drop the drug on the inclined upper portion of the drug application surface,
The antibacterial component contained in the drug vaporized from the drug spread on the drug application surface of the drug application part disposed along the sheet set part was supported by the support bar and the sheet pressing member in a lying posture. The electronic device is configured to antibacterial treatment
An antibacterial device for electronic equipment. 電子機器を抗菌処理する抗菌装置であって、
抗菌成分を含む液状の薬剤の浸透が不能な薬剤付与面を有し、本体に該薬剤付与面が傾斜するように配設された薬剤付与部と、
前記本体および前記薬剤付与部の少なくとも一方に設けられ、前記電子機器を前記薬剤付与面から離して該薬剤付与面に正対するよう支持する支持手段と、
前記薬剤付与面に設けられたＪＩＳ Ｒ６０１０に準拠したＰ２４０〜Ｐ８００の粒度の凹凸で構成され、前記薬剤を前記薬剤付与面に広げる薬剤拡張手段とを備え、
前記薬剤拡張手段は、前記薬剤付与面の傾斜上部に設定された該薬剤付与面への前記薬剤の滴下位置より遠い領域を、滴下位置に近い領域より前記粒度が細かくなるよう構成し、
前記薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、前記支持手段で支持した前記電子機器を抗菌処理するよう構成した
ことを特徴とする電子機器の抗菌装置。 An antibacterial device for antibacterial treatment of electronic equipment,
A drug application portion having a drug application surface incapable of penetrating a liquid drug containing an antibacterial component, and disposed so that the drug application surface is inclined on the main body;
A support means provided on at least one of the main body and the drug application section, and supporting the electronic device so as to face the drug application surface away from the drug application surface;
It is composed of irregularities having a particle size of P240 to P800 conforming to JIS R6010 provided on the drug application surface, and includes a drug expansion means for spreading the drug on the drug application surface,
The drug expanding means is configured such that the area farther from the position where the drug is dropped onto the drug application surface set on the upper slope of the drug application surface is smaller than the area near the position where the drug is applied,
An antibacterial device for an electronic device, wherein the antibacterial component contained in the drug vaporized from the drug spread on the drug application surface is subjected to an antibacterial treatment on the electronic device supported by the support means . 電子機器を抗菌処理する抗菌装置であって、
本体に配設され、抗菌成分を含む液状の薬剤の浸透が不能な薬剤付与面を有する薬剤付与部と、
前記本体および前記薬剤付与部の少なくとも一方に設けられ、前記電子機器を前記薬剤付与面から離して該薬剤付与面に正対するよう支持する支持手段と、
前記薬剤付与部と別体に構成され、前記薬剤を前記薬剤付与面に広げる薬剤拡張手段とを備え、
前記薬剤付与部は、前記支持手段で支持された前記電子機器に前記薬剤付与面が対向するよう前記本体に固定され、
前記薬剤拡張手段は、スライド手段により前記薬剤付与部の薬剤付与面に沿ってスライド変位するよう前記本体に配設され、該薬剤付与面に対向しかつ該薬剤拡張手段のスライド変位方向と交差する方向へ延在する薬剤均し縁部を備え、
前記薬剤均し縁部は、該薬剤均し縁部と前記薬剤付与面との間に滴下される前記薬剤の液滴より狭い案内空間を設けて該薬剤付与面に対して非接触状態で対向し、
前記薬剤拡張手段は、前記薬剤均し縁部と前記薬剤付与面との間に滴下した薬剤を、前記案内空間において該薬剤均し縁部に沿って前記スライド変位方向と交差する方向へ導き、前記薬剤均し縁部で拡張した薬剤を、薬剤付与面に対して前記スライド手段によるスライド変位方向へ広げるよう構成し、
前記薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、前記支持手段で支持した前記電子機器を抗菌処理するよう構成した
ことを特徴とする電子機器の抗菌装置。 An antibacterial device for antibacterial treatment of electronic equipment,
A drug application portion disposed on the main body and having a drug application surface incapable of penetrating a liquid drug containing an antibacterial component;
A support means provided on at least one of the main body and the drug application section, and supporting the electronic device so as to face the drug application surface away from the drug application surface;
It is configured separately from the drug application unit, and comprises a drug expansion means for spreading the drug on the drug application surface,
The medicine application part is fixed to the main body so that the medicine application surface faces the electronic device supported by the support means,
The medicine expanding means is disposed in the main body so as to slide and displace along the medicine applying surface of the medicine applying section by a sliding means, and faces the medicine applying surface and intersects the sliding displacement direction of the medicine expanding means. With a drug leveling edge extending in the direction,
The drug leveling edge portion is provided in a non-contact state with the drug application surface by providing a guide space narrower than the drug droplet dropped between the drug leveling edge and the drug application surface. And
The medicine expanding means guides the medicine dropped between the medicine leveling edge and the medicine application surface in a direction intersecting the slide displacement direction along the medicine leveling edge in the guide space , The medicine expanded at the medicine leveling edge is configured to spread in the slide displacement direction by the slide means with respect to the medicine application surface ,
The antibacterial component contained in the drug vaporized from the drug spread on the drug application surface is configured to antibacterialize the electronic device supported by the support means.
An antibacterial device for electronic equipment. 電子機器を抗菌処理する抗菌装置であって、
本体に配設され、抗菌成分を含む液状の薬剤の浸透が不能な薬剤付与面を有する薬剤付与部と、
前記本体および前記薬剤付与部の少なくとも一方に設けられ、前記電子機器を前記薬剤付与面から離して該薬剤付与面に正対するよう支持する支持手段と、
前記薬剤付与部と別体に構成され、前記薬剤を前記薬剤付与面に広げる薬剤拡張手段とを備え、
前記薬剤付与部は、スライド手段により、前記支持手段で支持された前記電子機器に前記薬剤付与面が対向した位置および該電子機器から該薬剤付与面が退避した位置の間でスライド変位するよう前記本体に配設され、
前記薬剤拡張手段は、前記本体における前記薬剤付与部の移動経路上に設けられ、前記薬剤付与面に対向しかつ前記薬剤付与部のスライド変位方向と交差する方向へ延在する薬剤均し端部を備え、
前記薬剤均し端部は、前記薬剤付与面に滴下される前記薬剤の液滴より狭い案内空間を該薬剤付与面との間に設けて該薬剤付与面に対して非接触状態で対向し、
前記薬剤拡張手段は、前記薬剤付与面に滴下した薬剤を、前記案内空間において前記薬剤均し端部に沿って前記スライド変位方向と交差する方向へ導き、前記薬剤均し端部で拡張した薬剤を、薬剤付与面に対して前記スライド手段による前記薬剤付与部のスライド変位方向へ広げるよう構成し、
前記薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、前記支持手段で支持した前記電子機器を抗菌処理するよう構成した
ことを特徴とする電子機器の抗菌装置。 An antibacterial device for antibacterial treatment of electronic equipment,
A drug application portion disposed on the main body and having a drug application surface incapable of penetrating a liquid drug containing an antibacterial component;
A support means provided on at least one of the main body and the drug application section, and supporting the electronic device so as to face the drug application surface away from the drug application surface;
It is configured separately from the drug application unit, and comprises a drug expansion means for spreading the drug on the drug application surface,
The medicine application section is slidably displaced by a slide means between a position where the medicine application surface is opposed to the electronic device supported by the support means and a position where the medicine application surface is retracted from the electronic device. Arranged in the body,
The medicine expanding means is provided on a movement path of the medicine application section in the main body, and faces the medicine application surface and extends in a direction intersecting the slide displacement direction of the medicine application section. With
The medicine leveling end portion is provided with a guide space narrower than the medicine droplet dropped onto the medicine application surface between the medicine application surface and faces the medicine application surface in a non-contact state.
The drug expanding means guides the drug dropped on the drug application surface in the guide space along the drug leveling end in a direction intersecting the slide displacement direction, and expands at the drug leveling end. Is configured to spread in the slide displacement direction of the drug application portion by the slide means with respect to the drug application surface ,
The antibacterial component contained in the drug vaporized from the drug spread on the drug application surface is configured to antibacterialize the electronic device supported by the support means.
An antibacterial device for electronic equipment. 前記薬剤拡張手段は、前記薬剤付与面の傾斜上部に設定された該薬剤付与面への前記薬剤の滴下位置より遠い領域を、滴下位置に近い領域より前記粒度が細かくなるよう構成した請求項２記載の電子機器の抗菌蔵置。 The drug expansion means, the distant region from the dropping position of the agent to the agent imparting surface inclined upper set have been agent applied surface of, claim and adapted to the particle size than the region near the dropping position becomes finer 2 Antibacterial storage of electronic devices as described. 前記支持手段は、前記電子機器の前記薬剤付与面に対向する面と該薬剤付与面との間隔が、０ｍｍより大きく２０ｍｍ以下となるように該電子機器を支持する請求項１〜６の何れか一項に記載の電子機器の抗菌装置。   The said support means supports the said electronic device so that the space | interval of the surface which opposes the said chemical | medical agent provision surface of the said electronic device and this chemical | medical agent provision surface may be larger than 0 mm and 20 mm or less. The antibacterial device for electronic equipment according to one item. 電子機器を抗菌処理する抗菌方法であって、
液体の浸透が不能な薬剤付与面の傾斜上部に、抗菌成分を含む液状の薬剤を滴下し、前記薬剤付与面に滴下した前記薬剤を、この薬剤付与面に設けられたＪＩＳ Ｒ６０１０に準拠したＰ２４０〜Ｐ８００の粒度の凹凸により該薬剤付与面に広げ、
前記薬剤付与面を、前記薬剤を滴下した状態より傾斜角度が大きくなるようにセットし、前記凹凸により薬剤を薬剤付与面に広げて、前記電子機器の該薬剤付与面に対向する被抗菌処理部分以上に広げ、
前記電子機器を、前記薬剤付与面に広げられた薬剤に前記被抗菌処理部分が非接触で正対するよう支持し、薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、電子機器を抗菌処理する
ことを特徴とする電子機器の抗菌方法。 An antibacterial method for antibacterial treatment of electronic equipment,
A liquid medicine containing an antibacterial component is dropped on the inclined upper portion of the medicine application surface where the liquid cannot penetrate, and the medicine dropped on the medicine application surface is added to P240 according to JIS R6010 provided on the medicine application surface. Spread to the drug application surface by unevenness of particle size of ~ P800,
The drug application surface is set so that the inclination angle is larger than the state where the drug is dripped , the drug is spread on the drug application surface by the unevenness , and the antibacterial treatment portion facing the drug application surface of the electronic device spread to more,
The electronic device is supported so that the antibacterial treatment part faces the drug spread on the drug application surface in a non-contact manner , and the antibacterial component contained in the drug vaporized from the drug spread on the drug application surface allows the electronic device to An antibacterial method for an electronic device, characterized by antibacterial treatment of the device. 電子機器を抗菌処理する抗菌方法であって、
液体の浸透が不能な薬剤付与面の一部分に、抗菌成分を含む液状の薬剤を滴下し、
前記薬剤付与面に滴下した前記薬剤を、該薬剤の液滴より狭い案内空間を設けて薬剤付与面と対向する薬剤拡張手段により該薬剤拡張手段に沿って広げると共に、薬剤拡張手段と薬剤付与面との相対的なスライド変位により、前記電子機器の該薬剤付与面に対向する被抗菌処理部分以上に広げ、
前記電子機器を、前記薬剤付与面に広げられた薬剤に前記被抗菌処理部分が非接触で正対するよう支持し、薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、電子機器を抗菌処理する
ことを特徴とする電子機器の抗菌方法。 An antibacterial method for antibacterial treatment of electronic equipment,
A liquid medicine containing an antibacterial component is dropped on a part of the medicine application surface where the liquid cannot penetrate,
The drug dripped onto the drug application surface is spread along the drug expansion means by a drug expansion means facing the drug application surface by providing a guide space narrower than the drug droplet, and the drug expansion means and the drug application surface With relative slide displacement, and spread over the antimicrobial treatment part facing the drug application surface of the electronic device,
The electronic device is supported so that the antibacterial treatment part faces the drug spread on the drug application surface in a non-contact manner, and the antibacterial component contained in the drug vaporized from the drug spread on the drug application surface allows the electronic device to Antibacterial treatment of equipment
An antibacterial method for electronic equipment. 電子機器を抗菌処理する抗菌方法であって、
液体の浸透が不能な薬剤付与面の一部分に、抗菌成分を含む液状の薬剤を滴下し、
前記薬剤付与面に滴下した前記薬剤を、該薬剤付与面に対して相対的な近接・離間方向へ回転変位が可能に構成され、近接位置において薬剤付与面に滴下した薬剤の液滴より狭い案内空間を設けて薬剤付与面と対向する薬剤拡張手段により、前記電子機器の該薬剤付与面に対向する被抗菌処理部分以上に広げ、
前記電子機器を、前記薬剤付与面に広げられた薬剤に前記被抗菌処理部分が非接触で正対するよう支持し、薬剤付与面に広げた薬剤から気化した該薬剤に含まれる抗菌成分により、電子機器を抗菌処理する
ことを特徴とする電子機器の抗菌方法。 An antibacterial method for antibacterial treatment of electronic equipment,
A liquid medicine containing an antibacterial component is dropped on a part of the medicine application surface where the liquid cannot penetrate,
The medicine dripped onto the medicine application surface is configured to be capable of rotational displacement in a direction close to and away from the medicine application surface, and is guided narrower than the medicine droplet dropped onto the medicine application surface at the proximity position. Spreading more than the antibacterial treatment part facing the drug application surface of the electronic device by means of drug expansion means facing the drug application surface with a space,
The electronic device is supported so that the antibacterial treatment part faces the drug spread on the drug application surface in a non-contact manner, and the antibacterial component contained in the drug vaporized from the drug spread on the drug application surface allows the electronic device to Antibacterial treatment of equipment
An antibacterial method for electronic equipment. 前記電子機器は、前記被抗菌処理部分が前記薬剤付与面に対して０ｍｍより大きく２０ｍｍ以下となるよう支持される請求項８〜１０の何れか一項に記載の電子機器の抗菌方法。   The antibacterial method for an electronic device according to any one of claims 8 to 10, wherein the electronic device is supported so that the antibacterial treatment portion is greater than 0 mm and 20 mm or less with respect to the drug application surface.
JP2010214611A 2009-09-30 2010-09-25 Antibacterial device and antibacterial method for electronic device Expired - Fee Related JP5751660B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010214611A JP5751660B2 (en) 2009-09-30 2010-09-25 Antibacterial device and antibacterial method for electronic device

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009228742 2009-09-30
JP2009228742 2009-09-30
JP2010214611A JP5751660B2 (en) 2009-09-30 2010-09-25 Antibacterial device and antibacterial method for electronic device

Publications (2)

Publication Number Publication Date
JP2011092700A JP2011092700A (en) 2011-05-12
JP5751660B2 true JP5751660B2 (en) 2015-07-22

Family

ID=44110301

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010214611A Expired - Fee Related JP5751660B2 (en) 2009-09-30 2010-09-25 Antibacterial device and antibacterial method for electronic device

Country Status (1)

Country Link
JP (1) JP5751660B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102158599B1 (en) * 2020-05-19 2020-09-22 전현수 UV phone sterilizer with wireless charger

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005095106A (en) * 2003-09-26 2005-04-14 Seiko Epson Corp Device for diffusing chemical
JP2005304404A (en) * 2004-04-22 2005-11-04 Seiko Epson Corp Chemical-radiating device
JP4296997B2 (en) * 2004-06-17 2009-07-15 セイコーエプソン株式会社 Drug release method and apparatus
KR200423534Y1 (en) * 2006-05-17 2006-08-10 김익성 Sterilizing apparatus of mobile device with emitting sweet fragrance

Also Published As

Publication number Publication date
JP2011092700A (en) 2011-05-12

Similar Documents

Publication Publication Date Title
KR101782198B1 (en) Cosmetic vessel
CN105705170B (en) Emanation system and application method
US20160228924A1 (en) Devices and methods for dispensing fluids and wiping surfaces
EP1781350A4 (en) A method of making a coated medical device
JP5751660B2 (en) Antibacterial device and antibacterial method for electronic device
JP2010536453A5 (en)
US20160310625A1 (en) Device and method for sustained release of fragrant compound
US20190217343A1 (en) Devices and methods for dispensing fluids and wiping surfaces
CN207121032U (en) One kind can sterilize type sticking film for mobile phone
CN205522993U (en) Colored drawing device
KR101197743B1 (en) Bubble removal pad for attaching screen protection film
JP2022087373A (en) Article for antimicrobial treatment of room air conditioner
CN204037194U (en) A kind of multifunctional closestool type pen container seat
DE102008058733A1 (en) Eyeglass lens cleaning device, has wick section sucking cleaning liquid from storage material, and wick system sucking evaporated cleaning liquid, where cleaning liquid is forwarded from wick section to cleaning surface
DE102009028424A1 (en) Cooling device, particularly household cooling device, for storage of organically growing cooling goods such as herbs or plants, has reefer container for retaining of cooling goods
JP2001328909A (en) Antibacterial and antifungal agent and method of controlling bacteria and fungi

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130920

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20130920

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140724

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140805

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141003

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150428

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150515

R150 Certificate of patent or registration of utility model

Ref document number: 5751660

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees